Investigation of bioactive compounds with anti-cancer potential in Carica papaya leaves by Nguyen, Thi ThanhThao
  
 
 
 
 
Investigation of bioactive compounds with anti-cancer potential  
in Carica papaya leaves  
Thao Thi Thanh Nguyen 
Master of Pharmacy (Pharmaceutical Science) 
Bachelor of Pharmacy (Honours) 
 
 
 
 
 
 
 
 
 
A thesis submitted for the degree of Doctor of Philosophy at 
The University of Queensland in 2016 
School of Pharmacy 
 
i 
Abstract 
 
Carica papaya is widely cultivated in tropical and subtropical countries and is used as a 
traditional medicine to treat a range of diseases as well as a foodstuff. Increasing 
anecdotal reports of the use of papaya leaf in successful cancer treatment and prevention 
have warranted the scientific authentication of the pharmacological properties of papaya 
leaf. An extensive review that was conducted at the beginning of this study further 
confirmed that more research is needed to explore the bioactive compounds in C. papaya 
for their anticancer activities. 
Fresh C. papaya leaves that were not sprayed with any chemicals were collected from 
Tropical Fruit World, a plantation orchard farm and research park in northern New South 
Wales, Australia. Chapter 2 of this thesis focuses on an investigation of the in vitro 
cytotoxicity on human oral squamous cell carcinoma SCC25 cells and non-cancerous 
human keratinocyte HaCaT cells, of eight different papaya leaf extracts, which were 
obtained by two extraction schemes – serial and parallel with a medium polar solvent 
(ethanol) and a polar solvent (water) at acidic and basic pH values. The 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method utilised for cytotoxicity 
assays has been thoroughly optimised for this study. The serial extraction scheme showed 
better discrimination of cytotoxic effects in comparison to the parallel scheme. Two acidic 
extracts, of the four serial extractions, demonstrated significantly selective cytotoxicity 
towards the cancer cells relative to non-cancerous cells. Total phenolic and flavonoid 
contents were measured and found to be elevated in these two acidic serial extracts.  
In Chapter 3, extractions of papaya leaf were carried out using traditional methods: leaf 
decoction/tea (Australian Aboriginal remedy for cancer treatment) prepared by boiling and 
concentrating papaya leaves in water, and papaya leaf juice prepared by mechanical 
crushing followed by squeezing of the juice from fresh leaves. In comparison with the leaf 
decoction, the leaf juice not only exhibited a more potent cytotoxic effect on SCC25 cancer 
cells, but also produced much greater selective effects on cancer cells as shown by tests 
on HaCaT cells. In this chapter, leaf juice and leaf decoction were also tested on colon 
cancer cells and the viability of neither H29 cells nor HCT116 cells was decreased by 
papaya leaf extracts; this indicates that the effect of papaya extracts on the survival of 
cancer cells is likely to be cancer-type specific. 
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The chemical compositions of the extracts were then explored using Ultra High 
Performance Liquid Chromatography-Quadrupole Time of Flight-Mass Spectrometry 
followed by chemometric analysis. Comparative analysis in Chapter 2 and multivariate 
data analysis in Chapter 3 were used to analyse the metabolomic profiles of papaya leaf 
extracts to identify tentatively the compounds responsible for the significantly selective 
anti-cancer effects towards the cancer cells. A customised personal compound database 
library consisting of 1,574 entries of plant-derived compounds with reported anticancer 
activities was assembled and curated to facilitate the putative identification of compounds. 
Comparative analysis of LC-MS profiles of serial extracts in Chapter 2 revealed that the 
principal compounds identified were flavonoids or flavonoid glycosides particularly 
compounds from the kaempferol and quercetin families, of which several have previously 
been reported to possess anticancer activities. Multivariate data analysis of chemical 
profiles of leaf juice and leaf decoction in Chapter 3 revealed 90 and 104 peaks in positive 
and negative ionisation mode respectively as discriminatory features from the chemical 
profile of leaf juice and >1500 putative compound IDs were obtained via database 
searching. Direct comparison of chromatographic and tandem mass spectral data to 
available reference compounds confirmed one feature as a match with its proposed 
authentic standard, namely pheophorbide A. However, despite pheophorbide A exhibiting 
cytotoxic activity on SCC25 cancer cells, it did not prove to be the compound principally 
contributing to the selective activity of leaf juice.  
Subsequently, the chemical composition of papaya leaf juice, which has the greatest 
selectivity in cytotoxic effects, was further explored via bioassay-guided fractionation using 
preparative chromatography. Thirteen fractions were isolated using preparative reversed 
phase HPLC and tested on SCC25 and HaCaT cells. The results suggested the possibility 
of multi-component additive effects among the fractions with different polarities and         
C. papaya probably belongs to the category of plants with a complement of active 
compounds. 
In conclusion, the results from this thesis provide further scientific evidence of the 
anticancer activities of C. papaya leaves. To the best of our knowledge, this is the first 
study to report the selective cytotoxic effect of papaya leaf juice on squamous carcinoma 
cells and the effects imparted by the long heating process of the Australian Aboriginal 
remedy preparation. Other key contributions of this study are the investigation of bioactive 
compounds in C. papaya leaf extracts by LC-MS based-metabolomics and detail 
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bioactivity-guided fractionation of papaya leaf juice with the highlight of potential additive 
interactions among its bioactive components. 
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Chapter 1: Literature Review 
  
2 
1.1 Foreword 
There are numerous anecdotal reports (in magazines, newspapers etc.) of patients with 
different types of cancer achieving good results following consumption of parts of papaya 
plant but a review of scientific research in this field could not be found. Therefore, we have 
comprehensively assessed the literature and gathered all research that has been 
performed in this area to present a review relating to the anti-cancer activity of Carica 
papaya, which was subsequently published in the Molecular Nutrition and Food 
Research journal. 
Certain changes have been made to include the review in this chapter, which also 
presents a general introduction about the importance of medicinal plants as anticancer 
agents and biology of C. papaya including its general and traditional uses. Copyright 
permission to use this material in the thesis has been obtained from the publisher, John 
Wiley and Sons. 
 
 
 
 
  
Nguyen, TTT, Parat, MO, Shaw, PN, Hewavitharana, AK, 2013. Anti-cancer activity 
of Carica papaya: A review. Molecular Nutrition and Food Research journal 
57(1):153-164. http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201200388 
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1.2 Medicinal Plants and Cancer 
1.2.1 The importance of medicinal plants in healthcare 
Significant evidence indicates that humans were using plants as medicines during the 
Middle Palaeolithic period, approximately 60,000 years ago (Fabricant and Farnsworth, 
2001). From that time, the use of traditional medicines, of which treatment by medicinal 
plants is the most popular form, has become widespread in many parts of the world, 
especially in developing countries. Up to 80% of the population of Africa, 40% of the 
population of China and Asia, and 40% of the population of South America are using 
traditional medicines to help meet their healthcare needs (World Health Organization, 
2002). In most developing countries, medicinal plants are relied upon as the primary 
source of medical treatment due to accessibility and affordability, and because they are 
deeply embedded in wider belief systems, such as the traditional Chinese medicine 
system (TCM), and the traditional Indian medicine system (Ayurveda). 
Meanwhile, in many developed countries, the use of medicinal plants as complementary 
and alternative medicines is becoming increasingly popular. A recent survey among 
Member States of the European Union reported that approximately 1,400 herbal drugs 
were used in the European Economic Community (World Health Organization, 2003). The 
percentage of the population that has used medicinal plants at least once comprises 48% 
in Australia, 70% in Canada, 42% in the United States (US), 38% in Belgium and 75% in 
France (World Health Organization, 2003). Concerns regarding the adverse effects of 
contemporary chemical drugs, questioning of the assumptions of allopathic medicine, and 
greater public access to health information have increased the use of medicinal plants in 
developed countries. In 2001, the World Health Organisation published two volumes of the 
WHO Monographs of Selected Medical Plants, with the most up-to-date scientific 
information on the safety, efficacy and quality of widely used herbal medicines in order to 
promote the proper use of medicinal plants throughout the world (Mahady, 2001). 
There is an estimated number of approximately 70,000 species of plants in the world that 
have been explored for medicinal purposes (Schippmann et al., 2006). The use of plants in 
medicine ranges from crude preparations or extracts, to refined extracts and individual 
bioactive compounds. In addition to the isolated compounds used directly as drug entities 
such as digoxin, digitoxin, morphine, reserpine, taxol, vinblastine and vincristine, drugs 
derived from medicinal plants can serve as drug leads for design, semi-synthesis and 
synthesis to produce novel substances of higher activity and/or lower toxicity, such as 
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metformin, nabilone, oxycodone (and other narcotic analgesics), taxotere, teniposide, 
verapamil and amiodarone (Fabricant and Farnsworth, 2001). Approximately 50% of 850 
small molecules introduced as drugs over the last 20 years were derived from medicinal 
plants, plant-derived or plant mimetics, meaning that the synthetic medicinal compounds 
were discovered from the study of plants (Fowler, 2006). 
Based on the past history of success in finding new compounds from natural products, 
coupled with the use of unexplored traditional knowledge, medicinal plants are predicted to 
remain a critical component in the search for new medicines to fight many of the complex 
diseases of contemporary society. 
 
1.2.2 An overview of cancer 
Cancer is a worldwide public health problem that is likely to affect almost every person on 
the planet, with the estimation that one in three people will develop cancer at some point 
during their lifetime. It is second only to heart disease as a leading cause of death in 
developed nations, and is among the three leading causes of death for adults in 
developing countries (Rang and Dale, 2012). In Australia, over 120,710 new cases were 
diagnosed in 2012, with the number set to rise to 150,000 by 2020, with prostate, 
colorectal, breast, melanoma and lung cancer comprising the largest categories 
(Australian Institute of Health and Welfare, 2012). Projections also indicate that deaths 
from cancer around the world will increase to more than 13.1 million in 2030 (World Health 
Organization, 2012). 
 
‘Cancer’ is a general name for a large group of diseases that can affect any part of the 
body. There are four characteristics that distinguish cancer cells from normal cells: 
uncontrolled proliferation; a lack of capacity to differentiate, which leads to loss of function; 
invasiveness; and the ability to metastasise (Hanahan and Weinberg, 2011, Hanahan and 
Weinberg, 2000). One crucial feature of cancer is the rapid creation of abnormal cells that 
grow beyond their usual boundaries and can then invade adjoining parts of the body and 
spread to other organs—a process referred to as ‘metastasis’. Most types of cancer are 
classified into one of five stages as illustrated in Figure 1 (National Cancer Institute, 2015).  
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Figure 1.1: Five stages of cancer (National Cancer Institute, 2015) 
 
The three main approaches for treating established cancer are surgical excision, 
irradiation and chemotherapy. Depending on the type of the tumour, the stage of tumour 
development and the general state of the patient’s health, a suitable therapy is used alone 
or in combination with other forms of therapy (Rang and Dale, 2012), with drug therapy 
use predominating in the twenty-first century (Amin et al., 2009). Most anticancer drugs 
are anti-proliferative by exerting an action during the S phase of the cell cycle, the part 
when DNA is replicated, and the resultant damage to DNA initiates apoptosis. Due to the 
general similarity between cancer cells and normal cells, anticancer drugs also affect the 
division of normal cells, and are subsequently likely to depress bone marrow, impair 
healing and impair growth. The first-line anticancer drugs such as doxorubicin, synthetic 
cisplatin and cyclophosphamide are highly toxic compounds with many side effects, 
including nausea, vomiting, sterility, hair loss and teratogenicity (Rang and Dale, 2012). 
However, there is little or no other option but to accept these effects due to the 
unavailability of more specific drugs. Hence, undoubtedly, more effort is needed to search 
for new anti-tumour agents that are specific to cancer cells in order to improve the 
treatment of cancer. 
 
1.2.3 Medicinal plants as anticancer agents 
Medicinal plants have played an important role in the development of contemporary 
anticancer drugs throughout the history of combating cancer. The effort to search for 
anticancer agents from plants began by the US National Cancer Institute (NCI) in 1957 
with the successful discovery of vinca alkaloids (vinblastine and vincristine) from 
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Catharanthus roseus (Johnson et al., 1963). As a result, from 1960 to 1982, an extensive 
program at the NCI screened around 114,000 extracts from an estimated 35000 plant 
samples for anticancer activity (Balunas and Kinghorn, 2005). Subsequently, a new natural 
products program using an in vitro human cancer cell line was initiated in 1987. Until the 
end of 1991, 28800 plant samples were collected from over 20 countries to be screened 
for chemotherapeutic activity (Cragg et al., 1993). A survey by Cragg et al. showed that, of 
the 87 clinically useful anticancer drugs, 62% are of natural origin or are modelled on 
natural product parents (Cragg et al., 1997). Table 1.1 lists seven plant-derived anticancer 
drugs that have received US Food and Drug Administration (FDA) approval for commercial 
production. 
 
Table 1.1: Plant-derived anticancer drugs approved by the US-FDA 
Drug Plant source Clinical use Reference 
Taxol Taxus brevifolia 
Ovarian and breast 
cancers 
(Wani et al., 1971, 
Dubois et al., 2003) 
Vinblastine and 
vincristine 
Catharanthus 
roseus 
Leukaemia, bladder 
and testicular 
cancers 
(Ngan et al., 2001, 
Dhamodharan et al., 
1995) 
Etoposide and 
teniposide 
Podophyllum 
peltatum 
Small-cell lung 
cancer, testicular 
cancer, lymphomas 
and other cancers 
(Van Maanen et al., 
1988, Huff and Kreuzer, 
1990) 
Topotecan 
Camptotheca 
acuminata 
Ovarian and small-
cell lung cancers 
(Arun and Frenkel, 
2001, Liew and Yang, 
2008) 
Irinotecan 
Camptotheca 
acuminata 
Metastatic colorectal 
cancer 
(Fujiwara and Minami, 
2010, Innocenti and 
Ratain, 2006) 
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Although many pharmaceutical companies have terminated their natural product discovery 
program in the last decade as the search for novel natural compounds was not rewarding, 
the natural product research keeps renewing silently, especially through academic sector 
collaborations (David et al., 2014).  Furthermore, the efficiency of the discovery process 
continues to be improved by the advances in ultra-sensitive analytical techniques and 
sophisticated structure prediction software for the rapid identification of novel bioactive 
compounds as well as the emergence of metabolomics for dealing with mixtures to identify 
potential biomarkers. Therefore, in view of the abundance of medicinal plants and history 
of successful anticancer drug development from natural products, it is realistic to believe 
that more potential anticancer compounds exist in nature and can be discovered using the 
advanced development in technology together with appropriate strategies and effort. 
 
1.3 Biology of Carica papaya L. 
Carica papaya L. (C. papaya, papaya) is a major fruit crop in all tropical and many 
subtropical regions of the world. It is known by the following common names (Parle and 
Gurditta, 2011, Lim, 2012, da Silva et al., 2007): 
 Australia: pawpaw or papaw 
 Brazil: mamao or papaia 
 China: fan mugua 
 Cuba: fruta bomba 
 France: papago, papaye or arbre de melon 
 India: papita, pepe, pappli or omakai 
 Indonesia: dangan-dangan or gedang castela 
 Philippines: kapaya or tapays 
 Thailand: malakaw or tengton. 
1.3.1 Classification 
The papaya is classified as follows: 
 kingdom: Plantae 
 subkingdom: Tracheobionta 
 superdivision: Spermatophyta 
 division: Magnoliophyta  
 class: Magnoliopsida 
 subclass: Dilleniidae  
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 order: Violales 
 family: Caricaceae  
 genus: Carica 
 species: Carica papaya. 
 
The classification of papaya has undergone many changes over the years. According to 
the most recent taxonomic revision, the family Caricaceae comprises six genera: Carica, 
Cyclicomorpha, Jarilla, Jacaratia, Horovitzia and Vasconcellea, with Carica papaya the 
only species in the genus Carica (Office of the Gene Technology Regulator, 2008). 
1.3.2 Origin and distribution 
There are different opinions on the origin of C. papaya; however, it is most likely that it 
originated in Southern Mexico and Costa Rica. Later, the Spanish introduced the papaya 
to the Caribbean and Asia during their exploration in the sixteenth century, from where the 
plant was distributed to other parts of the world (Office of the Gene Technology Regulator, 
2008, Parle and Gurditta, 2011). Nowadays, C. papaya is widely cultivated, with over 11.2 
million tonnes of fruit produced in an area of more than 440,000 hectares in 60 countries 
(Emmanuelle Bournay, 2012). Table 1.2 presents a list of the areas harvested and 
produced in the top 10 papaya producing countries of the world. 
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Table 1.2: Production of papaya fruit by the top 10 producing countries in 2010 
Region/country 
2010 production 
(tonnes) 
2010 areas 
harvested (Ha) 
India 4,713,800 112,400 
Brazil 1,871,300 34,357 
Nigeria 703,800 93,700 
Indonesia 695,214 8,100 
Mexico 616,215 14,180 
Colombia 263,178 8,852 
Ethiopia 232,400 10,100 
Democratic Republic of Congo 225,772 13,406 
Thailand 211,594 12,366 
Guatemala 200,000 3,800 
 
1.3.3 Plant description 
C. papaya is a fast growing, soft-wooded, herbaceous plant that reaches three to 10 
metres in height. The stem is single and hollow centred, and bears prominent scars from 
fallen leaves. The leaves are large (30 to 60 cm long), yellow-green to dark green in 
colour, palmately lobed, arranged spirally and clustered at the crown (Figure 1.2). 
Papaya plants are mostly dioecious (having male and female flowers on separate plants) 
or hermaphroditic (having bisexual flowers); are rarely monoecious (having both male and 
female flowers); and have fragrant, white or cream coloured flowers. Male flowers are 
borne on long stalks, while the pear-shaped female or cylindrical bisexual flowers are 
larger and borne on short peduncles in leaf axils along the main stem (Office of the Gene 
Technology Regulator, 2008). 
Plants begin bearing fruits approximately 10 to 14 months after germination. Fruits have 
various shapes: elongated oblong, spherical, ovoid, obovate or pyriform. The skin of 
immature fruit is green, hard and rich in white latex until becoming ripe, when it turns 
yellow or red-orange. The flesh is yellow-orange to pinkish-orange at maturity, juicy and 
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pleasantly sweet. Mature fruits contain many grey-black ovoid peppery seeds of about 5 
mm in length (Office of the Gene Technology Regulator, 2008) (Figure 1.2). 
 
 
                              (A)                                    (B)    (C) 
Figure 1.2: (A) Papaya tree, (B) Green papaya fruit and (C) Ripe papaya fruit 
 
1.3.4 Active constituents of various parts of Carica papaya 
Papaya fruit is recognised worldwide as a rich source of a variety of vitamins and minerals 
that are essential for wellbeing (US Department of Agriculture, 2012, Papaya Australia, 
2007). Table 1.3 highlights the key nutritional elements of papaya fruit. 
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Table 1.3: Nutritional values of Carica papaya fruit (per 100 g of edible portion) 
Nutrient 
Value from USDA 
nutrient database  
(US Department of 
Agriculture, 2012) 
Value from Papaya 
Australia  
(Papaya Australia, 2007) 
Energy 43 kcal 29 kcal 
Water 88.06 g 89.3 g 
Protein 0.47 g 0.4 g 
Total fat 0.26 g 0.1 g 
Cholesterol 0 mg 0 mg 
Total carbohydrates 10.82 g 6.9 g 
Sugars 7.82 g 12 g 
Dietary fibre 1.7 g 2.3 g 
Beta-carotene 274 µg 910 µg 
Calcium 20 mg 28 mg 
Vitamin A 47 µg 150 µg 
Vitamin C 60.9 mg 60 mg 
Riboflavin 0.027 mg 0.03 mg 
Thiamine 0.023 mg 0.03 mg 
Vitamin B6 0.038 mg NA 
Vitamin E 0.30 mg NA 
Vitamin K 2.6 µg NA 
Folate 37 µg NA 
Sodium 8 mg 7 mg 
Iron 0.25 g 0.5 mg 
Magnesium 21 mg 14 mg 
Niacin 0.357 mg 0.3 mg 
Potassium 182 mg 140 mg 
Zinc 0.08 mg 0.3 mg 
Phosphorus 10 mg NA 
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The fruit contains a broad spectrum of phytochemicals, including flavonoids (quercetin, 
kaempferol and myricetin) and carotenoids (β-carotene, lycopene, cryptoxanthin, 
violaxanthin and zeaxanthin), with different carotenoid profiles between yellow-fleshed and 
red-fleshed papaya (Chandrika et al., 2003). The milky latex from unripe fruits and other 
plant parts of the papaya is a rich source of different types of enzymes, such as papain, 
chymopapain, protease omega (Brocklehurst et al., 1985, Dubois et al., 1988b), glycyl-
endopeptidase and caricain (Dubois et al., 1988a, Azarkan et al., 2003). The presence of 
many phenolic compounds (such as protocatechuic acid, p-coumaric acid, caffeic acid, 
chlorogenic acid, 5,7-dimethoxycoumarin, kaempferol and quercetin) has been detected in 
papaya leaves (Canini et al., 2007), together with several alkaloids, such as carpaine, 
pseudocarpaine and dehydrocarpaine I and II (Imaga et al., 2009). Benzyl glucosinolate 
(BG) and its enzymatic hydrolysed product, benzyl isothiocyanate, have been found in the 
pulp, pericarp and especially in the seeds of the papaya (Nakamura et al., 2007, Miranda 
Rossetto et al., 2008). The seeds are also reported to be rich in proteins, lipids and crude 
fibre (Marfo et al., 1986). Figure 1.3 presents some of the important phytochemicals found 
in C. papaya. 
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Figure 1.3: Important phytochemicals found in different parts of Carica papaya 
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1.3.5 General and traditional uses 
With its high vitamin and mineral content and delicious sweet taste, papaya is a popular 
fruit worldwide. One medium papaya fruit (~350 g of edible portion) provides quantities of 
vitamins A and C that exceed the Dietary Reference Intakes established by the US Food 
and Nutrition Board for an adult’s minimum daily requirement (Directorate, 2005). The 
people of several Asian countries cook the green fruits, leaves, young shoots and flowers 
of the papaya as vegetables (Morton, 1987), and grind dried papaya seeds to use as 
pepper (Papaya Australia, 2007). Papain, a proteolytic enzyme that is a component of the 
milky papaya latex, has many important pharmaceutical and industrial applications (El 
Moussaoui et al., 2001). It is used in food biotechnology to produce chewing gums and 
dehydrated pulses and beans, for chill-proofing beer and for tenderising meat, and in the 
textile industry for degumming silk and softening wool (Office of the Gene Technology 
Regulator, 2008). Papain has also been employed as a component of soap, shampoo, 
toothpaste and skincare products (Morton, 1987). The medical applications of papain 
include its use in US FDA-approved topical preparations as an enzymatic debridement for 
necrotic tissue in burns, ulcers and other wounds (Ernst, 2002), and in the preparation of 
vaccines and drugs for various digestive ailments (Office of the Gene Technology 
Regulator, 2008). 
In traditional medicine, different parts of C. papaya, including its leaves, bark, roots, latex, 
fruit, flowers and seeds, have a wide range of reputed medicinal applications. In Jamaica, 
the ripe fruit is used as topical ulcer dressing to promote desloughing, granulation, healing 
and reducing odour in chronic skin ulcers (Hewitt et al., 2000). The green fruit is used for 
contraceptive purposes by traditional healers in Pakistan, India and Sri Lanka, and for 
various human and veterinary diseases, such as malaria, hypertension, diabetes mellitus, 
jaundice and intestinal helminthiasis in Nigeria (Lim, 2012). The leaves have been used to 
treat asthma, colic, fever and beriberi (thiamine deficiency) in India (Krishna et al., 2008, 
Gammulle et al., 2012); malaria and dengue fever in Sri Lanka, Pakistan and Malaysia 
(Ahmad et al., 2011, Gammulle et al., 2012, Subenthiran et al., 2013); and cancer in 
Vietnam and Australia (Otsuki et al., 2010, Lucas, 1914, Vien and Thuy, 2013). The milky 
juice (latex) is employed as a styptic and debridement when applied externally to burns 
and scalds (Lim, 2012). People in Laos, Cambodia and Vietnam use the latex to treat 
eczema and psoriasis (Amenta et al., 2000). The seeds have been used as a vermifuge, 
thirst quencher and pain alleviator (Krishna et al., 2008). Table 1.4 summarises the main 
traditional uses of different parts of the papaya in various localities around the world.  
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Table 1.4: Traditional uses of different parts of Carica papaya in various localities  
Plant part Method of use Medicinal use and locality Reference 
Ripe fruit 
Fruit juice, 
topical ulcer 
dressings and 
cosmetics 
(ointments and 
soaps) 
Warts, corns, sinuses and chronic 
forms of skin induration (scaly 
eczema and cutaneous tubercles) 
in the Caribbean, Philippines; 
chronic skin ulcers in Jamaica; 
and stomachic, digestive, diuretic, 
expectorant, sedative and tonic, 
bleeding piles and dyspepsia in 
India 
(Hewitt et 
al., 2000) 
Green fruit Juice 
Contraceptive and abortifacient in 
Pakistan, India and Sri Lanka; 
malaria, hypertension, diabetes 
mellitus, hypercholesterolaemia, 
jaundice, intestinal helminthiasis 
in Nigeria 
(Lim, 2012) 
Latex Topical use 
Dermatitis and psoriasis in Africa, 
Asia and Europe; and 
abortifacient in India and Malaysia 
(Lim, 2012, 
Amenta et 
al., 2000) 
Seeds 
Chewing, juice, 
powder, paste 
and pessaries 
Abortifacient, anthelminthic, thirst 
quencher, pain alleviator, 
bleeding piles and enlarged liver 
and spleen in the West Indies and 
India 
(Krishna et 
al., 2008) 
Leaves 
Fine paste, 
smoke, juice, 
infusion and 
decoction 
Heart tonic, febrifuge, vermifuge, 
colic, fever, beriberi, abortion, 
asthma in India; rheumatic 
complaints in the Philippines; and 
stomach troubles and cancer in 
Australia and Vietnam 
(Otsuki et 
al., 2010, 
Lucas, 
1914, Vien 
and Thuy, 
2013) 
Flowers 
Infusion and 
decoction 
Jaundice, cough, hoarseness, 
bronchitis, laryngitis and tracheitis 
in Asia 
(Krishna et 
al., 2008) 
Roots/barks 
Decoction, 
poultice and 
infusion 
Digestive, tonic and abortifacient 
in Australia; sore teeth in India; 
and syphilis in Africa 
(Lucas, 
1914, 
Otsuki et 
al., 2010) 
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1.3.6 Pharmacological activities 
Scientific studies have been undertaken to validate the traditional uses of different parts of 
the papaya, and have shown that C. papaya possesses anthelminthic, anti-protozoan, 
antibacterial, antifungal, anti-viral, anti-inflammatory, anti-hypertensive, hypoglycaemic and 
hypolipidaemic, wound healing, free radical scavenging, anti-sickling, neuroprotective, 
diuretic, abortifacient and antifertility properties. 
For example, Dawkins et al. observed significant antibacterial activity of papaya seed 
extracts against Bacillus cereus, Escherichia coli, Streptococcus faecalis, Staphylococcus 
aureus, Proteus vulgaris and Shigella flexneri (Dawkins et al., 2003). Another study 
unveiled the bacteriostatic property of papaya seeds and pulp against several 
enteropathogens, such as Bacillus subtilis, Enterobacter cloacae, Escherichia coli, 
Salmonella typhi, Staphylococcus aureus, Proteus vulgaris, Pseudomonas aeruginosa and 
Klebsiella pneumoniae with the highest zone of inhibition of 15.0 mm, and the authors 
correlated this activity with the scavenging action on superoxide and hydroxyl radicals of 
the anti-oxidative components in papaya (Osato et al., 1993). Giordani’s research showed 
the antifungal activity of papaya latex against Candida albicans with inhibitory effect of 
approximately 60%, and a synergistic action when mixing latex with fluconazole (Giordani 
et al., 1997, Giordani et al., 1996). 
The anthelminthic properties of papaya seeds and benzyl isothiocyanate, the main 
bioactive in the seeds, have been studied extensively (Hounzangbe-Adote et al., 2005, 
Kermanshai et al., 2001, Okeniyi et al., 2007). Air-dried papaya seeds have shown a 
significant effect in the treatment of human intestinal parasites without side effects when 
the stool clearance rate for the various types of parasites was between 71.4% and 100% 
(Okeniyi et al., 2007). Previous research has also found a positive correlation between 
anthelminthic activity and benzyl isothiocyanate content in papaya seeds, suggesting that 
benzyl isothiocyanate is the chief or sole anthelminthic. Further, the efficacy of papaya 
latex and cysteine proteinases from papaya against the gastrointestinal nematode 
Heligmosomoides polygyrus was suggested for a novel class of anthelminthics (Stepek et 
al., 2005, Satrija et al., 1995). 
An animal study demonstrated the wound-healing activity of C. papaya by reporting a 77% 
reduction in the wound area in streptozotocin-induced diabetic rats treated with an 
aqueous extract of C. papaya fruit, in comparison with only 59% reduction in the control 
group (Nayak et al., 2007). Another study by Mikhal’chik also showed that the wound 
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healing was accelerated and the severity of local inflammation in rats with burn wounds 
was reduced (Mikhal'chik et al., 2004). 
Carica papaya seed extract administered orally was found to induce a reversible 
contraceptive effect in male rats, rabbits and langur monkeys (Lohiya et al., 1994, Lohiya 
et al., 2002, Lohiya et al., 2000b). The antifertility effect was explained by degeneration of 
the germinal epithelium and germ cells, and reduction in the number of Leydig cells with 
the presence of vacuoles in the tubules (Udoh and Kehinde, 1999), or by changes in the 
plasma membrane of the head and mid-piece of human spermatozoa, leading to a total 
inhibition of in vitro motility (Lohiya et al., 2000a). 
When considering the effect of papaya on female reproduction, the results of 
investigations using a rat model suggested that normal consumption of ripe papaya during 
pregnancy might not cause any significant risk. However, the unripe or semi-ripe papaya 
could be unsafe in pregnancy because the high concentration of latex produces marked 
uterine contraction (Adebiyi et al., 2002). Carica papaya seed extract was also tested for 
its abortifacient potential in female Sprague Dawley rats in the experiments of Oderinde   
et al. The results showed that low doses of the crude extract of papaya seeds do not affect 
prenatal development, yet a high dose can adversely affect the foetus (Oderinde et al., 
2002). 
1.4 Carica Papaya and Cancer 
A book entitled The Most Wonderful Tree in the World—The Papaw Tree (Carica Papaia), 
published some 100 years ago, contains many anecdotes relating to the cure of breast, 
liver or rectal cancer after ‘treatment’ with Carica papaya preparations (Lucas, 1914). 
Subsequent reports have been published in various media that have detailed ‘the healing 
capabilities of an old Australian Aboriginal remedy—boiled extract of pawpaw leaves—
against cancer’ (Clarks, 2008, Gallo, 2014, Dillan, 2012, Barrett, 2012) and several other 
anecdotes relating ‘cancer cure’ following consumption of various preparations of papaya 
plant (Tietze, 2003). However, thorough scientific methodologies are necessary to 
separate facts from anecdote. At the beginning of this project, a comprehensive literature 
review was conducted to examine the scientific evidence that Carica papaya may be of 
use in the treatment and prevention of cancer (Nguyen et al., 2013). Different databases 
were searched for studies investigating the anticancer activities of Carica papaya, 
including PubMed, SciFinder, Web of Knowledge, Scopus and Embase. The search terms 
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used were ‘papaya’ and ‘anticancer’ or ‘antitumour’. The reference lists of related articles 
were also reviewed for additional relevant studies. 
It is important to note that Carica papaya is also known as ‘pawpaw’. Searching in some 
databases with the keyword ‘papaya’ also gave results for ‘pawpaw’; however, there are 
many reports of an anticancer effect among a totally different species - pawpaw Asimina 
triloba in the family of Annonaceae. Therefore, the bioactive compounds and the 
anticancer properties of Carica papaya from the family Caricaceae (Figure 1. 4A) need to 
be clearly distinguished from that of pawpaw Asimina triloba (Figure 1. 4B). Several 
articles have been found to include annonaceous acetogenins, effective chemotherapeutic 
agents in Asimina triloba, as bioactive compounds in Carica papaya (Oduola et al., 2007, 
Oduola et al., 2010, Tiwari et al., 2011, Ayoola and Adeyeye, 2010). 
   
                                (A)                                                                    (B)                
Figure 1.4: (A) Carica papaya and (B) Asimina triloba 
 
No human clinical trials were identified in our literature search, and no in vivo cancer 
studies have been conducted with extracts from any part of Carica papaya. Several case 
studies have been reported in a patent application as experimental examples, with very 
limited data (Morimoto et al., 2008). Case 1 was a 47-year-old female with stomach cancer 
that had metastasised to the pancreas. She drank approximately 750 mL of papaya leaf 
extract every day (one dried papaya leaf was boiled in a wooden vessel with 3,000 mL of 
water until concentrated to 750 mL) for two 90-day periods, with a 90-day break between 
the two periods. The pancreatic metastases disappeared, the tumour marker 
(carcinoembryonic antigen) dropped from 49 to 2.3 and the alpha-fetoprotein dropped from 
369 to 2.0, with no subsequent relapse. Other cases were reported without any specific 
data; however, long-term survival was observed for five lung cancer patients, three 
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stomach cancer patients, three breast cancer patients, one pancreatic cancer patient, one 
liver cancer patient and one blood cancer patient after drinking papaya leaf extract 
(Morimoto et al., 2008). 
More surprisingly, the number of previous in vitro cancer studies for Carica papaya is also 
limited, with only several cell culture-based studies. These studies are detailed briefly here 
and the scientific evidence derived from them summarised in Table 1.5. 
1.4.1 In vitro studies 
In 2002, Rahmat et al. screened, using human breast and liver cancer cell lines, the anti-
proliferative activity of pure lycopene and of both juice and extracted lycopene from 
papaya and watermelon (two fruits with high lycopene contents) (Rahmat et al., 2002). 
They reported that papaya juice and pure lycopene caused cell death in the liver cancer 
cell line Hep G2, with an IC50 of 20 mg/mL and 22.8 µg/mL, respectively. However, neither 
papaya juice nor pure lycopene showed any effect on the cell viability of breast cancer cell 
MDA-MB-21. The extracted lycopene from papaya juice did not display any effect on the 
proliferation of either cell line. The lack of action of the extracted lycopene was explained 
by multiple potential factors, such as the unsuccessful extraction process, the sensitivity of 
lycopene to light and oxidation, and microbial contamination during treatment (Rahmat et 
al., 2002). 
Although papaya is a significant source of glucosinolates and benzyl isothiocyanate (BITC) 
(Nakamura et al., 2007, Miranda Rossetto et al., 2008, Hu et al., 2010, Abdullah et al., 
2011, Sheu and Shyu, 1996, Tang, 1971), compounds which have been extensively 
studied for their anticancer activities, only one in vitro study was conducted to examine the 
apoptosis induction and inhibition of superoxide generation of n-hexane extract from 
papaya seed and pulp, in comparison with authentic BITC (Nakamura et al., 2007). In 
terms of inhibiting superoxide generation and the viability of acute promyelocytic 
leukaemia HL-60 cells, the papaya seed extract exhibited biological effects similar to BITC 
(IC50 was 10 µg/mL for generation of superoxide and 20 µg/mL for viability), but this was 
not observed for papaya pulp extract, even at a concentration of 100 µg/mL. The 
experimental results suggested that the effects of papaya seed extract might be due to 
electrophilic compounds, such as benzyl isothiocyanate. 
The effects of papaya flesh extracts on the viability of breast cancer cell line MCF-7 were 
examined concurrently with extracts from other fruits in two studies by Garcia-Solis et al. 
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(Garcia-Solis et al., 2009) and Jayakumar et al. (Jayakumar and Kanthimathi, 2011). In 
these studies, the authors also evaluated antioxidants in the fruits, such as β-carotene, 
polyphenols and flavonoids, to focus on the contribution of these antioxidants to inhibiting 
proliferation. Among 14 plant foods commonly consumed in Mexico (avocado, black 
sapote, guava, mango, prickly pear cactus [nopal], pineapple, grapes, tomato, pear, grape, 
tomato and papaya), Garcia-Solis et al. found that only papaya had a significant inhibitory 
effect on breast cancer cell growth. The extracts from papaya flesh at all five tested 
concentrations (0.01%, 0.5%, 1%, 2% and 4% v/v) resulted in inhibition of proliferation of 
MCF-7 cells after a 72-hour treatment, in which the extract at concentrations of 2% and 
4% caused 30% and 53% inhibition of cell proliferation, respectively. Interestingly, they 
found that the anti-proliferative effect in cancer cells did not correlate with the total 
phenolic content or antioxidant activity of the fruit extracts (Garcia-Solis et al., 2009). In 
contrast, Jayakumar et al. concluded that, among 13 fruits analysed, chiku, pomegranate, 
dragon fruit, lychee, durian, grape and apple, with higher sources of polyphenols and 
flavonoids, showed more protective effects against nitric oxide-induced proliferation of 
MCF-7 cells. In this study, an ethanolic extract from papaya pericarp inhibited cancer cell 
growth and scavenged nitric oxide (approximately 35% of nitric oxide was scavenged by 
the extract at concentration of 640 µg/mL) (Jayakumar and Kanthimathi, 2011). 
In a study by Rumiyati, cytotoxicity was observed when another breast cancer cell line, 
T47D, was treated with a protein fraction containing ribosome-inactivating proteins isolated 
from Carica papaya leaves, with an IC50 of 2.8 mg/mL (Rumiyati, 2006). The authors used 
immunocytochemistry to show the induction of apoptosis via the mitochondrial pathway: in 
breast cancer cells treated with the protein fraction, the expression of the tumour 
suppressor gene p53 was increased by approximately 59.4% and anti-apoptotic factor Bcl-
2 protein expression was decreased by approximately 63% in comparison to the control 
cells (Rumiyati, 2006). 
In 2008, Morimoto et al. patented the extremely high effectiveness of a brew/extract of 
different parts of papaya in water for the prevention, treatment or improvement of many 
types of cancers: stomach, lung, pancreatic, colon, liver, ovarian, neuroblastoma and other 
solid cancers, or lymphoma, leukaemia and other haematological cancers (Morimoto et al., 
2008). Although only data that tested papaya leaf extract (1.25 to 27 mg/mL) in an MTT 
assay and 3H-thymidine incorporation were presented, the anticancer effects were claimed 
for many other parts (roots, stems and fruit) of the papaya plant. The authors carried out 
gel filtration chromatography to fractionate the papaya leaf extract according to molecular 
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weight, and measured the antitumour effect of the different fractions. They found two 
fractions that were capable of suppressing the proliferation of the tested cancer cell lines; 
one fraction containing components with molecular weights of 1700, 1000, 700 and 300 
which absorbed ultraviolet (UV) light at the peak of 260 nm, and the other fraction 
containing compounds with molecular weights of 1700, 1000, 600, 400 and 200. 
In 2010, Otsuki et al. studied the effect of a similar aqueous papaya leaf extract (0.625 to 
20 mg/mL) on the growth of various tumour cell lines, including solid tumour and 
haematopoietic cell lines (Otsuki et al., 2010). They found that the proliferation of those 
cell lines was inhibited with no statistical difference between solid and haematopoietic 
tumour cell lines, and proposed the induction of apoptosis as one of the mechanisms 
involved in the growth inhibitory activity. In addition to this antitumour effect, the authors 
also reported the ability of papaya extract to increase the production of Th1 type cytokines, 
such as the interleukins IL-12p40 and IL-12p70, interferon (IFN-γ) and tumour necrosis 
factor (TNF-α), as well as the expression of 23 immunomodulatory genes in peripheral 
blood mononuclear cells. This study also attempted to identify the functional fraction in the 
papaya leaf extract by performing molecular weight cut-off selection with a cellulose 
membrane tube. The active components with growth inhibitory effect on tumour cells and 
immunomodulatory effects were identified to be present in the fraction with a molecular 
weight lower than 1,000 (Otsuki et al., 2010). 
More recently, a group of researchers from New South Wales, Australia, optimised the 
extraction conditions by using response surface methodology to obtain saponin-enriched 
water and ethanolic papaya leaf extracts (Vuong et al., 2015). They then assessed the 
cytotoxic effect of those extracts on pancreatic cancer cells derived from both primary and 
metastatic sites. Ethanolic extracts with a higher level of saponins were found to be more 
effective in inhibiting the proliferation of two pancreatic cancer cell lines. The correlation 
between saponin concentration and the activity suggested that further studies be 
undertaken to isolate individual saponins and characterise their bioactivity. 
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Table 1.5: In Vitro studies of extracts of different parts of Carica papaya 
Cancer cell lines Treatment Results Reference 
Breast cancer cell line (MDA-MB-231) 
Liver cancer cell line (Hep G2) 
Chang liver cell line (normal cell) 
Papaya fruit juice 
(0.28–28 mg/mL), 
lycopene extracted 
from papaya juice, 
pure lycopene 
(3–30 µg/mL) 
Pure lycopene and papaya juice inhibited viability of liver 
cancer cell line Hep G2 (IC50 = 22.8 µg/mL and 20 
mg/mL, respectively), but had no effect on breast cancer 
cells or normal cells. 
Lycopene extracted from papaya juice did not show any 
effect on either cell line. 
(Rahmat et 
al., 2002) 
Acute promyelocytic leukaemia HL-60 
cells 
 
n-hexane extract of 
papaya seed or pulp 
(0.1–100 µg/mL), pure 
benzyl isothiocyanate 
(10 µM) 
Extract of the seed dose-dependently inhibited the 
superoxide generation (IC50=10 µg/mL) and viability of 
cells (IC50 = 20 µg/mL), comparable to that of pure BITC. 
Extract of the pulp had no effects at 100 µg/mL. 
(Nakamura 
et al., 2007) 
Breast cancer cell line (MCF-7) 
Aqueous extract of 
papaya flesh 
(0.01–4% v/v) 
Significant inhibitory effect on proliferation of MCF-7 cells 
(p < 0.05). 
(Garcia-
Solis et al., 
2009) 
Breast cancer cell line (MCF-7) 
treated with sodium nitroprusside—a 
nitric oxide donor 
Ethanolic extract of 
papaya pericarp (50–
640 µg/mL) 
Inhibited cell growth in MCF-7 cells (decrease in cell 
viability). 
Scavenged nitric oxide in dose-dependent manner 
(about 35% of nitric oxide was scavenged by extract at 
640 µg/mL). 
(Jayakumar 
and 
Kanthimathi, 
2011) 
Breast cancer cell line (T47D) 
 
Protein fraction 
containing ribosome-
activating proteins 
isolated from leaves 
The protein fraction possessed cytotoxicity: IC50 = 2.8 
mg/mL). 
Induction of apoptosis by regulation of p53 and BCl-2 
protein expression (increased by 59.4% and decreased 
by 63%, respectively). 
(Rumiyati, 
2006) 
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Cancer cell lines Treatment Results Reference 
Stomach cancer cell line (AGS) 
Pancreatic cancer cell line (Capan-1) 
Colon cancer cell line (DLD-1) 
Ovarian cancer cell line (Dov-13) 
Lymphoma cell line (Karpas) 
Breast cancer cell line (MCF-7) 
Neuroblastoma cell line (T98G) 
Uterine cancer cell line (Hela) 
T cell leukaemia cell line (CD26 negative or negative 
Jurkat) 
Aqueous extract of 
papaya leaves (1.25–
27 mg/mL) 
Papaya leaf extract showed a 
concentration-dependent anticancer 
effect on each of the cancer cell lines, 
and suppressed DNA synthesis by 
suppressing the incorporation of 3H-
thymidine. (Morimoto 
et al., 2008) 
T cell lines (H9, Jurkat, Molt-4, CCRF-CEM and HPB-
ALL) 
Burkitt’s lymphoma cell lines (Ramos and Raji) 
Chronic myelogenous leukaemia cell line (K562) 
Cervical carcinoma cell line (Hela) 
Hepatocellular carcinoma cell lines (HepG2 and Huh-7) 
Lung adenocarcinoma cell line (PC14) 
Pancreatic epithelioid carcinoma cell line (Panc-1) 
Mesothelioma cell lines (H2452, H226, and MESO-4) 
Plasma cell leukaemia cell line (ARH77) 
Anaplastic large cell lymphoma cell line (Karpas-299) 
Breast adenocarcinoma cell line (MCF-7) 
Mesothelioma cell line (JMN) 
Pancreatic adenocarcinoma cell line (Capan1) 
Aqueous extract of 
papaya leaves (0.625–
20 mg/mL) 
Inhibited the proliferative responses of 
both haematopoietic cell lines and 
solid tumour cell lines. 
In peripheral blood mononuclear cells, 
papaya extract reduced the production 
of IL-2 and IL-4, and increased the 
production of Th1 types cytokines, 
such as IL-12p40, IL-12p70, IFN-γ and 
TNF-α. 
The expression of 23 
immunomodulatory genes was 
enhanced by the addition of papaya 
extract. 
(Otsuki et 
al., 2010) 
Human pancreatic cancer cells (Mia-Paca2 and ASPC-1) 
Saponin-enriched 
water and ethanolic 
extracts (100 µg/mL) 
Ethanolic extracts were more effective 
than or at least as effective as the 
chemotherapeutic agent, gemcitabine. 
(Vuong et 
al., 2015) 
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1.4.2 Phytochemicals in Carica papaya with reported anticancer activities 
In a review of major Australian tropical fruit biodiversity, Pierson et al. noted that, although 
papaya is a major tropical fruit, only a few pharmacological studies have been conducted 
for Carica papaya, in comparison to other fruits (Pierson et al., 2011). As mentioned 
above, no in vivo and limited in vitro studies have been completed to date to evaluate the 
effects of papaya extracts on cancer. However, despite these limited data, via indirect 
means, several studies have claimed health benefits of Carica papaya, including 
protection against cancer, due to the antioxidant properties of papaya extract (Indran et al., 
2008, Srikanth et al., 2010, Vijay and Sriram, 2010, Mi Hee et al., 2011, Oloyede et al., 
2011, Maisarah et al., 2013, Zunjar et al., 2014). There is continuous debate regarding 
whether high antioxidant activity is a good indicator of high anticancer activity, and no 
conclusive proof has been attained or presented thus far (Wang et al., 2011, Thornalley et 
al., 2011). Therefore, further investigation is required to assess the underlying mechanism 
of action, rather than attributing the putative anticancer effects to the antioxidant properties 
of the bioactive compounds in papaya. 
In the literature, among more than 5,000 compounds from plants that have been identified 
to be associated with anticancer properties (Huang et al., 2009), three groups of bioactive 
compounds have attracted considerable interest in anticancer studies: phenolics, 
carotenoids and glucosinolates. Pure compounds of these three groups have been 
extensively researched in in vivo and in vitro studies on many types of cell lines for their 
potential effects in cancer treatment and prevention. These bioactive compounds act via 
multiple mechanisms, such as cancer cell signalling, proliferation, apoptosis, migration and 
invasion, as well as angiogenesis and carcinogen elimination (Huang et al., 2009, Zhang, 
2004, Thornalley, 2002, Nakamura and Miyoshi, 2006, Wu et al., 2009, Navarro et al., 
2011, Wahle et al., 2011, Soobrattee et al., 2006, Tanaka et al., 2012, Van Breemen and 
Pajkovic, 2008), to exhibit in vitro and in vivo anticancer activities. Table 1.6 highlights 
(Column 4) their reported anticancer activities and proposed mechanisms of action. 
Concurrently, Table 1.6 summarises the results of the studies in which glucosinolates, 
phenolics and carotenoids have been determined in Carica papaya plant parts by different 
analytical methods. The availability of carotenoids, phenolics and glucosinolates in papaya 
is listed in Column 3 of the same table. Although the occurrence of these bioactive 
compounds is not restricted to Carica papaya; for example, glucosinolates are found in 
several vegetables, including Brassica species, while phenolics and carotenoids are 
abundant in many other fruits, such as mango, strawberry, tomato and passionfruit; the 
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availability and anticancer activities of the compounds recapitulated in Table 1.6 indicate 
that there are opportunities for new research to evaluate the anticancer potential of this 
medicinal plant. 
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Table 1.6: Glucosinolates, phenolics and carotenoids in Carica papaya and their potential mechanisms for anticancer activities 
Group 1: Glucosinolates (Benzyl glucosinolate: BG, Benzyl Isothiocyanate: BITC) 
Method of 
determination 
Compounds extracted Reported anticancer activities and mechanism of action of pure compounds 
HPLC-UV at 230 nm 
for BG and 254 nm 
for BITC 
BG: 12.7 µmol/g seed, < 0.03 
µmol/g pulp 
BITC: 4.6 µmol/g seed, < 0.003 
µmol/g pulp 
(Nakamura et al., 2007) 
In vivo animal studies in rat, mouse or hamster for inhibitory effect on: 
 intestinal carcinogenesis (Sugie et al., 1994) 
 hepatocarcinogenesis (Sugie et al., 1993) 
 lung tumourigenesis and metastasis (Kim et al., 2011a, Hecht et al., 2000, Hecht et al., 2002) 
 pancreatic carcinogenesis (Kuroiwa et al., 2006) 
 urinary bladder carcinogenesis (Okazaki et al., 2002) 
 mammary carcinogenesis (Warin et al., 2009). 
In vitro studies on: 
 MDA-MB-231 breast cancer cells (Kim et al., 2012) 
 MCF-7 breast cancer cells and HCT-116 (colon) cancer cells (Antony et al., 2012) 
 prostate cancer cells (Tsai et al., 2012, Liu et al., 2011) 
 human leukaemia HL-60 cells (Abe et al., 2012) 
 A375.S2 human melanoma cancer cells (Huang et al., 2012) 
 human pancreatic cancer (Ohara et al., 2011, Sahu and Srivastava, 2009, Boreddy et al., 
2011a, Boreddy et al., 2011b) 
 human osteogenic sarcoma U-2 OS cells (Wu et al., 2011) 
 AGS human gastric cancer cells (Ho et al., 2011) 
 human colon cancer HT29 cells (Lai et al., 2010) 
 SK-Hep1 human hepatocellular carcinoma cells (Hwang and Lee, 2008) 
Proposed mechanism (Zhang, 2004, Thornalley, 2002, Nakamura and Miyoshi, 2006, Wu et al., 
2009, Navarro et al., 2011): 
 inhibition of carcinogen-activating P450 enzymes 
 modulation of oxidative stress 
 depression of activation of carcinogens 
 acceleration of carcinogen disposal 
 induction of apoptosis 
 arrest of cell cycle progression 
 inhibition of angiogenesis 
 inhibition of histone deacetylation 
 regulation of translation initiation 
 inhibition of cell invasion and metastasis 
 inhibition of nuclear factor kappa B (NF-κB) pathways. 
HPLC-UV at 228 nm 
for BG 
GC with mass 
selective detector for 
BITC 
BG: ~ 4 µmol/g seed, ~ 0.04 
µmol/g pulp, ~ 2 µmol/g peel 
(decreases during development) 
BITC (decreases in peel and 
increases in pulp during 
development) 
(Miranda Rossetto et al., 2008) 
UV at 520 nm 
HPLC-UV at 235 nm 
Total glucosinolates: 18.7±0.8 
µmol/g seed 
(Hu et al., 2010) 
HPLC-UV at 214 nm 
BG: 6-8 µmol/g seed, 0.4-0.6 
µmol/g pulp (in young stage), 
not detected in mature pulp 
(Li et al., 2012) 
GC 
BITC: 141.7-342.7 ppm in seed, 
23.3-45.1 ppm in pericarp, 21.2-
43.1 ppm in pulp 
(Sheu and Shyu, 1996) 
GC 
BITC: 2,910 ppm in seed (ripe 
papaya),  4 ppm in pulp 
(Tang, 1971) 
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Group 2: Phenolics 
Method of 
determination 
Compounds extracted 
Reported anticancer activities and mechanism of action of pure 
compounds 
HPLC-DAD at 250-
380 nm 
HPLC-ESI-MS 
Peel: ferrulic acid (1.33-1.62 mg/g); caffeic acid 
(0.46-0.68 mg/g); rutin (0.1-0.16 mg/g); 
quercetin, myricetin, isorhamnetin: detected 
Flesh: only traces of caffeic acid, gallic acid, 
protocatechuic 
(Rivera-Pastrana et al., 2010) 
In vivo animal studies in rat or mouse for inhibitory effect on: 
 hepatic cancer (Seufi et al., 2009) 
 prostate carcinoma (Kaur et al., 2009) 
 colorectal carcinoma (Nirmala and Ramanathan, 2011) 
 colon carcinogenesis (Pereira et al., 1996, Giftson et al., 2010) 
 mammary cancer (Johnson et al., 1988, Verma et al., 1988) 
 lung cancer (Kawada et al., 2001). 
In vitro studies on: 
 human lung cancer cell line (Zheng et al., 2012) 
 human prostate adenocarcinoma cell line (Noori-Daloii et al., 2011, 
Maurya et al., 2011) 
 human monocytic cell line U937 (Kim et al., 2011b) 
 human glioblastoma cell line T98G (Nakatsuma et al., 2010) 
 human pancreatic carcinoma cell (Borska et al., 2010). 
Proposed mechanism (Huang et al., 2009, Wahle et al., 2011, Soobrattee 
et al., 2006): 
 inhibition of cell proliferation 
 induction of tumour suppressor gene expression 
 enhancement of immune functions and surveillance 
 inhibition of phase I and phase II enzymes 
 inhibition of cell adhesion and invasion 
 induction of cell cycle arrest and induction of apoptosis 
 inhibition of signal transduction pathways 
 inhibition of formation of possible carcinogens 
 suppression of angiogenesis. 
HPLC-DAD at 280 
and 320 nm 
Peel at four different ripeness stages (RS1–
RS4) (phenolics decrease during ripening): 
Ferrulic acid 2.78mg/g in RS1 to 1.87mg/g in 
RS4 
Caffeic acid: 1.76mg/g in RS1 to 1.13mg/g in 
RS4 
p-coumaric acid: 2.23mg/g in RS1 to 1.36mg/g 
in RS4 
(Gayosso-Garcia Sancho et al., 2011) 
GCMS 
Leaf: 5,7-dimethoxycoumarin (0.14mg/g) 
Protocatechuic acid: 0.11 mg/g 
p-coumaric acid: 0.33 mg/g 
Caffeic acid: 0.25 mg/g 
Kaempferol: 0.03 mg/g 
Quercetin: 0.04 mg/g 
(Canini et al., 2007) 
HPLC-UV at 450 
nm 
Ripe fruit (different cultivars): 
Kaempferol: 350.32–605.20 µg/100g 
Quercetin: 82.74–257.09 µg/100g 
Total flavonoid: 961.00–1515.18 µg/100g 
(Kongkachuichai et al., 2010) 
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Group 3: Carotenoids 
Method of 
determination 
Compounds extracted 
Reported anticancer activities and mechanism of action of 
pure compounds 
HPLC-DAD at 430, 450, 
471 nm 
HPLC-APCI-MS 
Mature-green flesh: 
Lycopene: 1.5–12 µg/g 
β-cryptoxanthin: 3.1–8.0 µg/g 
β-carotene: 2.3–3.1 µg/g 
(Rivera-Pastrana et al., 2010) 
In vivo human studies for prevention effects in lung, prostate and 
pancreatic cancer (Bunker et al., 2007, Goralczyk, 2009, Jeon et al., 
2011, Kristal et al., 2011, Lin et al., 2009, Lynch et al., 2011, 
Magbanua et al., 2011, Schwenke et al., 2009, van Breemen et al., 
2011). 
In vivo animal studies in rat, mouse or hamster for inhibitory effect 
on: 
 skin cancer (Epstein, 1977) 
 respiratory tract cancer (Wolterbeek et al., 1995) 
 mammary cancer (Zhu et al., 1999) 
 colon cancer (Feng-Yao et al., 2011, Tang et al., 2011) 
 prostate cancer (Limpens et al., 2006, Tang et al., 2005) 
 gastric cancer (Luo and Wu, 2011) 
 breast cancer (Sahin et al., 2011) 
 liver cancer (Watanabe et al., 2001) 
In vitro studies on: 
 human colon carcinoma (HuCC) (Salman et al., 2007) 
 B chronic lymphocytic leukaemia (EHEB) (Salman et al., 2007) 
 human erythroleukemia (K562) (Salman et al., 2007) 
 prototype of Burkitt lymphoma cell (Raji) (Salman et al., 2007) 
 HepG2 human hepatocellular carcinoma cell (Yurtcu et al., 
2011) 
 prostate cancer cells (Palozza et al., 2010) 
 colon cancer cells (Palozza et al., 2010) 
 lung cancer cells (Palozza et al., 2010) 
 MCF-7 breast cancer cell (Minervini et al., 2008, Fornelli et al., 
2007) 
 human lung adenocarcinoma cell line A549 (Yeh and Hu, 2003) 
HPLC-DAD at 430, 450, 
471 nm 
HPLC-APCI-MS 
UV-VIS at 450 and 
470nm for total 
carotenoids 
Fruit at four different ripeness stages (RS1–RS4) 
Total carotenoid: 0.92 mg/100g in RS1 to 3.27 
mg/100g in RS4 
Lycopene increases 10 times during ripening: 
0.35 mg/100g RS1 to 3.5 mg/100g RS4 
β-cryptoxanthin: 0.29 mg/100 g RS1 to 1.06 
mg/100 g RS4 
β-carotene: 0.24 mg/100 g RS1 to 0.5 mg/100 g 
RS4 
(Gayosso-Garcia Sancho et al., 2011) 
HPLC-DAD at 450 nm 
Fruit: 
β-carotene: 10.6 µg/g 
α-carotene: 5.6 µg/g 
β-cryptoxanthin: 24.3 µg/g 
α-cryptoxanthin: 16.5 µg/g 
Lutein: 7.1 µg/g 
9-cis β-carotene: 7.0 µg/g 
Neoxanthin, violaxanthin, zeaxanthin: detected 
(Ben-Amotz and Fishler, 1998) 
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Group 3: Carotenoids 
Method of 
determination 
Compounds extracted 
Reported anticancer activities and mechanism of action of 
pure compounds 
UV-VIS for total 
carotenoid at 450 nm 
HPLC at 450, 350 and 
290 nm 
Fruit: 
Total carotenoid: 3.4 mg/100 g 
β-carotene: 0.38 mg/100 g 
Lycopene: 2.07 mg/100 g 
(Mueller, 1997) 
Proposed mechanism (Tanaka et al., 2012, Van Breemen and 
Pajkovic, 2008):  
 immuno-modulation 
 modulation of phase I and phase II enzyme 
 induction of cell differentiation 
 modulation of growth factor signalling 
 anti-angiogenesis 
 anti-proliferation 
 induction of apoptosis 
 enhancement of gap junction communication 
  inhibition of cell invasion and metastasis. 
MPLC 
Fruit: 
Yellow-fleshed papaya: 
β-carotene: 1.4 ± 0.4 µg/g 
β-cryptoxanthin: 15.4 ± 3.3 µg/g 
Lycopene: not detected 
Red-fleshed papaya: 
β-carotene: 7.0 ± 0.7 µg/g 
β-cryptoxanthin: 16.9 ± 2.9 µg/g 
Lycopene: 11.5 ± 1.8 µg/g 
(Chandrika et al., 2003) 
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1.5 Hypothesis and Aims 
 
The above literature review summarised the results of extract-based investigations, 
indicating that Carica papaya extracts may alter the growth of several types of cancer cell 
lines. This review has also focused on specific compounds in papaya and their reported 
anticancer effects in order to emphasise the need to further explore the bioactive 
compounds in Carica papaya for their anticancer activities. The results of the literature 
review have led to the following research hypothesis: 
 
Carica papaya contains bioactive compounds with cytotoxic activity; 
therefore, it can be a source for the discovery of anticancer agents. 
 
This project was conducted with the following main aims: 
 
Aim 1 
To investigate the selective cytotoxic activity of different extracts from Carica papaya 
leaves on cancerous and non-cancerous epithelial cell lines. 
 
Aim 2 
To explore the chemical composition of extracts by different spectrophotometric assays 
and High Performance Liquid Chromatography-Quadrupole Time of Flight-Mass 
Spectrometry. 
 
Aim 3 
To tentatively identify the bioactive compounds by applying comparative analysis and 
multivariate data analysis to the metabolomic profiles of extracts. 
 
Aim 4 
To explore the bioactive compounds in active extracts by preparative chromatography via 
bioassay-guided fractionation. 
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Chapter 2: In Vitro Cytotoxicity of Carica 
Papaya Leaf Extracts on Squamous Cell 
Carcinoma Cells and Tentative Identification 
of Bioactive Compounds by Application of 
LC-MS based-Metabolomics and 
Comparative Analysis 
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2.1 Foreword 
In this chapter, two extraction schemes were employed to obtain eight different papaya 
leaf extracts to be used in cytotoxicity studies: serial and parallel, with a medium polarity 
solvent (ethanol) and a polar solvent (water) at acidic and basic pH values. We 
investigated the in vitro cytotoxicity of the obtained extracts on human oral squamous cell 
carcinoma SCC25 cells and non-cancerous human keratinocyte HaCaT cells. The 
chemical composition of the extracts was putatively investigated using Ultra High 
Performance Liquid Chromatography-Quadrupole Time of Flight-Mass Spectrometry 
followed by comparative analysis to tentatively identify the compounds responsible for the 
significantly selective anti-cancer effects towards the cancer cells.  
Sections 2.2 to 2.5 form a research article that has been published in special issue 
“Dietary and Non-Dietary Phytochemicals and Cancer” in Toxins journal.  
 
 
 
 
 
 
Additional experiments relevant to this chapter, but not incorporated in the manuscript are 
presented in section 2.6 of this chapter. 
  
Thao Nguyen, Marie-Odile Parat, Mark Hodson, Jenny Pan, Paul Shaw, 
Amitha Hewavitharana, 2015. Chemical Characterisation and in Vitro Cytotoxicity 
on Squamous Cell Carcinoma Cells of Carica Papaya Leaf Extracts. Toxins 
journal 8(1): 7.1-7.11; doi: 10.3390/toxins8010007.  
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2.2 Abstract 
In traditional medicine, Carica papaya leaf has been used for a wide range of therapeutic 
applications including skin diseases and cancer. In this study, we investigated the in vitro 
cytotoxicity of aqueous and ethanolic extracts of Carica papaya leaves in parallel studies 
using the human oral squamous cell carcinoma SCC25 cell line and the non-cancerous 
human keratinocyte HaCaT cells. Two out of four extracts showed a significantly selective 
effect towards the cancer cells and were found to contain high levels of phenolic and 
flavonoid compounds. The chromatographic and mass spectrometric profiles of the 
extracts obtained with Ultra High Performance Liquid Chromatography-Quadrupole Time 
of Flight-Mass Spectrometry were used to tentatively identify the bioactive compounds 
using comparative analysis. The principal compounds identified were flavonoids or 
flavonoid glycosides, particularly compounds from the kaempferol and quercetin families, 
of which several have previously been reported to possess anticancer activities. These 
results confirm that papaya leaf is a potential source of anticancer compounds and warrant 
further scientific investigation to validate the traditional use of papaya leaf to treat cancer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Carica papaya; cytotoxicity; mass spectrometry; cancer; flavonoids; 
chromatography 
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2.3 Introduction 
A book entitled “The most wonderful tree in the world – the papaw tree (Carica papaia)”, 
published some 100 years ago, contains many anecdotes relating to the cure of breast, 
liver or rectal cancer after “treatment” with Carica papaya preparations (Lucas, 1914). 
Subsequent reports have been published in various media that have detailed “the healing 
capabilities of an old Australian Aboriginal remedy - boiled extract of pawpaw leaves - 
against cancer” (Tietze, 2003) and several other anecdotes relating “cancer cure” following 
consumption of various preparations of papaya plant (Gallo, 2014, Barrett, 2012, Dillan, 
2012, Clarks, 2008).  
Recently, we undertook a comprehensive literature review (Nguyen et al., 2013) and found 
that research providing scientific evidence for the effectiveness of Carica papaya in the 
treatment and prevention of cancer was limited. 
However, in contrast to the limited number of studies that have been done to evaluate the 
effects of papaya extracts on cancer, the abundance in Carica papaya of phytochemicals 
with reported anticancer activities, such as carotenoids (in fruits and seeds), alkaloids (in 
leaves), phenolics (in fruits, leaves, shoots) and glucosinolates (in seeds and fruits), 
suggests that there are opportunities for further research to evaluate the anticancer 
potential of this medicinal plant (Nguyen et al., 2013).   
Squamous cell carcinoma (SCC) is the second most common type of skin cancer and also 
occurs in many other epithelia such as lips, mouth, urinary bladder, prostate, lung and 
vagina. Skin squamous cell carcinomas are not only more likely to metastasize but also to 
cause mortality, when compared with skin basal cell carcinoma (Clayman et al., 2005). 
Although different parts of the Carica papaya plant have been used as traditional medicine 
for the treatment of skin infections and wound healing in general, and this widespread use 
has been scientifically validated (Hewitt et al., 2000, Mikhal'chik et al., 2004, Nayak et al., 
2007), no information is available on the activity of this plant on skin cancer. Furthermore, 
the effects of Carica papaya leaf extracts have previously been reported to have been 
tested on the growth of different cancer cell lines: breast, stomach, lung, pancreatic, colon, 
liver, ovarian, cervical, neuroblastoma, lymphoma, leukaemia and other haematological 
cancers (Morimoto et al., 2008, Otsuki et al., 2010, Rumiyati, 2006); to our knowledge, no 
skin cancer cell lines have been tested. We hypothesised that Carica papaya leaf extracts 
exerted in vitro cytotoxicity on human squamous cell carcinoma. In this study, human oral 
squamous cell carcinoma (SCC25) cells and immortal, non-cancerous human keratinocyte 
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cells (HaCaT) were selected for the cytotoxic studies of papaya extracts. The HaCaT cell 
line was selected to permit experiments to be performed in parallel with SCC25 in order to 
screen for candidate extracts with selective growth inhibition towards cancer cells, a highly 
desirable feature of potential cancer preventative and therapeutic agents. Our aim was 
also to preliminarily identify the bioactive compounds using ultra high performance liquid 
chromatography-quadrupole time-of-flight-mass spectrometry (UHPLC-QToF-MS). 
2.4 Materials and Methods 
2.4.1 Chemicals and reagents 
Dulbecco’s Modified Eagle’s Medium (DMEM), DMEM-F12, penicillin/ streptomycin, trypsin 
and foetal bovine serum (FBS) were purchased from Invitrogen (Life Technologies, 
Mulgrave, VIC, Australia). 3-(4,5-Dimethylthiazol-2-yl)−2,5-diphenyltetrazolium bromide 
(MTT),  dimethyl sulfoxide (DMSO), LC-MS grade ammonium bicarbonate and formic acid, 
Folin-Ciocalteu’s phenol reagent, gallic acid (>97.5% purity), quercetin (98% purity) and 
epigallocatechin-3-gallate (EGCG) (99%) were obtained from Sigma-Aldrich (Castle Hill, 
NSW, Australia). HPLC grade methanol and acetonitrile were obtained from Merck 
(Darmstadt, Germany). Other chemicals such as hydrochloric acid, sodium hydroxide were 
of analytical grade purchased from Ajax Finechem (Cheltenham, VIC, Australia). Purified 
water was generated using a MilliQ system (Millipore, Billerica, MA, USA). 
2.4.2 Preparation of papaya leaf extracts 
Fresh Carica papaya leaves (medium mature leaves without stem) were collected from 
Tropical Fruit World (TFW), a privately-owned plantation orchard farm and research park 
in northern New South Wales, Australia (http://www.tropicalfruitworld.com.au/). Permission 
for the use of the Carica papaya leaves was granted by Mr. Aymon Gow, manager of 
TFW. The papaya plants in this facility are neither protected nor endangered species and 
had not been sprayed with any chemicals. The leaves were thoroughly washed under 
running tap water to remove any particulate matter, and then rinsed with MilliQ water to 
obtain clean leaves. A Christ Alpha 2-4 LD freeze-dryer (Martin Christ 
Gefriertrocknungsanlagen GmbH, Germany) was used to lyophilise the leaves at -60°C 
and 0.1 mbar, for 24 hr. One kilogram of dried leaves was then ground into powder using a 
food processor (Oskar Mini, Sunbeam, NSW, Australia). The dried powder was portioned 
and stored at -80°C until extraction. 
36 
A mass of 20 g of the freeze-dried leaf powder was extracted sequentially with ethanol and 
water in acidic or basic conditions in the order: basic ethanol, acidic ethanol, acidic water, 
basic water (2 × 200 mL for each solvent; pH was maintained at pH 1-2 or 10-11 during 
the extraction process by adjusting with either 3M hydrochloric acid or 5M sodium 
hydroxide solution). The obtained ethanolic extracts were concentrated at 30°C and 120 
rpm under vacuum by a rotary evaporator (IKA®RV 10, IKA-Werke, Staufen im Breisgau, 
Germany). The resulting concentrates of ethanolic extracts and water extracts were 
lyophilised using the freeze-dryer. All lyophilised fractions (Basic ethanol: SBE, Acidic 
ethanol: SAE, Acidic water: SAW, Basic water: SBW) were stored at -80°C prior to 
analysis. 
2.4.3 Cell culture conditions 
SCC25 cells (ATCC® CRL-1628™, Manassas, VA, USA) were maintained in DMEM/F12 
medium supplemented with 10%v/v heat-inactivated foetal bovine serum, 1% penicillin-
streptomycin and 0.4 μg/mL hydrocortisone.  HaCaT cells, a generous gift from Professor 
Fusenig (Boukamp et al., 1988), were propagated in DMEM supplemented with 10% foetal 
bovine serum and 1% penicillin-streptomycin. The cells were grown in a humidified 
incubator at 37°C in a 5% CO2 atmosphere. The cells were passaged every 3 days and 
cultures were allowed to reach 70-90% confluence before experiments were performed.  
2.4.4 Cell viability assays 
The effect of extracts on SCC25 and HaCaT viability was evaluated using the colorimetric 
tetrazolium dye procedure (3-(4,5-Dimethylthiazol-2-yl)−2,5-diphenyltetrazolium bromide) 
commonly referred to as the MTT assay developed by Mosmann (Mosmann, 1983) and 
applied here with minor modification. SCC25 or HaCaT cells were plated into 96-well 
plates at densities of 6 × 103 cells per well in 100 µL of DMEM/F12 (10% serum) and 3 × 
103 cells well in 100 µl of DMEM (10% serum), respectively. Cells were incubated at 37oC 
for 24 hr and were subsequently treated for 48 hr with 0.5% serum medium containing 
increasing concentrations (5-100 µg dry mass/mL) of extracts in ethanol (0.3% final 
concentration in medium). Control cells were exposed to an equivalent volume of ethanol 
(0.3% final concentration). Cells were then incubated in 100 µL of MTT-containing medium 
(0.2 mg/mL MTT in 0.5% serum medium) at 37oC for an additional two hours. The medium 
was then removed and the formazan crystals trapped in cells were dissolved in 100 µL of 
DMSO by gentle shaking for 20 min on an orbital shaker. Absorbance of the solubilised 
product was measured at 595 nm using an Imark plate reader (BioRad, Hercules, CA, 
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USA). The absorbance of cells exposed to medium containing 0.3% ethanol only was 
taken as 100% cell viability (i.e. the control).  The results are expressed as percent of the 
viability of control cells ± standard error of the mean (SEM) from 4-8 parallel 
determinations in three independent experiments (n=3). Dose-effect analysis on SCC25 
cells was performed by Kruskal-Wallis test. Differences between the SCC25 and HaCaT 
cell lines, and interaction between cell line and extract effects were analysed by two-way 
ANOVA with Bonferroni post-hoc tests. All statistical analyses were carried out using 
GraphPad Prism 6.0 (GraphPad Software Inc., San Diego, USA). 
2.4.5 Determination of total phenolic content 
Total phenolic content of ethanol and water extracts was determined using the Folin-
Ciocalteu assay as described previously (Singleton and Rossi, 1965) with minor 
modifications. Briefly, 0.5 mL of diluted extract was mixed with 2.5 mL of freshly prepared 
10% (v/v) Folin-Ciocalteu’s phenol reagent, followed by the addition of 2 mL of 7.5% 
Na2CO3. For a blank solution, 0.5 mL of water or ethanol was used. The mixture was 
vortex mixed for 2 min and left in the dark at room temperature for 30 min. The 
absorbance of each sample was then measured at the maximum wavelength of 758 nm 
against a control sample comprising 0.5 mL diluted extract, 2.5 mL water and 2 mL of 
7.5% Na2CO3. Gallic acid was used as the phenolic standard, and results were expressed 
as gallic acid equivalents (GAE) in mg/g of dry weight of each extract. 
2.4.6 Determination of total flavonoid content 
Total flavonoid content of the extracts was determined using a colorimetric assay 
developed previously (Maisarah et al., 2013). Diluted extract was mixed with 2% AlCl3 in 
ethanol in equal volume and absorbance was measured after 15 min at 425 nm, against 
the blank sample consisting of equal volume of dilute extract and ethanol without AlCl3. 
Quercetin was used as the flavonoid standard, and results were expressed as quercetin 
equivalents (QE) in mg/g of the dry weight of each extract. 
2.4.7 UHPLC-QToF-MS analysis 
Chromatographic analysis of compounds in papaya leaf extracts was performed on an 
Agilent 1290 UHPLC system (Agilent Technologies, Santa Clara, CA, USA). 
Chromatographic separation was achieved on a 2.1×150 mm, 3.5 μm ECLIPSE PLUS 
C18 analytical column (Agilent) with guard protection. Mobile phase A was MilliQ water 
containing 5 mM ammonium bicarbonate and 0.1% formic acid, adjusted to pH 7.0 ± 0.1 
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and mobile phase B was 95% acetonitrile and 5% MilliQ water (v/v) containing 5 mM 
ammonium bicarbonate and 0.1% formic acid. The following gradient elution was adopted: 
10 to 80% B for the first 42 min; 80 to 90% B from 42 to 45 min; 90 to 100% B from 46 to 
48 min; held at 100% B from 48 to 50 min; returned to 10% B over the next 2 min, and the 
column re-equilibrated with 10% B for 10 min prior to the next injection. Thus the total 
chromatographic run time was 60 min. A flow rate of 0.2 mL/min was applied and 20 μL of 
sample was injected.  
Each extract was run in triplicate in both positive and negative ionisation modes. Mass 
spectrometric detection was performed on an Agilent 6520 high-resolution accurate mass 
quadrupole time-of-flight (QToF) mass spectrometer equipped with a multimode source in 
both Electrospray Ionisation (ESI) and Atmospheric Pressure Chemical Ionisation (APCI). 
Mass spectral acquisition was controlled using MassHunter acquisition software (Version 
B.02.01 SP3 - Agilent). The mass spectrometer was operated in the range of m/z 100 - 
1700, at a scan rate of 0.8 cycles/second under the following conditions: capillary voltage 
2500 V, nebulizer pressure 30 psi, drying gas flow 5.0 L/min, gas temperature 300°C, 
fragmenting voltage 175 V, skimmer voltage 65 V. To ensure the desired mass accuracy 
of recorded ions, continuous internal calibration was performed during analysis with 
infusion of reference ions - m/z 121.050873 (protonated purine) and m/z 922.009798 
(protonated hexakis) in positive ion mode; in negative ion mode, ions with m/z 119.0362 
(deprotonated purine) and m/z 966.000725 (formate adduct of hexakis) were used to 
correct for scan to scan variations. 
2.4.8 MS data analysis 
Data analysis was performed using Agilent MassHunter Qualitative software (Version 
B.05.00) with Molecular Feature Extractor (MFE) algorithms in concert with Mass Profiler 
Professional (MPP) software (Version 12.1 - Agilent) to align features from the 
chromatograms of all samples from four extracts of papaya leaves. The following cut-off 
settings were employed: minimum peak filters of 500 counts, peak spacing tolerance of 
0.0025 m/z plus 7.0 ppm, assigned charge states limited to a maximum of two, minimum 
compound filters of 3000 counts. The Molecular Feature Generator algorithm was utilised 
to generate putative molecular formulae from the following common elements C, H, N, O, 
P and S. Compound identification was carried out using a Personal Compound Database 
Library (PCDL) (Agilent, USA) with the METLIN Personal Metabolite Database and a 
customised PCDL database which was compiled using the PCDL platform with 
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compounds obtained from Naturally occurring Plant-based Anticancerous Compound-
Activity-Target Database (NPACT) (Mangal et al., 2013).  
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2.5 Results and Discussion  
The MTT assay has been widely applied in proliferation and cytotoxicity studies to screen 
the chemo-preventive potential of natural products. It provides preliminary data for further 
in vitro and in vivo studies. The addition of organic solvents is required to solubilize the 
extracts from natural products in cell culture media; therefore it is prudent to investigate 
the effect of the solvents on the cell lines under experimentation to identify the most 
suitable solvent and its optimal concentration in media. This information can then be used 
during sample preparation for rigorous cytotoxicity studies using the MTT assay. Dimethyl 
sulfoxide (DMSO) has been reported to be the solvent of choice for sample preparations 
with a final concentration in the medium from 0.1% to 1.0% but typically data have not 
been reported relating to impact of such DMSO concentrations on cell viability (Kaneshiro 
et al., 2005, Manosroi et al., 2006, Wang et al., 2008). In our investigation, we found that 
DMSO at a concentration as low as 0.05% causes significant toxicity to SCC25 and a 
significantly different effect was observed between the two cell lines. In contrast, ethanol 
(EtOH) up to a concentration of 1.0% did not significantly impact upon the viability of either 
cell line (Figure 2.1). 
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(A)     (B) 
Figure 2.1: Effect of a 48-hr incubation with DMSO (A) or EtOH (B) on the survival of 
SCC25 and HaCaT cells. Results are shown as mean ± SEM (n=3). *, p<0.05, **, p<0.01; 
***, p<0.001, HaCaT vs SCC25 (two-way ANOVA with Bonferroni post-hoc tests). 
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Therefore, in this study, ethanol at a concentration of 0.3% was chosen as the solvent for 
the preparation of ethanolic extracts in media for cell experiments. To investigate the effect 
of the papaya leaf extracts on SCC25 and HaCaT cells, cells were treated with extracts 
over a range of concentrations (5-100 µg/mL) for 48 hr and the percentage cell viability 
was analysed. As revealed in Figure 2.2, all four extracts showed a significant effect on 
SCC25 cancer cell viability, starting at different concentrations: 25 µg/mL for serial basic 
ethanol (SBE), 10 µg/mL for serial acidic ethanol (SAE), and 5 µg/mL for both serial acidic 
water (SAW) and serial basic water (SBW) fractions. However, when the cell viability 
effects between SCC25 cancer cells and non-cancerous HaCaT cells were compared, the 
two fractions with acidic pH showed a significantly selective cytotoxicity towards the 
SCC25 cells with an effective range from 25-100 µg/mL for SAE and 5-20 µg/mL for SAW 
fractions (Figure 2.3). 
0 5
1
0
2
5
5
0
1
0
0
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
****
C o n c e n t r a t io n  (µ g /m l )
 S C C 2 5  - L e a v e s
S e r ia l B a s ic  E th a n o l (S B E )
****
%
 c
e
ll
 v
ia
b
il
it
y
**
0 5
1
0
2
5
5
0
1
0
0
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
****
C o n c e n t r a t io n  (µ g /m l )
****
****
*
S C C 2 5  -  L e a v e s
S e r ia l A c id ic  E th a n o l (S A E )
%
 c
e
ll
 v
ia
b
il
it
y
0 5
1
0
2
5
5
0
1
0
0
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
****
C o n c e n t r a t io n  (µ g /m l )
S C C 2 5  - L e a v e s
S e r ia l A c id ic  w a te r  (S A W )
%
 c
e
ll
 v
ia
b
il
it
y
**
****
****
0 5
1
0
2
5
5
0
1
0
0
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
************
****
C o n c e n t r a t io n  (µ g /m l )
S C C 2 5  -  L e a v e s
S e r ia l B a s ic  W a te r  (S B W )
%
 c
e
ll
 v
ia
b
il
it
y
 
(A)                                (B)                             (C)                                 (D)   
Figure 2.2: Effect of papaya leaf extracts (serially extracted in the listed order, with 
basic ethanol (A); acidic ethanol (B); acidic water (C); and basic water (D)) on the 
survival of SCC25 cells. Results are shown as mean ± SEM (n=3). *, p<0.05; **, p<0.01; 
****, p<0.0001, vs EtOH-treated control (Kruskal-Wallis test). 
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(A)                                (B)                             (C)                                 (D)   
Figure 2.3: Effect of papaya leaf extracts (serially extracted in the listed order with 
basic ethanol (A); acidic ethanol (B); acidic water (C); and basic water (D)) on the 
survival of SCC25 and HaCaT cells. Results are shown as mean ± SEM (n=3). *, 
p<0.05; **, p<0.01; ***, p<0.001, HaCaT vs SCC25 (two-way ANOVA with Bonferroni post-
hoc test). 
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The IC50 values clearly showed the selective effect of two acidic extracts with IC50 values 
for SCC25 cells smaller than those for HaCaT cells. This was not observed to be the case 
for either of the two basic extracts (Table 2.1). To eliminate the possibility that this 
selective effect might due to cancer cells being more sensitive to acidic pH than the non-
cancerous cells, the pH of the medium containing extracts at the highest tested 
concentration (100 µg/mL) was measured. The pH of the media was unaffected by the 
addition of either acidic or basic extracts, likely due to the buffer capacity of the medium 
and the small volume of addition of the extracts. Therefore, we conclude here that the 
acidic conditions provided extracts containing important compounds with selective effects 
on skin cancer cell viability. 
Table 2.1: IC50 values of serial extracts for SCC25 and HaCaT cells 
Cell lines 
IC50 (µg/mL) 
(95% Confidence interval) 
SBE SAE SAW SBW 
SCC25 
172.9 
(151.6-197.3) 
77.18 
(62.71-94.99) 
57.72 
(41.99-79.35) 
40.14 
(27.03-59.61) 
HaCaT 
157.6 
(119.8-207.4) 
199.5 
(155.4-256.2) 
85.74 
(71.63-102.6) 
34.24 
(21.47-54.60) 
 
Interestingly, examination of the phenolic and flavonoid content of the same four fractions 
(Figure 2.4) indicated that the phenolic and flavonoid contents positively correlated with 
the differential effect on cell viability as shown in Figure 2.3. Acidic ethanolic and water 
fractions had much higher flavonoid content (SAE = 15.60 ± 0.07; SAW = 9.95 ± 0.05 mg 
QE/g extract) compared to the basic fractions that contained less than 2.00 mg QE/g (SBE 
= 0.63 ± 0.30; SBW = 1.90 ± 0.23 mg QE/g extract). The phenolic content of acidic 
fractions was also found to be higher than that in basic fractions but to a lesser extent than 
the flavonoid content (SAW = 62.98 ± 0.30; SAE = 44.26 ± 0.27 mg GAE/g extract and 
SBW = 40.18 ± 0.16; SBE = 26.92 ± 2.53 mg GAE/g extract).  
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Figure 2.4: Total flavonoid and phenolic content in the extracts. Results are shown as 
mean ± SEM (n=3). 
 
The apparent positive correlation between the selective effects on the SCC25 cancer cells 
and the content of flavonoids and phenolic compounds initiated further comparative 
analysis of the chemical constituents to identify the compounds that are present 
exclusively or at higher concentrations in the acidic extracts compared to basic extracts. 
The chromatographic data were extracted to features by Molecular Feature Extractor 
algorithms and then aligned by Mass Profiler Professional software. In positive ionisation 
mode, a total of 432 and 191 features (based on retention time and mass-over-charge 
values) were detected in acidic water and acidic ethanolic extracts, respectively; 118 
features were common to both extracts. These 118 features were compared to the 586 
features that appeared in either of the basic extracts in order to search for the features 
detected specifically in acidic extracts or with higher intensity than in basic extracts. A total 
of 59 features were found to fit these criteria (Figure 2.5). A similar procedure was then 
applied to the features obtained in negative ionisation mode, resulting in five features of 
interest.  The neutral mass of the 64 features obtained in both modes was queried against 
the METLIN Personal Metabolite Database and the customised NPACT database to match 
to compounds using a mass tolerance window of ≤10 ppm. The METLIN database 
contains 64,092 structures of endogenous and exogenous metabolites (as of June 2015) 
whereas the customised NPACT database consists of 1,574 entries of plant-derived 
natural compounds that exhibit anti-cancerous activity (Mangal et al., 2013). 
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Figure 2.5: Diagrammatic representation of the selection of features obtained from 
comparative analysis of chromatographic profiles between acidic and basic extracts 
in positive ionisation mode (A: Acidic extracts, B: Basic extracts). 
The METLIN-based search resulted in a total of 880 hits for 64 features, among that the 
most remarkable were the flavonoids or flavonoid glycosides (kaempferol, quercetin, rutin, 
manghaslin, nicotiflorin, clitorin, quercetin 7-galactoside, myricetin 7-rhamnoside, luteolin 
3,7-diglucoside) (Table 2.2). These correlated with the results of the total flavonoid content 
in acidic extracts compared to basic extracts. Furthermore, the search within NPACT 
database revealed several compounds with previously reported anti-cancer activities 
including fisetin, kaempferol, luteolin, scullarein, tetrahydroxyflavone, quercetin, morin, 
viscidulin I, kaempferol β-D-glucopyranoside, luteolin β-D-glucopyranoside, myricetin 3-O-
rhamnoside, and rutin (Mangal et al., 2013). Kaempferol and quercetin have been 
detected and quantified in Carica papaya leaves by gas chromatography-mass 
spectrometry analysis with quantities of 0.03±0.001 mg/g and 0.04±0.001 mg/g dry leaf, 
respectively (Canini et al., 2007). Due to the presence of aromatic phenol groups, these 
flavonoids are considered weak acids; therefore, they would be more readily extracted into 
an acidic environment in preference to a basic environment. Quercetin has been found to 
selectively affect viability of SCC25 cells without causing toxicity to human gingival 
fibroblasts (Chen et al., 2013). The mechanism by which quercetin inhibited the 
proliferation of SCC25 cells included both G1 phase cell cycle arrest and mitochondria-
mediated apoptosis. Quercetin further decreased the migration and invasion of SCC25 
cells in a dose-dependent manner (Chen et al., 2013). For other flavonoids, many 
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mechanisms of action on tumours have been identified such as inhibition of proliferation, 
apoptosis induction, carcinogen inactivation, impairment of invasion and angiogenesis 
(Kanadaswami et al., 2005, Chahar et al., 2011). The molecular mechanisms by which 
flavonoids exert these effects have been proposed to include the signalling pathways of 
PI3-kinase (phosphoinositide 3-kinase), Akt/PKB (protein-kinase B), tyrosine kinase P1KC 
(protein-1 kinase C) and MAP (mitogen-activated protein) kinase as reviewed elsewhere 
(Hertzogi and Tica, 2012). Using primary SCC cells and normal oral mucosa cells as a 
control, the flavonoid morin was shown to cause G2/M arrest without causing apoptosis, 
and to impact kinases AKT, JNK and p38 signalling pathways (Brown et al., 2003). 
However, of the three kinases, AKT was the only one that was selectively inhibited in 
cancer cells compared to non-cancer cells, and the authors suggested that AKT might 
mediate the enhanced tumour sensitivity to morin (Brown et al., 2003).   
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Table 2.2: Tentative identification of compounds which appear in acidic extracts 
exclusively or at greater extent than in basic extracts 
Formula 
Experimental 
mass 
Error 
(ppm)* 
Number of 
candidates from 
METLIN database 
Putative compounds from 
NPACT database 
C4H5NO3 115.0269 0 1 - 
C5H7NO3 129.0428 1 7 - 
C14H25NO3 255.1835 0 1 - 
C14H25NO3 255.1846 4 1 - 
C15H10O6 286.0486 3 28 
Fisetin, Kaempferol, 
Luteolin, Scullarein, 
Tetrahydroxyflavone 
C18H33NO2 295.252 2 1 - 
C15H10O7 302.0436 3 22 Quercetin; Morin;Viscidulin I 
C18H19NO3 307.2158 3 4 - 
C22H43NO 337.335 1 3 - 
C22H41NO2 351.3145 2 1 - 
C21H30O10 442.1843 0 1 - 
C21H20O11 448.1009 0 74 
Kaempferol β-D-
glucopyranoside, Luteolin β-
D-glucopyranoside 
C21H20O12 464.0958 0 56 Myricetin 3-O-rhamnoside 
C20H26O13 474.1373 0 1 - 
C28H46N2O4 474.346 0 1 - 
C28H46N2O4 474.3467 1 1 - 
C28H46N2O4 474.3468 2 1 - 
C28H48N2O4 476.3624 2 1 - 
C30H48N2O4 500.3617 0 1 - 
C26H55O8P 526.3631 0 1 - 
C33H50O5 526.3631 5 1 - 
C34H56N2O4 556.4245 0 1 - 
C29H44O12 584.2809 4 2 - 
C34H48O8 584.3322 4 3 - 
C27H30O15 594.158 0 120 - 
C27H30O16 610.153 0 109 Rutin 
C27H30O16 610.1531 0 109 - 
C28H32O16 624.1686 0 78 - 
C28H32O16 624.1689 0 78 - 
C34H65O13P 712.4155 1 1 - 
C33H40O19 740.2154 1 33 - 
C33H40O20 756.2107 0 81 - 
C33H40O21 772.2069 0 56 - 
C46H77O9P 804.5319 1 1 - 
*Error (ppm): the difference between experimental mass and theoretical mass of compound/ theoretical mass of 
compound 
47 
 
Although our study presents limitations inherent to this type of research, in which database 
searching and matching based on accurate mass data alone provides numerous 
compound identities for each mass, the results revealed that papaya leaf acidic extracts 
contain numerous bioactive compounds with selective activities on SCC cells. Further 
studies are required to confirm the identities of these compounds by wider variety of 
isolation, purification and identification techniques (MSn, NMR) and to investigate the 
possible mechanism of anticancer activities of Carica papaya leaf extracts. 
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2.6 Additional experiments relevant to this chapter but not included in 
the manuscript 
2.6.1 Introduction  
Although the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay has 
been widely applied in proliferation and cytotoxicity studies to screen the chemo-
preventive potential of natural products, there are many variations in the literature 
regarding the protocols for the assay, and various parameters have been identified that 
can result in an under- or over-estimation of the tested samples (Wang et al., 2010, Vistica 
et al., 1991, Carmichael et al., 1987). Therefore, the following experiments in this chapter 
established assay conditions for these two cell lines in order to obtain a robust method to 
investigate the in vitro selective effect of extracts on human squamous cell carcinoma 
SCC25 cells in comparison with non-cancerous human HaCaT keratinocytes. 
Together with extracts obtained from serial extraction scheme, we investigated the 
cytotoxicity of extracts obtained from parallel extraction scheme with four solvents – basic 
ethanol, acidic ethanol, basic water and acidic water.  
The description of database build-up using a Personal Compound Database Library 
(PCDL) platform (Agilent Technologies) with the entries from Naturally occurring Plant-
based Anticancerous Compound-Activity-Target Database (NPACT) (Mangal et al., 2013) 
is also included herein.  
2.6.2 Materials and Methods  
 Parallel extraction scheme 
A mass of 20 g of the freeze-dried leaf powder was extracted with one of four solvents: 
basic ethanol, acidic ethanol, acidic water or basic water (2 × 200 mL for each solvent; pH 
was maintained at pH 1–2 or 10–11 during the extraction process by adjusting with either 
3M hydrochloric acid or 5M sodium hydroxide solution). The obtained ethanolic extracts 
were concentrated at 30°C and 120 rpm under vacuum using an IKA®RV 10 rotary 
evaporator (IKA-Werke, Germany). The resulting concentrates of ethanolic extracts and 
water extracts were lyophilised using the freeze-dryer. All lyophilised fractions (parallel 
basic ethanol [PBE], parallel acidic ethanol [PAE], parallel acidic water [PAW] and parallel 
basic water [PBW]) were stored at -80°C prior to analysis. 
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 Optimisation of MTT assay parameters to test SCC and HaCaT cell lines 
 General MTT assay protocol 
The cells (100 μL cell suspension/well) were plated at suitable seeding densities into a 96-
well microtiter plate, and allowed to attach for 24 hours. The medium was removed from 
the wells and replaced with medium containing samples at a range of concentrations 
(several wells were exposed to the medium only as control). Following 48-hour incubation 
at 37°C, the medium was removed and MTT solution in the culture medium (100 μL) was 
added to the cells and incubated at 37°C. At the end of the incubation, the medium was 
removed from the wells and the formazan crystals trapped in the cells were dissolved in 
100 μL of dimethyl sulfoxide (DMSO) by gentle shaking for 20 minutes on an orbital 
shaker. The absorbance of the solubilised product was measured at 595 nm using a plate 
reader. Absorbance values were adjusted against the blank (without cells) wells (the 
blanks should give values of 0.00 ± 0.01 units). The absorbance of cells exposed to the 
medium only was taken as 100% cell viability (i.e. the control). The results were expressed 
as the number of viable cells as percentage of the control. 
 Cell densities 
Cell seeding densities over the range of 750 to 24000 cells/well were tested to determine 
the optimal cell number for each cell line. The absorbance value of formazan production 
was plotted on the y-axis, versus the cell number per well on the x-axis. The cell seeding 
densities that were chosen as optimal yielded an interpretable absorbance of 0.40 to 0.80, 
and fell within the linear portion of the absorbance versus cell density relationship. 
 MTT concentrations 
The MTT stock solution was prepared at a concentration of 5 mg/mL in phosphate-
buffered saline, sterile filtered and stored at -20°C, protected from light with aluminium foil. 
Before addition to the cells, the MTT stock solution was diluted with the medium to final 
concentrations of 0.01 to 0.5 mg/mL. The MTT concentration with optimal absorbance 
value was chosen for further studies. 
 MTT incubation time 
The cells were incubated at 37°C for varying times using the optimal MTT concentration, 
and the absorbance was determined at 0, 1, 2, 3, 4, 5 hours following MTT addition. The 
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shortest time with optimal absorbance value was chosen as the standardised incubation 
time for further study. 
 Solvent for sample preparation 
Media containing different concentrations ranging from 0.01% to 1% (v/v) of DMSO or 
0.1% to 1% (v/v) of ethanol (EtOH) were tested for their effect on cell viability in order to 
select the optimal solvent and its concentration for the preparation of extracts. The viability 
of cells treated with media containing DMSO or EtOH was compared with that of the 
control cells treated with the medium only. 
 Positive control 
Two compounds, epigallocatechin gallate (EGCG; 10 to 5000 nM) and benzyl 
isothiocyanate (BITC; 25 to 200 µM), were tested at different concentrations for their 
cytotoxic activity on the two cell lines (SCC and HaCaT) with the objective of including 
them in future experiments as positive controls. 
 Assessment of the direct interaction of EGCG and papaya extracts with MTT 
EGCG at a concentration of 5,000 nM and papaya extracts at the highest concentration in 
the tested concentration range were mixed with MTT directly in the well without cells, and 
incubated for two hours. Absorbance values were then measured at 595 nm. 
2.6.3 Results  
 Yield of different Carica papaya leaf extracts 
The mass of the freeze-dried residue following extraction of Carica papaya leaves was 
measured for each extract (Table 2.3). 
Table 2.3: Yield of extracts from 1 g of fresh leaf 
Extract Yield (mg/g) 
SBE 26.95 
SAE 13.92 
SAW 84.27 
SBW 17.97 
PBE 27.60 
PAE 26.54 
PAW 102.12 
PBW 107.51 
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 Optimum MTT assay protocol for SCC25 and HaCaT cell lines 
Figures 2.6A and 2.6C illustrate the relationship between the cell seeding number and 
absorbance of formazan over the testing range of 750 to 24000 cells/well in the SCC25 
cells and HaCaT cells, respectively. A linear relationship between the optical density and 
number of cells seeded per well in the range of 750 to 12000 cells per/well was observed 
for the SCC25 cell line (Figure 2.6B), whereas the HaCaT cells displayed a linear 
relationship over the range of 750 to 6000 cells/well (Figure 2.6D). The optimum cell 
densities of 6000 and 3000 cells/well were therefore chosen for SCC25 and HaCaT cells, 
respectively, to avoid saturation and to yield interpretable absorbance values of 0.40 to 
0.80. 
 
              
 
              
Figure 2.6: Relationship between cell seeding number and absorbance of formazan 
production in SCC25 cells (A and B) and HaCaT cells (C and D) 
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Using the optimum number of cells, as described above, experiments to optimise the MTT 
concentration between a range of 0.01 to 0.5 mg/mL and the duration of exposure to MTT 
were conducted. A concentration of 0.1 mg/mL proved to be optimal for both cell lines 
because it produced similar results to higher concentrations of MTT but required a lesser 
amount of reagent (Figure 2.7A). Figure 2.7B shows that there was a continuous increase 
in the absorbance between zero and two hours, then reaching a plateau between two and 
five hours of incubation of the cells with MTT. A two-hour incubation following MTT 
addition to the cells was chosen for further studies. 
        
Figure 2.7: (A) Relationship between MTT concentration and absorbance value and    
(B) Time-course of formazan production after addition of MTT  
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EGCG and BITC were tested for their anti-proliferative effects using the optimised MTT 
method. EGCG at concentrations of 50 and 100 nM showed a statistically significant 
toxicity to SCC25 cells as compared with control cells, whereas no effect was observed at 
similar concentrations on HaCaT cells (Figure 2.8A and B). A two-way ANOVA test 
confirmed the significantly different effect of EGCG on the two cell lines (Figure 2.8C). In 
contrast, BITC appeared more toxic in HaCaT cells than in the SCC25 cell line. Therefore, 
EGCG at concentration of 50 and 100 nM was chosen for inclusion as a positive control in 
screening for selective growth inhibition towards cancer cells. 
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Figure 2.8: Effect of EGCG on the survival of SCC25 and HaCaT cells. Results are 
shown as mean ± SEM (n = 4). *, p < 0.05; **, p < 0.01; ***, p < 0.001. (A) SCC25; (B) 
HaCaT (one-way ANOVA with Dunnett’s post-hoc test); (C) HaCaT vs. SCC25 (two-way 
ANOVA with Bonferroni post-hoc test). 
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Bruggisser et al. reported the direct interaction of compounds, such as kaempferol and 
resveratrol, that occurred in natural products, with the MTT tetrazolium reduction reaction 
in a cell-free system (Bruggisser et al., 2002). These compounds instantaneously formed a 
dark blue formazan with the MTT reagent in the absence of cells, which led to false 
positive results. Therefore, before applying the method for screening papaya extracts, the 
intrinsic reductive potential of the positive control, as well as different extracts, was 
examined. Table 2.4 reveals the absence of intrinsic reducing activity of tested samples in 
our optimised assay. 
Table 2.4: The absorbance of blank wells containing medium or EGCG/ papaya 
extracts 
Absorbance values (at 595 nm) 
Medium 0.057 SBW (100 µg/mL) 0.047 
EGCG (5000 nM) 0.060 PBE (100 µg/mL) 0.055 
SBE (100 µg/mL) 0.055 PAE (100 µg/mL) 0.051 
SAE (100 µg/mL) 0.051 PAW (100 µg/mL) 0.055 
SAW (100 µg/mL) 0.050 PBW (100 µg/mL) 0.051 
 
 Cytotoxic activities of papaya leaf ethanolic and aqueous extracts following parallel 
scheme on SCC25 and HaCaT cell lines 
Similar to the results obtained for extracts from serial extraction scheme, all four parallel 
extracts showed a significant effect on SCC25 cancer cell viability with the effects 
commencing at different concentrations: 25 µg/mL for PBE; 10 µg/mL for PAE and PAW; 
and 5 µg/mL for PBW fraction (Figures 2.9 A). When the cell viabilities between SCC25 
cancer cells and non-cancerous HaCaT cells were compared, the parallel acidic ethanol 
fraction showed a significantly selective cytotoxicity towards the SCC25 cells with an 
effective range from 10 to 50 µg/mL (Figures 2.9B and C). However, all four fractions 
yielded smaller IC50 values for SCC25 cells than for HaCaT cells (Table 2.5). 
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Table 2.5: IC50 values of parallel extracts for SCC25 and HaCaT cells 
Cell lines 
IC50 (µg/mL) 
(95% Confidence interval) 
PBE PAE PAW PBW 
SCC25 
119.2 
(99.14-143.4) 
80.21 
(68.95-93.32) 
102.8 
(81.83-129.2) 
53.92 
(39.69-73.25) 
HaCaT 
182.8  
(133.2-250.7) 
136.5 
(116.8-159.5) 
131.8 
(117.5-147.9) 
60.85 
(45.96-80.57) 
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Figure 2.9: Effect of acidic/basic ethanolic and water leaf extracts after parallel extraction scheme on the survival of SCC25 
cells and HaCaT cells. Results are shown as mean ± SEM (n = 3). *, p < 0.05; **, p < 0.01; ***, p < 0.001. (A) SCC25; (B) HaCaT (one-
way ANOVA with Dunnett’s post-hoc test); (C) HaCaT vs. SCC25 (two-way ANOVA with Bonferroni post-hoc test).  
B 
C 
A 
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2.6.4 Discussion 
The colorimetric tetrazolium dye procedure, commonly referred to as the MTT assay, 
developed by Mosmann, is widely accepted as a convenient, reliable and quantitative 
method for measuring cell proliferation and cell viability (Mosmann, 1983). In metabolically 
active cells, the yellow, water soluble tetrazolium salt MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) is converted to purple-blue, water insoluble formazan by 
the enzyme mitochondrial succinate dehydrogenase (Figure 2.10). The amount of 
intracellular formazan formed in a culture well or plate during a given exposure period is 
directly proportional to the number of metabolically active cells. This colorimetric reaction 
can be measured spectrophotometrically. 
 
Figure 2.10: Reduction of MTT 
Although the method is rapid and convenient, a number of parameters need to be 
optimised for given tested cell lines in order to generate accurate and reliable results. 
Therefore, the optimised variables of cell density, MTT concentration and duration of 
incubation time with MTT were established for SCC25 and HaCaT cells in this study. In 
addition, this study investigated the effects of the organic solvents required to solubilise 
the extracts in cell culture media in order to identify the most suitable solvent and its 
optimal concentration in media. The concentration of ethanol identified herein can be 
successfully applied for the screening of extracts from natural products to identify 
candidates with selective anti-proliferative effects on SCC25 cancer cells, but not on 
HaCaT non-cancerous cells.  
The optimised MTT method was used to screen eight extracts (acidic and basic ethanol 
and water, following serial and parallel extraction schemes, together with leaf juice, 
brewed leaf juice and leaf decoction in Chapter 3) for their in vitro cytotoxic activities on 
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squamous cell carcinoma SCC25 cell line, in parallel with non-cancerous human 
keratinocyte HaCaT cells. 
When the effects of papaya extracts obtained following serial and parallel schemes were 
examined, it was clearly seen that the acidic extracts produced more selective cytotoxicity 
towards the SCC25 cells, especially when using the serial extraction scheme. Generally, 
phenolics and flavonoids would be more readily extracted in an acidic environment 
compared with a basic environment, because they are considered weak acids due to the 
presence of aromatic phenol groups. A study by Lai et al. demonstrated that the optimal 
conditions for antioxidant compound extraction from the Rhus typhina L. plant were 
observed at pH 2.0. Furthermore, they also outlined that, although the ideal pH for 
extraction differed between plants and particular antioxidants, an acidic environment 
produced significantly better antioxidant yield than did basic environments (Lai et al., 
2010). In the case of the extraction of catechins (flavanols from green tea), Vuong et al. 
found the yield of catechins was significantly lower with extraction pH values higher than 5 
due to epimerisation and degradation. They therefore concluded that green tea extractions 
should be conducted at acidic pH values <6 to ensure an optimal yield and stability of 
catechins  (Vuong et al., 2011). Other studies have also chosen acidic polar solvents to 
obtain anthocyanin-rich extracts from different plants that were subsequently used to 
investigate anticancer activities (Faria et al., 2010, Barrios et al., 2010, Hui et al., 2010).  
As the serial extraction scheme showed a clearer discrimination in selective cytotoxicity 
effects between acidic extracts and basic extracts (Table 2.1 and 2.5), serial extracts were 
chosen for be further studied using LC-MS based-metabolomics and comparative analysis.  
2.6.5 Database compilation for compound identification 
After obtaining a list of features of interest from LC-MS based-metabolomic experiments, 
database searches/matches using accurate mass MS information can significantly narrow 
down the list of possible identities, and can therefore greatly improve metabolite 
identification. As metabolomics has expanded significantly over the last decade, a wide 
range of databases involving information related to mass spectra, compound names and 
structures, metabolite profile data and metabolic pathways have been developed to 
support the growth in this area.  There are number of compound-oriented databases such 
as KNApSAcK, Plant metabolome database (PMDB), KEGG COMPOUND or mass-
spectrum oriented databases including METLIN, MetaboLights, MassBank, MassBase or 
pathway-oriented databases such as PlantCyc, MapMan, MetaCyc available for plant 
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metabolomic studies (Fukushima and Kusano, 2013). In our study, the accurate mass 
values of selected metabolites from metabolomic analysis were compared against the 
METLIN Personal Metabolite Database as it is one of the most comprehensive databases 
with more than 64000 compounds (as of June 2015). In addition, it seamlessly integrates 
with the Agilent MassHunter Workstation Software and GeneSpring/MPP MS software, 
which enables the efficient search with mass lists obtained from MS data analysis by 
Agilent MassHunter Qualitative software and Mass Profiler Professional software.  
In order to facilitate the identification of compounds with anticancer activities in the 
extracts, a customised database was compiled using the Agilent Personal Compound 
Database Library (PCDL) platform and the entries obtained from Naturally occurring Plant 
based Anticancerous Compound-Activity-Target Database (NPACT) (Mangal et al., 2013). 
NPACT was constructed by extracting data from literature to obtain 1574 bioactive 
compounds from plants having activity against 353 cancer cell lines (corresponding to 
5214 in vitro compound-cell line interactions). However, the NPACT database allows 
single searches for individual compounds only. Therefore, by assembling the information 
from NPACT within the PCDL platform, the customised database compiled in this body of 
work allows flexible manual searching as well as productive batch mode searching to 
improve identification of the compounds with anticancer activities in the extracts. At 
present, all 1574 compounds have been curated and included in the PCDL database with 
masses, chemical formulae and structures (Figure 2.11).    
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Figure 2.11: Typical layout for customised PCDL. 1574 plant-based anticancerous 
compounds have been included in this customised database with name, formula, 
monoisotopic mass, CAS ID and structure. 
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Chapter 3: In vitro Cytotoxicity of Carica 
Papaya Leaf Juice and Leaf Decoction on 
Squamous Cell Carcinoma Cells and 
Tentative Identification of Bioactive 
Compounds by Application of LC-MS based-
Metabolomics and Multivariate Data Analysis 
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3.1 Foreword 
The following chapter reports the investigation of Carica papaya leaf juice and leaf 
decoction for their in vitro cytotoxicity on human squamous cell carcinoma cells. In 
addition, the application of an untargeted metabolomic approach followed by multivariate 
data analysis was used to tentatively identify the compounds contributing to the distinct 
selective anticancer activity of leaf juice. The activity of papaya leaf juice and leaf 
decoction on another type of epithelial cells, colon cancer cells, is also explored and 
presented in this chapter. 
 
Sections 3.2 to 3.6 form a research article that has been accepted for publication in PLoS 
ONE journal (19th January 2016).  
 
 
 
 
 
 
 
Additional experiments relevant to this chapter, but not incorporated in the manuscript are 
presented in section 3.7 of this chapter. 
 
  
Thao Nguyen, Marie-Odile Parat, Paul Shaw, Amitha Hewavitharana, Mark Hodson. 
Traditional Aboriginal Preparation Alters the Chemical Profile of Carica papaya 
Leaves and Impacts on Cytotoxicity towards Human Squamous Cell Carcinoma 
(accepted for publication in PLoS ONE journal).  
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3.2 Abstract 
Carica papaya leaf decoction, an Australian Aboriginal remedy, has been used widely for 
its healing capabilities against cancer, with numerous anecdotal reports. In this study we 
investigated its in vitro cytotoxicity on human squamous cell carcinoma cells followed by 
metabolomic profiling of C. papaya leaf decoction and leaf juice/brewed leaf juice to 
determine the effects imparted by the long heating process typical of the Aboriginal 
remedy preparation. MTT assay results showed that in comparison with the decoction, the 
leaf juice not only exhibited a more pronounced cytotoxic effect on SCC25 cancer cells, 
but also produced a significant cancer-selective effect as shown by tests on non-
cancerous human keratinocyte HaCaT cells. Furthermore, evidence from testing brewed 
leaf juice on these two cell lines suggested that the brewing process markedly reduced the 
selective effect of C. papaya leaf on SCC25 cancer cells. To tentatively identify the 
compounds that contribute to the distinct selective anticancer activity of leaf juice, an 
untargeted metabolomic approach employing Ultra High Performance Liquid 
Chromatography-Quadrupole Time of Flight-Mass Spectrometry followed by multivariate 
data analysis was applied. Some 90 and 104 peaks in positive and negative ion mode 
respectively were selected as discriminatory features from the chemical profile of leaf juice 
and >1500 putative compound IDs were obtained via database searching. Direct 
comparison of chromatographic and tandem mass spectral data to available reference 
compounds confirmed one feature as a match with its proposed authentic standard, 
namely pheophorbide A. However, despite pheophorbide A exhibiting cytotoxic activity on 
SCC25 cancer cells, it did not prove to be the compound contributing principally to the 
selective activity of leaf juice. With promising results suggesting stronger and more 
selective anticancer effects when compared to the Aboriginal remedy, Carica papaya leaf 
juice warrants further studies to explore its activity on other cancer cell lines. Additionally, 
an investigation to confirm the identity of compounds contributing to its selective effect, 
particularly those compounds altered by the long heating process applied during the 
traditional Aboriginal remedy preparation, is warranted. 
 
 
 
 
Keywords: Carica papaya, cytotoxicity, Aboriginal preparation, metabolomics, cancer, LC-
MS.   
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3.3 Introduction 
Carica papaya is a fast growing, soft-wooded, herbaceous plant reaching 3-10 m in height. 
The leaves are large (30-60 cm long), yellow-green to dark-green in colour, palmately-
lobed, arranged spirally and clustered at the crown. In traditional medicine, Carica papaya 
leaves have been used for treatment of asthma, colic, fever, beriberi (thiamine deficiency), 
and as an abortifacient in India (Krishna et al., 2008), for malaria and dengue fever in Sri 
Lanka, Pakistan, Malaysia (Gammulle et al., 2012, Ahmad et al., 2011, Subenthiran et al., 
2013) and cancer in Vietnam and Australia (Vien and Thuy, 2013, Lucas, 1914, Tietze, 
2003). 
Carica papaya leaf decoction, an Australian Aboriginal remedy, has been reported widely 
for its healing capabilities against cancer, with numerous anecdotal reports (Nguyen et al., 
2013). Recently, scientific studies have demonstrated the inhibitory activity of this 
decoction on the proliferation of both haematopoietic cell lines and solid tumour cell lines 
(Morimoto et al., 2008, Otsuki et al., 2010). The decoction was prepared by brewing Carica 
papaya leaves with water in a glass beaker or wooden vessel for a period of time (varying 
from 5 minutes to 12 hours in various reports). The heating process to prepare the 
decoction can potentially affect temperature-sensitive compounds, leading to possible 
changes in bioactivity. This type of effect has been reported for other herbal medicines 
such as ginseng root and ginger, where the steaming preparation has been observed to 
increase the anti-proliferative effect when compared to unprocessed materials (Cheng et 
al., 2011, Wang et al., 2006, Qi et al., 2010) or with garlic, where the heating process 
dramatically reduces the effectiveness of the original garlic preparation on the local growth 
of fibrosarcoma in mice (Shirzad et al., 2011). We therefore conducted a study to test the 
hypothesis that the preparation of Carica papaya leaves following an Aboriginal remedy 
alters the chemical pattern and thus the anticancer effect of Carica papaya leaf. 
Human squamous cell carcinoma SCC25 cells and non-cancerous human HaCaT 
keratinocytes were selected for the cytotoxic studies of papaya leaf because skin and oral 
mucosa are directly accessible to the tested extracts, i.e. they do not require 
gastrointestinal absorption for the cells to be exposed to bioactive compounds. Moreover, 
squamous cell carcinoma, together with basal cell carcinoma, are the most frequent 
environmentally induced cancers, with UV light being recognized as a key etiologic factor 
(Slominski et al., 2012, Leiter et al., 2013, Slominski et al., 2014a, Slominski et al., 2014b, 
Xiang et al., 2014), which is a significant issue in Australia. Research into the development 
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of new therapeutic agents is of considerable importance and attention has recently 
focused on natural products. Interestingly, there is some overlap between the geographical 
distribution of Carica papaya (Food and Agriculture Organization, 2013) and that of UV 
exposure (Emmanuelle Bournay, 2012). As the widespread use of different parts (leaves, 
fruits and flowers) of Carica papaya plants for the treatment of skin infections and wound 
healing has been scientifically validated (Hewitt et al., 2000, Mikhal'chik et al., 2004, Nayak 
et al., 2007), testing of the effect of papaya leaf preparations on skin cancer is warranted. 
With the application of an untargeted metabolomic approach employing Ultra High 
Performance Liquid Chromatography-Quadrupole Time of Flight-Mass Spectrometry 
followed by multivariate data analyses, our study aimed to explore the relationship of the 
heating process with the chemical constituents and biological activity to tentatively identify 
the bioactive compounds responsible for the difference in the anticancer effect of the 
extracts. 
3.4 Materials and Methods 
3.4.1 Chemicals and reagents 
Dulbecco’s Modified Eagle’s Medium (DMEM), DMEM-F12, penicillin/streptomycin, trypsin, 
fetal bovine serum (FBS) were purchased from Invitrogen (Life Technologies, Mulgrave, 
VIC, Australia). Dihydrocoumarin (2-chromanone; 99% purity), fucoxanthin 
((3S,3'S,5R,5'R,6S,6'R,8'R)-3,5'-dihydroxy-8-oxo-6',7'-didehydro-5,5',6,6',7,8-hexahydro-
5,6-epoxy-β,β-caroten-3'-yl acetate; 99% purity), pheophorbide A (3-[(3S,4S,21R)-14-
ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-9-vinyl-3-phorbinyl]propanoic 
acid; 99% purity), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 
dimethyl sulfoxide (DMSO), LC-MS grade ammonium bicarbonate and formic acid were 
obtained from Sigma-Aldrich (Castle Hill, NSW, Australia). Anacardic acid (2-hydroxy-6-
pentadecylbenzoic acid; >98% purity), cinnamic acid ((2E)-3-phenylacrylic acid; >95% 
purity), dihydromethysticin (6-[2-(1,3-benzodioxol-5-yl)ethyl]-4-methoxy-5,6-dihydro-2H-
pyran-2-on; >98% purity), fucoxanthin ((3S,3'S,5R,5'R,6S,6'R,8'R)-3,5'-dihydroxy-8-oxo-
6',7'-didehydro-5,5',6,6',7,8-hexahydro-5,6-epoxy-β,β-caroten-3'-yl acetate; 99% purity), 
hyperforin ((1R,5S,6R,7S)-4-hydroxy-5-isobutyryl-6-methyl-1,3,7-tris(3-methyl-2-buten-1-
yl)-6-(4-methyl-3-penten-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione; >90% purity), pinolenic 
acid ((5Z,9Z,12Z)-5,9,12-octadecatrienoic acid; >98% purity), stearidonic acid 
((6Z,9Z,12Z,15Z)-6,9,12,15-octadecatetraenoic acid; >98% purity), and traumatic acid 
((2E)-2-dodecenedioic acid; >98% purity) were purchased from Sapphire Bioscience 
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(Redfern, NSW, Australia). HPLC grade acetonitrile was obtained from Merck (Darmstadt, 
Germany). Purified water was generated using a MilliQ system (Millipore, USA). 
3.4.2 Extract preparation 
Fifty fresh Carica papaya leaves (medium mature leaves without stem) were collected 
from Tropical Fruit World, a plantation orchard farm and research park in northern New 
South Wales, Australia. The papaya plants in this facility had not been sprayed with any 
chemicals. The leaves were thoroughly washed under running tap water to remove any 
particulate matter and rinsed carefully with deionised water to obtain clean leaves. 
 Leaf decoction 
A leaf decoction was prepared following the Australian remedy for cancer treatment; this 
recipe was also used in the recent investigations of Morimoto et al. (Morimoto et al., 2008) 
and Otsuki et al. (Otsuki et al., 2010). Cleaned leaves (200 g) were partly dried in air at 
room temperature for one day and then added to 2.5 L of deionised water in a glass 
beaker, brought to the boil and further heated uncovered for 4 hr. The leaf decoction was 
then lyophilised at -60°C and 0.1 mbar using a Christ Alpha 2-4LD freeze-dryer (Martin 
Christ Gefriertrocknungsanlagen GmbH, Germany) to obtain a brown leaf decoction 
powder, which was portioned for storage at -80°C prior to analysis. 
 Leaf juice 
The method to obtain leaf juice was adapted from procedures in studies on dengue fever 
(Ahmad et al., 2011, Subenthiran et al., 2013) or on the toxicity of Carica papaya leaves 
(Afzan et al., 2012, Halim et al., 2011, Ismail et al., 2014) and was prepared as follows: 
500 g of the cleaned leaves were crushed using a mortar and pestle, without the addition 
of water. The juice was manually separated from the crushed leaf debris using clean 
muslin fabric then lyophilised under the same conditions as the leaf decoction to obtain a 
dark green powder, which was portioned for storage at -80°C prior to analysis.  
 Brewed leaf juice  
To comprehensively evaluate the effect of the heating process, we included in our study 
an extract obtained by brewing the leaf juice powder under the same conditions as used 
for processing the whole leaf to obtain the leaf decoction. Leaf juice powder was added to 
deionised water in a glass beaker with a ratio 200 mg in 100 mL of water (equivalent to the 
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ratio between leaves and water to prepare the decoction) and heated to the boil, then 
further heated uncovered for 4 hr to create brewed leaf juice. The brewed leaf juice was 
then lyophilised under the same conditions as the leaf decoction to obtain a brown 
(brewed leaf juice) powder, which was portioned for storage at -80°C prior to analysis. 
 Sample preparation for cytotoxic studies 
Leaf juice powder, brewed leaf juice powder, and leaf decoction powder (n=3) were 
dissolved at concentrations of 2 mg/mL in medium (stock solution). The stock solutions 
were sterile filtered through a 0.22 µm polyvinylidene fluoride (PVDF) sterile filter (Merck 
Millipore, Germany) and diluted to the desired final concentrations with medium before the 
test.  
 Sample preparation for chemical profile analysis by LC-MS 
Leaf juice powder, brewed leaf juice powder, and leaf decoction powder were dissolved at 
concentrations of 2 mg/mL in water then the obtained solutions subsequently filtered 
through a 0.22 µm PVDF filter (Merck Millipore, Germany). When filtering, an adequate 
volume was passed through membrane filter; the first 1.0 mL was discarded and the 
remaining volume was collected in an HPLC vial, ready for injection. 
To facilitate direct comparison among the extracts, the concentrations of extracts used in 
following cell viability assay and mass spectrometric/chemometric analysis were 
equivalently converted and expressed as concentrations of original leaf (mg/mL). 
3.4.3 Cell culture conditions 
SCC25 cells (ATCC® CRL-1628™, Manassas, VA, USA) were maintained in DMEM/F12 
medium supplemented with 10% v/v heat-inactivated foetal bovine serum, 1% penicillin-
streptomycin and 0.4 µg/mL hydrocortisone. HaCaT cells, a generous gift from Professor 
Fusenig (Boukamp et al., 1988) were propagated in DMEM medium supplemented with 
10% foetal bovine serum and 1% penicillin-streptomycin. The cells were grown in a 
humidified incubator at 37C in a 5% CO2 atmosphere and passaged every 3 days. 
Experiments were performed once cultures reached 70-90% confluence.  
3.4.4 Cell viability assay 
The colorimetric tetrazolium dye procedure, commonly referred to as the MTT assay, 
developed by Mosmann (Mosmann, 1983), was used (with minor modifications) to 
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evaluate the effect of extracts on SCC25 and HaCaT viability. SCC25 or HaCaT cells were 
plated into 96-well plates at densities of 6 × 103 cells per well in 100 µL of DMEM/F12 
(10% serum) and 3 × 103 cells well in 100 µL of DMEM (10% serum), respectively. Cells 
were incubated at 37oC for 24 hr and were subsequently treated for 48 hr with 0.5% serum 
medium containing increasing concentrations of extracts. Control cells were exposed to 
medium only. Cells were then incubated in 100 µL of MTT-containing medium (0.2 mg/mL 
MTT in 0.5% serum medium) at 37C for an additional 2 hr. The medium was then 
removed and the formazan crystals trapped in cells were dissolved in 100 µL of DMSO by 
gentle shaking for 20 min on an orbital shaker. Absorbance of the solubilised product was 
measured at 595 nm using an Imark plate reader (BioRad, USA). The absorbance of cells 
exposed to medium only was taken as 100% cell viability (i.e. the control).  The results 
were expressed as a percentage of the viability of control cells ± standard error of the 
mean (SEM) from 4-8 parallel determinations in three independent experiments (n=3). 
Dose-effect analysis on SCC25 cells was performed by one-way analysis of variance 
(ANOVA) followed by Dunnett’s post-hoc test. Differences between the SCC25 and 
HaCaT cell lines, and interaction between cell line and extract effects were analysed by 
two-way ANOVA with Bonferroni post-hoc tests. All univariate statistical analyses were 
carried out using GraphPad Prism 6.0 (GraphPad Software Inc., San Diego, USA). 
3.4.5 UHPLC-QToF-MS analysis 
Chromatographic analysis of compounds in papaya leaf extracts was performed on an 
Agilent 1290 UHPLC system (Agilent Technologies, Santa Clara, USA). Chromatographic 
separation was achieved using a 2.1×150 mm, 3.5 μm ECLIPSE PLUS C18 analytical 
column (Agilent) with guard protection. Mobile phase A was MilliQ water containing 5 mM 
ammonium bicarbonate and 0.1% formic acid, adjusted to pH 7.0 ± 0.1 and mobile phase 
B was 95% acetonitrile and 5% MilliQ water (v/v) containing 5 mM ammonium bicarbonate 
and 0.1% formic acid. The following gradient elution was adopted: 10 to 80% B from 0 to 
42 min; 80 to 90% B from 42 to 45 min; 90 to 100% B from 45 to 46 min; held at 100% B 
from 46 to 48 min; returned to 10% B over the next 2 min; column re-equilibration with 
10% B for 10 min prior to the next injection. Thus the total chromatographic run time was 
60 min. A flow rate of 0.2 mL/min was applied and 20 μL of sample was injected.  
Each extract was run in triplicate in both positive and negative ionisation mode. Mass 
spectrometric detection was performed on an Agilent 6520 high resolution accurate mass 
quadrupole time-of-flight (Q-ToF) mass spectrometer equipped with a multimode source 
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operating in both Electrospray Ionisation (ESI) and Atmospheric Pressure Chemical 
Ionisation (APCI) modes. Mass spectral acquisition was controlled using MassHunter 
software (B.02.01 SP3 - Agilent). The mass spectrometer was operated using a mass 
range of m/z 100-1700, at a scan rate of 3.0 cycles/second using the following acquisition 
parameters: capillary voltage 2500 V, nebulizer pressure 30 psi, drying gas flow 5.0 L/min, 
gas temperature 300°C, fragmenting voltage 175 V, skimmer voltage 65 V. To ensure the 
desired mass accuracy of recorded ions, continuous internal calibration was performed 
during analysis with the use of reference ions - m/z 121.050873 (protonated purine) and 
m/z 922.009798 (protonated hexakis) in positive ion mode; in negative ion mode, ions with 
m/z 119.0362 (deprotonated purine) and m/z 966.000725 (formate adduct of hexakis) 
were used to correct for scan to scan variations. 
3.4.6 MS data analysis 
Data processing and analysis were performed using Agilent MassHunter Qualitative 
software (Version B.05.00) with Molecular Feature Extractor (MFE) algorithms in concert 
with Mass Profiler Professional (MPP) software (Version 12.1 - Agilent) to align features 
from the chromatograms of all nine samples from three extracts of papaya leaves. The 
following cut-off settings were employed: minimum peak filters of 500 counts, peak 
spacing tolerance of 0.0025 m/z plus 7.0 ppm, assigned charge states limited to a 
maximum of two, minimum compound filters of 3000 counts.  
3.4.7 Chemometric analysis 
The data matrix obtained from MS data analysis was imported into SIMCA-P software 
(Version 13.0.3.0, MKS Umetrics AB, Sweden). Data were log10 transformed and mean 
centered prior to multivariate data analysis using principal component analysis (PCA - 
unsupervised analysis) and Orthogonal Projection to Latent Structures-Discriminant 
Analysis (OPLS-DA - supervised analysis). The scores and loadings plot from these 
analyses, which describe the multivariate relationships of the observations (samples) and 
the variables (LC-MS features) respectively, were then used to determine the features that 
contribute to the differences among the extracts. 
Preliminary compound identification of the features of interest was performed using a 
Personal Compound Database Library (PCDL) (Agilent, USA) with the METLIN Personal 
Metabolite Database and a customised database, compiled using the PCDL platform 
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populated with compounds obtained from Naturally occurring Plant-based Anticancerous 
Compound-Activity-Target Database (NPACT) (Mangal et al., 2013). 
3.5 Results  
3.5.1 Cytotoxicity comparison on SCC25 cells and HaCaT cells 
To evaluate and compare the effect of leaf juice (LJ), brewed leaf juice (BLJ), and leaf 
decoction (LD) on cancer cell viability, the MTT assay was performed on human 
squamous cell carcinoma SCC25 cells and immortal non-cancerous human keratinocyte 
HaCaT cells, using increasing concentrations equivalent to 0.5-20.0 mg/mL of original leaf. 
Figure 3.1 illustrates the effect of three extracts on the cell viability of SCC25 cancer cells. 
The brewed juice and decoction showed similar patterns of the effect, with a plateau at 
concentrations above 2 mg/mL, whereas the leaf juice inhibited the growth of SCC25 cells 
in a concentration-dependent manner (R2 = 0.98 for a near-linear inverse relationship 
between concentration and cell viability).  After treatment with leaf juice at a concentration 
equivalent to original leaf of 20 mg/mL, only approximately 20% of SCC25 cells survived, 
whereas leaf decoction showed a weaker effect by reducing cell viability to a constant 60% 
for much of the range of tested concentrations (2 to 20 mg/mL). Interestingly, the effect on 
SCC25 cells was lost when the leaf juice was brewed, with up to 80% of cells remaining 
viable even at the highest tested concentration. 
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Figure 3.1: Effect of Carica papaya leaf extracts on the survival of SCC25 cancer 
cells. The cell viability was determined by the MTT assay and calculated by comparison 
with the control cells (exposed to medium without extracts). Results are shown as mean ± 
SEM (n=3). 
 
An ideal cancer preventative and therapeutic agent should specifically target the cancer 
cells while the non-malignant cells should be unimpaired. Therefore, we selected the 
HaCaT cell line to perform experiments in parallel with SCC25 cells in order to examine 
the selective growth inhibition towards cancer cells of the extracts. When the cell viability 
between SCC25 cancer cells and non-cancerous HaCaT cells was compared, the leaf 
juice showed the most significant difference between the viability of two cell lines. At the 
highest concentration of test sample, approximately 20% of SCC25 cells surviving in 
comparison with more than 75% of non-cancerous HaCaT cells remaining viable (Figure 
3.2). Meanwhile, the brewed leaf juice had no selective effect and the decoction only 
exhibited a selective effect within a low concentration range (1.0-5.0 mg/mL) whereas, at 
higher concentrations, the leaf decoction killed SCC25 and HaCaT cells to the same 
extent (~40%). 
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                   (A)                                        (B)                                          (C)   
Figure 3.2: Effect of Carica papaya leaf extracts on the survival of SCC25 and HaCaT 
cells. (A) Leaf juice, (B) Brewed leaf juice, (C) Leaf decoction. Results are shown as 
mean ± SEM (n=3). *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001, HaCaT vs SCC25 
(two-way ANOVA with Bonferroni post-hoc test). 
 
3.5.2 Comparison of metabolite profiles of extracts 
The correlation between the changes in the anticancer activity of Carica papaya leaf juice 
(after being brewed) with the potential changes in chemical profile initiated further 
explorations of the differences in the chemical profile of the three extracts. The aim was, 
hence, to identify the compounds that contribute to the distinctly selective anticancer 
activity of leaf juice. Figures 3.3A and 3.3B show typical chromatograms from the LC-MS-
based analysis of leaf juice (LJ), brewed leaf juice (BLJ) and leaf decoction (LD) in positive 
and negative ion mode, respectively. By visual comparison of base peak chromatograms 
in the mass range of 100 to 1700 m/z using a retention time window of 2 to 48 minutes, 
several differences in the profiles were detected between three extracts. In the range from 
32 to 38 minutes in positive ion mode, LJ shows more peaks or larger peaks than BLJ and 
LD. In contrast, there are peaks at 24 min with higher intensities in BLJ and LD than in LJ. 
Similarly, the differences among the extracts are clearly observed for the peaks at about 
17.5 min and 21.5 min in negative ion mode. Figures 3.3C and 3.3D present the 
consistency in the metabolic profiles of three replicates from the same leaf juice extract, 
highlighting the reproducibility of the acquisition. 
0
0
.5
1
.0
2
.0
5
.0
1
0
.0
1
5
.0
2
0
.0
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
            L e a f ju ic e
C o n c e n t r a t io n  o f  le a v e s  ( m g /m L )
%
 c
e
ll
 v
ia
b
il
it
y
**
**
****
****
****
****
0
0
.5
1
.0
2
.0
5
.0
1
0
.0
1
5
.0
2
0
.0
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
            L e a f d e c o c tio n
C o n c e n t r a t io n  o f  le a v e s  ( m g /m L )
%
 c
e
ll
 v
ia
b
il
it
y
*
***
***
S C C 2 5
H aC aT
0
0
.5
1
.0
2
.0
5
.0
1
0
.0
1
5
.0
2
0
.0
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
                     B re w e d  le a f ju ic e
C o n c e n t r a t io n  o f  le a v e s  ( m g /m L )
%
 c
e
ll
 v
ia
b
il
it
y
73 
 
Figure 3.3: LC-MS chromatography of Carica papaya leaf extracts. (A) Base Peak 
Chromatograms (BPC) of leaf juice, brewed leaf juice, leaf decoction in positive ion mode 
and (B) in negative ion mode; (C) BPCs from the three replicates of leaf juice samples in 
positive ion mode and (D) in negative ion mode. The chromatographic region between 2 to 
45 min is shown as it contained almost all of the chromatographic peaks. 
 
Unsupervised analysis by PCA (whereby the grouping or “class” identity of the samples is 
unknown to the algorithm) was initially performed with the entire processed dataset of 
1448 detected features obtained from 9 samples of 3 extracts. The multidimensional liquid-
chromatography-mass spectral data were reduced to three principal components, 
accounting for 83.9% of the total variance. The first two component scores of the model 
are shown in Figure 3.4A. The variation between LJ samples and BLJ/LD samples are 
clearly defined by the first principal component (PC1). The LD and BLJ samples were also 
separated along the second principal component (PC2), suggesting a difference in 
chemical profile between samples brewed as whole leaves or as juice. However, with the 
main focus on the distinct biological activity of leaf juice, LD/BLJ were combined in the 
same group and a supervised multivariate data analysis by OPLS-DA was applied to show 
a more clearly defined separation between two groups: LJ and BLJ/LD (Figure 3.4B). The 
predictive component explains 50.4% of the variance in the data. The OPLS-DA model 
facilitated the retrieval of variables (features) responsible for the differences between two 
groups of extracts, as determined from the loadings plot (Figure 3.4C). In this plot, the 
variables with negative pq[1] values correspond to the metabolites/extract constituents 
with higher abundance in LJ, whereas the comparatively more abundant metabolites in 
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BLJ/LD are variables with positive pq[1] values. With the aim of tentatively identifying 
compounds contributing to the anticancer activity of LJ, all the variables with negative 
pq[1] (highlighted in red) were examined by visual inspection of extracted ion 
chromatograms (EIC) to search for the important/discriminatory features. For example, 
EICs of variables with m/z 518.374 at retention time 16.559 min showed clear differences 
in the abundance between LJ and BLJ/LD (Figure 3.4D-E). Following interrogation of the 
OPLS-DA loadings plot and subsequent visual inspection and curation of the EICs, 90 
metabolites in positive ion mode were identified as clear discriminatory features and are 
listed in Table S1 in Appendix. 
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Figure 3.4: Multivariate analysis of positive ionisation LC-MS data from Carica papaya leaf extracts. (A) PCA scores plot, PC1 [t1] 
versus PC2 [t2] generated from three extracts – Leaf juice (LJ, red triangle), leaf decoction (LD, blue square) and brewed leaf juice (BLJ, 
green circle). Each symbol represents one replicate. (B) OPLS-DA scores plot of predictive component t[1] versus orthogonal component 
t0[1]. The ellipse in (A) and (B) represents the Hotelling’s T2 95% confidence interval for the multivariate data. (C) Loadings plot derived 
from (B); the variables with higher abundance in LJ than BLJ/LD are highlighted in red. (D) Extracted ion chromatogram (EIC) of m/z 
518.374 at retention time 16.559 mins. (E) Mass spectrum for EIC peak.  
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Similarly, unsupervised analysis by PCA (Figure 3.5A) and supervised analysis by OPLS-
DA (Figure 3.5B) were applied to the dataset of 1,500 detected features acquired in 
negative ion mode. After analysis of the loadings plot (Figure 3.5C) and EICs of the 
highlighted features with higher abundance in LJ, 104 metabolites in negative ion mode 
were identified as clear discriminatory features and are shown in Table S2 in Appendix.  
 
The accurate mass values of selected metabolites were used to generate putative 
empirical formulae and were then compared against both the METLIN Personal Metabolite 
Database (64,092 compounds) and the customised NPACT database (1,574 entries of 
plant-derived natural compounds with anticancer activity) using a mass tolerance window 
of ≤ 10 ppm. A total of 1,755 hits were obtained via the database search, for 194 features 
in positive and negative ion modes. Several features had a large number of putative 
compounds, for example 78 different compounds were retrieved as matches for the m/z 
279.2326 in positive ion mode and similarly 99 different compounds corresponded to m/z 
354.2405 in negative ion mode (Tables S1 and S2 in Appendix).  
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Figure 3.5: Multivariate analysis of negative ionisation LC-MS data from Carica papaya leaf extracts. (A) PCA scores plot, PC1 [t1] 
versus PC2 [t2] generated from three extracts – Leaf juice (LJ, red triangle), leaf decoction (LD, blue square) and brewed leaf juice (BLJ, 
green circle). Each symbol represents one replicate. (B) OPLS-DA scores plot of predictive component t[1] versus orthogonal component 
t0[1]. The ellipse in (A) and (B) represents the Hotelling’s T2 95% confidence interval for the multivariate data. (C) Loadings plot derived 
from (B); the variables with higher abundance in LJ than BLJ/LD are highlighted in red. 
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3.5.3 Identification of compounds by authentic standard comparison 
The next step after obtaining the list of putative identifications through database searching 
and matching was confirmation of compound identity. In this study, we have reported the 
results of the direct comparison of chromatographic and spectral data to available 
reference compounds to confirm the authenticity. Among the compounds with reported 
anticancer activities that were tentatively identified in papaya leaf juice, eleven standard 
compounds were available in our laboratory. However, 10 out of 11 features identified on 
the basis of their accurate mass through database searching did not match to the retention 
times of the respective reference compounds as shown in Table 3.1 and Figure 3.6.  
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Table 3.1: Authentic standard comparison of putative compounds in leaf juice with available reference compounds. 
Test standard 
Mass of 
Standard  
Retention time of 
Standard (mins) 
Mass of 
Feature  
 
Mode 
Retention time of 
Feature (mins) 
Molecular 
formula 
Error 
(ppm) 
Anacardic acid 348.2664 17.20  
348.2668 
– 
348.2676 
 
Positive 
19.30 & 20.64 & 
25.15 & 25.83 & 
31.49 
C22H36O3 1-3 
Cinnamic acid 148.0524 4.98 148.0521 Negative 3.31 C9H8O2 2 
Dihydrocoumarin 148.0524 4.20 148.0521 Negative 3.31 C9H8O2 2 
Dihydromethysticin 276.0998 26.12 276.0996 Negative 3.86 C15H16O5 1 
Fucoxanthin 658.4233 40.05 658.4232 Positive 24.57 C42H58O6 1 
Hyperforin 536.3866 37.98 536.3835 Positive 15.65 C35H52O4 5 
Larixyl acetate 348.2664 *ND 
348.2668 
– 
348.2676 
 
Positive 
19.30 & 20.64 & 
25.15 & 25.83 & 
31.49 
C22H36O3 1-3 
Pheophorbide A 592.2686 33.26 592.2686 Positive 28.52 & 33.26 C35H36N4O5 0 
Pinolenic acid 278.2246 27.72 278.2253 Positive 21.76 C18H30O2 2 
Stearidonic acid 276.2089 25.65 276.21 Negative 20.29 C18H28O2 3 
Traumatic acid 228.1362 3.42 228.1362 Negative 5.38 & 5.96 C12H20O4 0 
*ND: Not detected 
80 
Figure 3.6: Authentic standard comparison with available reference compounds 
 
 
Figure 3.6A: Comparison with anacardic acid standard. (i) EIC of m/z 349.2741 for LJ, 
BLJ and LD extracts. (ii) EIC of m/z 349.2741 for LJ extract. (iii) EIC of m/z 349.2741 for 
anacardic acid standard. 
 
 
 
 
Figure 3.6B: Comparison with cinnamic acid standard. (i) EIC of m/z 147.0448 for LJ, 
BLJ and LD extracts. (ii) EIC of m/z 147.0448 for LJ extract. (iii) EIC of m/z 147.0448 for 
cinnamic acid standard. 
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Figure 3.6C: Comparison with dihydrocoumarin standard. (i) EIC of m/z 147.0448 for 
LJ, BLJ and LD extracts. (ii) EIC of m/z 147.0448 for LJ extract. (iii) EIC of m/z 147.0448 
for dihydrocoumarin standard. 
 
 
 
 
Figure 3.6D: Comparison with dihydromethysticin standard. (i) EIC of m/z 275.0923 
for LJ, BLJ and LD extracts. (ii) EIC of m/z 275.0923 for LJ extract. (iii) EIC of m/z 
275.0923 for dihydromethysticin standard. 
148.0521@3.32 
276.0996@3.86 
(ii) 
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Figure 3.6E: Comparison with fucoxanthin standard. (i) EIC of m/z 659.4305 for LJ, 
BLJ and LD extracts. (ii) EIC of m/z 659.4305 for LJ extract. (iii) EIC of m/z 659.4305 for 
fucoxanthin standard. 
 
 
 
Figure 3.6F: Comparison with hyperforin standard. (i) EIC of m/z 537.3908 for LJ, BLJ 
and LD extracts. (ii) EIC of m/z 537.3908 for LJ extract. (iii) EIC of m/z 537.3908 for 
hyperforin standard. 
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Figure 3.6G: Comparison with pinolenic acid standard. (i) EIC of m/z 279.2326 for LJ, 
BLJ and LD extracts. (ii) EIC of m/z 279.2326 for LJ extract. (iii) EIC of m/z 279.2326 for 
pinolenic acid standard. 
 
 
 
 
Figure 3.6H: Comparison with stearidonic acid standard (positive ion mode). (i) EIC 
of m/z 277.2173 for LJ, BLJ and LD extracts. (ii) EIC of m/z 277.2173 for LJ extract. (iii) 
EIC of m/z 277.2173 for stearidonic acid standard. 
278.2253@21.77 
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Figure 3.6K: Comparison with stearidonic acid standard (negative ion mode). (i) EIC 
of m/z 275.2016 for LJ, BLJ and LD extracts. (ii) EIC of m/z 275.2016 for LJ extract. (iii) 
EIC of m/z 275.2016 for stearidonic acid standard. 
 
 
 
 
Figure 3.6L: Comparison with traumatic acid standard. (i) EIC of m/z 227.1289 for LJ, 
BLJ and LD extracts. (ii) EIC of m/z 227.1289 for LJ extract. (iii) EIC of m/z 227.1289 for 
traumatic acid standard. 
276.2089@20.29 
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The feature 592.2686@33.257 was the only feature to be confirmed as a match with its 
proposed authentic standard, in this case pheophorbide A, using three properties: 
retention time, mass spectra and fragmentation spectra. The monoisotopic mass of the 
compound in leaf juice was 593.2758 [M+H]+ and that of pheophorbide A standard was 
593.2752 [M+H]+ (1 ppm difference) when the retention times were matched with 33.257 
min for the compound in LJ and 33.262 min for standard (Figure 3.7A-F). In MS/MS mode, 
both peaks of the compound in leaf juice and the pheophorbide A standard produced four 
major fragment ions with matching m/z values: (m/z 565.2727, 533.2461, 505.2212 and 
460.2235 for compound in LJ) and (m/z 565.2706, 533.2534, 505.2272 and 460.2249 for 
standard) (Figure 3.7G-H). The proposed fragmentation pattern of the pheophorbide A 
molecule producing the following major fragments (m/z 565, 533, 505 and 460) in positive 
ion mode is shown in Figure 3.8. 
 
Figure 3.7: Comparison of feature 592.2686@33.257 in leaf juice against authentic 
standard pheophorbide A. (A) BPC chromatogram of leaf juice. (B) BPC chromatogram 
of pheophorbide A standard. (C) EIC of m/z 593.2752 for leaf juice. (D) EIC of m/z 
593.2752 for pheophorbide A standard. (E) Mass spectrum of peak X in leaf juice. (F) 
Mass spectrum of pheophorbide A standard peak. (G) MS/MS spectrum of peak X in leaf 
juice. (H) MS/MS spectrum of pheophorbide A standard peak. 
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Figure 3.8: Proposed MS/MS fragmentation pattern of pheophorbide A in positive 
ion mode 
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To explore the contribution of pheophorbide A to the anticancer activity of Carica papaya 
leaf juice, the MTT assay was employed to test the effect of this compound on SCC25 
cancer cells and HaCaT cells. Figure 3.9A shows the cytotoxic activity of pheophorbide A 
on SCC25 cells over the range of tested concentrations, from 0.5 to 5 µM (the range 
encompassing the concentrations of pheophorbide A found in leaf juice). However, a 
selective effect was not observed, with pheophorbide A exhibiting higher cytotoxicity on 
non-cancerous HaCaT cells (Figure 3.9B).  
       
Figure 3.9: Effect of pheophorbide A on the survival of SCC25 cancer cells and 
HaCaT cells. Results are shown as mean ± SEM (n=3). ***, p <0.001; ****, p <0.0001,   
(A) SCC25 cells (one-way ANOVA with Dunnett’s post-hoc test). (B) HaCaT vs SCC25 
(two-way ANOVA with Bonferroni post-hoc test).  
  
A B 
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3.6 Discussion 
In traditional medicine, herbal remedies are prepared in many different ways including 
short infusions (e.g. hot tea), longer decoctions (e.g. boiled/brewed tea), tinctures (alcohol 
and water extracts) and macerations (cold-soaking extracts). The processing of medicinal 
plants has been claimed to play several important roles in their therapeutic application: 
reducing toxicity and side effects, improving biological effects, changing properties or 
functions, preserving the active ingredients, correcting an unpleasant taste, as well as 
facilitating administration. In the case of Carica papaya, due to bitterness especially when 
leaves are mature, the leaves are boiled before being consumed as food or as traditional 
medicine. Furthermore, there are other reports relating to the side effects of fresh Carica 
papaya leaves, such as stomach irritation, purgative effects and abortion (Morton, 1987). 
These may well be the principal reasons why a leaf decoction has been used as a 
traditional Aboriginal recipe for cancer treatment (Lucas, 1914, Tietze, 2003).  
However, more recently, people in Sri Lanka, Malaysia and Pakistan have used Carica 
papaya leaf juice widely for the treatment of dengue fever and malaria with promising 
results (Gammulle et al., 2012, Ahmad et al., 2011, Subenthiran et al., 2013). Together 
with validation of pharmacological activities by confirming the significant increase of 
platelet count in patients with dengue fever and dengue haemorrhagic fever, several 
toxicity studies have been conducted to reveal that papaya leaf juice is safe for oral 
consumption. An acute administration study with a single dose of papaya leaf juice 
showed that a dose of up to 2 g/kg body weight did not cause any death or acute adverse 
effects, following clinical observations of the treated rats (Halim et al., 2011). A subsequent 
repeat dose 28-day oral toxicity (subacute toxicity) study in rats (Afzan et al., 2012) and a 
repeat dose 90-day oral toxicity (sub-chronic toxicity) study (Ismail et al., 2014) indicated 
that juice with a dose equivalent of up to fourteen times the level used in traditional 
medicinal practice did not elicit any toxic effects.   
Although our study utilised skin cancer cells, which did not require the ingestion of papaya 
leaves in order to elicit its effects, this information prompted us to test Carica papaya leaf 
juice for anticancer activity in order to assess this extract prior to any potential deleterious 
effects encountered during a long heating process to prepare the decoction. To the best of 
our knowledge, this is the first study to explore the anticancer effect of Carica papaya leaf 
juice. The effects of Carica papaya leaf decoction prepared by using an Aboriginal remedy 
have previously been reported being tested on the growth of different cancer cell lines: 
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breast, stomach, lung, pancreatic, colon, liver, ovarian, cervical, neuroblastoma, 
lymphoma, leukaemia and other haematological cancers (Morimoto et al., 2008, Otsuki et 
al., 2010). In our study, in comparison with the decoction, the leaf juice not only exhibited a 
stronger cytotoxic effect on SCC25 cancer cells, but also produced a clearly significant 
selective effect when tested on non-cancerous HaCaT cells in parallel with cancer cells. 
Furthermore, the results demonstrating a paucity of effect for the brewed leaf juice on the 
cancer cells and no clear selective effect between the two cell lines suggested that the 
brewing process reduced the selective cancer effect of Carica papaya leaf juice on 
squamous cell carcinoma cells SCC25 significantly. This may result from heat inactivation 
of temperature-sensitive bioactive compounds in the leaf juice. In general, many common 
metabolites of the plants such as phenolics are easily hydrolysed and oxidised under the 
high extraction temperature; for example anthocyanin degrades rapidly at temperature 
>70°C and therefore conventional extraction of anthocyanins is typically conducted at 
temperatures from 20 to 50°C (Jackman et al., 1987). However, there are conflicting 
actions of temperature in the extraction of bioactive compounds from plant materials. An 
increase in the extraction temperature can increase both solubility and mass transfer rate 
of compounds thus promoting their solubility in the solvents. In addition, at higher 
temperature, the extraction solvents are able to reach the sample matrices more easily 
due to the decrease in the viscosity and the surface tension thereby improving the 
extraction rate (Dai and Mumper, 2010). This can help to explain some weak effect 
exhibited by the leaf decoction, whereby the high temperature of brewing process for an 
extended period may have increased the solubilisation and released some other active 
constituents from whole leaves. With the promising results of stronger and more selective 
anticancer effects when compared to the Aboriginal remedy, and the above safety data, 
leaf juice warrants further studies to explore its activities on other cancer cell lines.  
In the case of steamed ginger, an increased anti-proliferative effect was observed after 
steaming and subsequent exploration of the change in chemical profile allowed the 
elucidation of 6-shogaol as the compound of interest. 6-Shogaol exhibited a remarkable 
increase in concentration in the samples after being steamed and was identified to be the 
component contributing to the improved anticancer potential (Cheng et al., 2011). We 
therefore applied an untargeted metabolomic approach to compare the chemical profiles of 
leaf juice (exhibiting selective anticancer activity) with those of leaf decoction and brewed 
leaf juice. Multivariate data analyses of profiles acquired by Ultra High Performance Liquid 
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Chromatography-Quadrupole Time of Flight-Mass Spectrometry resulted in the selection 
of 90 and 104 features in positive and negative ion mode respectively.  
Following feature selection, putative compound identification was obtained via database 
searching/matching. Confirmation of this “identification” presents a significant challenge. 
The acquisition and detection of accurate mass data permits the generation of chemical 
formulae but for each mass a number of structures are feasible and this number grows 
considerably with increased molecular weight. In particular, structural isomers cannot be 
differentiated by mass spectral techniques alone. For example, corresponding with the 
mass 278.2 and the chemical formula C18H30O2, there exist at least five isomers including 
pinolenic acid, linolenic acid, calendic acid, punicic acid and eleostearic acid; all of them 
have been reported to possess anticancer activities (Mangal et al., 2013). In this study, a 
number of features with database-derived “identification” were subjected to putative 
comparison with reference compounds available in our laboratory. Tellingly, only one 
compound (pheophorbide A), out of eleven tested standards was successfully confirmed. 
In the light of similar research efforts and the reporting of tables of compound identities, 
this is of some concern (Zunjar et al., 2014, Arkhipov et al., 2014, Sirdaarta et al., 2015). 
Database searching and matching based on accurate mass data alone will provide 
numerous compound identities for each mass. It is therefore puzzling that such tables 
contain single “identities” for each mass with no supporting analytical confirmation, or 
reference to the multiplicity of possible additional identities.  
It is thus feasible to discover several sample constituents and their associated 
IDs/compounds that are unique to one preparation of interest but which are not relevant to 
the desired activity. Conversely, many constituents and their associated/putative IDs are 
unique and possibly relevant but this relevance cannot be confirmed or determined without 
definitive identification and subsequent re-testing in the biological system. 
However, despite pheophorbide A exhibiting cytotoxic activity on SCC25 cancer cells, it 
was found to not be the compound contributing principally to the selective activity of leaf 
juice. Further investigation using a wider variety of isolation, purification and identification 
techniques (MSn, NMR) are required to continue to confirm the identity of compounds 
contributing to the selective effect of Carica papaya leaf juice, particularly those altered by 
the long heating process applied during the traditional Aboriginal remedy preparation. 
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3.7 Additional experiments relevant to this chapter but not included in 
the manuscript 
3.7.1 Introduction  
To explore the activity of papaya leaf extracts on other types of epithelial cells that do not 
require absorption to be in contact with the bioactive molecules, and to attempt to identify 
the intracellular pathway affected by the extracts, in this chapter, an investigation of the 
effects of the leaf juice powder and leaf decoction powder, the extracts with promising 
activity on skin cancer cells, was also conducted on two colon cancer cell lines, HCT116 
and HT29 cells.  
3.7.2 Materials and Methods  
Colon cancer cell lines with a manipulated expression of genes known to promote or 
prevent colon cancer, namely phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic 
subunit α (PIK3CA), p53 and adenomatous polyposis coli (APC) were a generous gift from 
Professor Bert Vogelstein, Johns Hopkins University, USA. HCT116 wild type and HCT116 
p53 (-/-) cells, HCT116-123 (PIK3CA wild type) and HCT116-125 (PIK3CA mutant) were 
cultured in McCoy’s 5A medium, supplemented with 10% FBS and 1% penicillin-
streptomycin. HT29-25 (APC-clone B10) and HT29-26 (βgal-clone A11) cells were 
cultured in McCoy’s 5A medium, supplemented with 10% FBS and 0.6 mg/mL hygromycin 
B. These cells can be induced to express APC or β-galactosidase as a control, by addition 
of 100 µM zinc to their culture medium for 24 hours. The cells were grown in a humidified 
atmosphere with 5% CO2 at 37°C. 
The cells were passaged every three days, and cultures were allowed to reach 70% to 
90% confluence before experiments were performed. Sub-confluent cells were washed 
with Dulbecco’s phosphate-buffered saline, and harvested with trypsin-EDTA solution (1.0 
mL per P10-disc) by incubating for five minutes. The cells were suspended in 5 mL of pre-
warmed culture medium. One-eighth of the HCT116 cells and one-third of the HT29 cells 
were seeded in a new plate for maintenance as per in-house protocols. 
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3.7.3 Results 
Two pairs of HCT116 colon cell lines (Wild type vs. p53 [-/-] and 123PIK3CA Wild type vs. 
125PIK3CA Mutant) were unaffected by the leaf juice powder and leaf decoction powder; 
no increase or decrease in cell survival was observed (Figures 3.10 & 3.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Effect of LJP and LDP on the survival of HCT116 Wild type and HCT116 
p53 (-/-). Results are shown as mean ± SEM (n = 3). *, p < 0.05. (A) HCT116 Wild type; 
(B) HCT116 p53 (-/-) (one-way ANOVA with Dunnett’s post-hoc test); (C) HCT116 Wild 
type vs. HCT116 p53 (-/-) (two-way ANOVA with Bonferroni post-hoc test). 
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Figure 3.11: Effect of LJP and LDP on the survival of HCT116-123PIK3CA Wild type 
and HCT116-125PIK3CA Mutant. Results are shown as mean ± SEM (n = 3). (A) 
HCT116-123PIK3CA Wild type; (B) HCT116-125PIK3CA Mutant (one-way ANOVA with 
Dunnett’s post-hoc test); (C) HCT116-123PIK3CA Wild type vs. HCT116-125PIK3CA 
Mutant (two-way ANOVA with Bonferroni post-hoc test). 
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In the H29 cells, the LJP induced a slight, but significant increase in proliferation, which 
was seen whether or not the cells were made to express functional adenomatous 
polyposis coli (APC) or β-galactosidase (βgal). A similar trend was observed in APC or 
βgal transfected cells, and did not depend on the induction of APC or βgal by addition of 
zinc to the medium (Figures 3.12 & 3.13) 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12: Effect of LJP and LDP on the survival of HT29-25 (APC-clone B10) and 
HT29-26 (βgal-clone A11) induced of APC or β-gal by addition of zinc. Results are 
shown as mean ± SEM (n = 3). *, p < 0.05. (A) HT29-25 (APC-clone B10); (B) HT29-26 
(βgal-clone A11) (one-way ANOVA with Dunnett’s post-hoc test); (C) HT29-25 (APC-clone 
B10) vs. HT29-26 (βgal-clone A11) (two-way ANOVA with Bonferroni post-hoc test). 
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Figure 3.13: Effect of LJP and LDP on the survival of HT29-25 (APC-clone B10) and 
HT29-26 (βgal-clone A11) without addition of zinc. Results are shown as mean ± SEM 
(n = 3). *, p < 0.0. (A) HT29-25 (APC-clone B10); (B) HT29-26 (βgal-clone B11) (one-way 
ANOVA with Dunnett’s post-hoc test); (C) HT29-25 (APC-clone B10) vs. HT29-26 (βgal-
clone B11) (two-way ANOVA with Bonferroni post-hoc test). 
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3.7.4 Discussion 
With the promising results on skin cancer cells, both leaf juice powder and leaf decoction 
powder were further tested on cell lines of another type of cancer cell that, like skin cells, 
are directly accessible to the papaya compounds, i.e. they do not require gastrointestinal 
absorption for the cells to be exposed to extracts. We chose three pairs of colon cancer 
cells: HCT116 Wild type vs. p53(-/-); HCT116-123PIK3CA Wild type vs. 125PIK3CA 
Mutant; and HT29-25 (APC-clone B10) vs. 26 (βgal-clone B11) with the purpose of 
investigating the extracts’ effects on other types of epithelial cells and also to provide some 
information on the mechanisms of action if any activities were observed. In these cell lines, 
the pathways controlled by tumour suppressors p53 or APC, together with the PIK3 
pathway, can be selectively studied, and this is particularly important because they are 
commonly mutated genes in colon cancer (Chen and Huang, 2009).  
However, the colon cancer cells were not sensitive to the papaya leaf extracts, with no 
decrease in the viability of either HCT116 cells or HT29 cells observed after the treatment 
with leaf juice powder and leaf decoction. This result correlates well with the observation of 
only 10% cell death in the patent of Morimoto et al. when another type of colon cancer 
cells (DLD-1) was treated with papaya decoction at a high concentration equivalent to 27 
mg/mL of leaf (Morimoto et al., 2008). Similar results were also reported for a chloroform 
extract of Japanese papaya leaf, which showed no growth inhibitory effect on either 
HCT116 and HT29, as well as several other colon carcinoma cell lines (including SW480 
and SW837) (Kaneshiro et al., 2005). These results indicate that the effect of papaya 
extracts on the survival of cancer cells is likely to be cancer-type specific, which warrants 
the exploration of other directly accessible cancer types, such as melanoma. 
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Chapter 4: Bioassay-guided Fractionation 
of Leaf Juice Using Preparative 
Chromatography  
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4.1 Foreword 
To further explore the selective anticancer effects of leaf juice from Chapter 3, bioassay-
guided fractionation of this extract by preparative chromatography was performed. This 
chapter describes the investigation of thirteen fractions obtained from leaf juice on cancer 
cell toxicity and an evaluation of the chemical composition of those fractions with the most 
significant activity. 
 
Sections 4.2 to 4.4 form a manuscript that is being prepared for publication.  
 
 
 
 
 
 
 
  
Thao Nguyen, Marie-Odile Parat, Paul Shaw, Mark Hodson, Amitha Hewavitharana. 
Multicomponent additivity is responsible for the cytotoxicity of Carica papaya 
leaf juice on human squamous cell carcinoma cells (manuscript in preparation).  
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4.2 Introduction 
Carica papaya originated in Southern Mexico and Costa Rica and is widely cultivated in an 
area of more than 440,000 hectares in over 60 countries (Emmanuelle Bournay, 2012, 
Office of the Gene Technology Regulator, 2008). The leaves, bark, roots, latex, fruit, 
flowers and seeds of Carica papaya have a wide range of reported medicinal applications 
in traditional medicine. One preparation from Carica papaya leaves, a decoction prepared 
for use as an Australian Aboriginal remedy, has attracted the attention of scientists as well 
as various media with respect to its potential use in the treatment of cancer (Nguyen et al., 
2013). Recently, in order to investigate the effects imparted by the lengthy heating process 
in the preparation of such a decoction, we compared the cytotoxic effects of Carica papaya 
leaf decoction on human squamous cell carcinoma cells (SCC25) with those obtained 
using untreated leaf juice prepared by mechanical crushing and squeezing of fresh papaya 
leaves (Nguyen et al., 2016). Interestingly, the leaf juice not only exhibited a stronger 
cytotoxic effect on SCC25 cancer cells than the leaf decoction, but also produced a 
significant cancer-selective effect when tested in parallel on cancer SCC25 cells and non-
cancerous human keratinocyte HaCaT cells. To better understand the composition of leaf 
juice and purify the observed selective cytotoxic effect, we carried out bioactivity-guided 
fractionation of leaf juice. To our knowledge, this is the first study of this type carried out 
using Carica papaya leaf juice. 
4.3 Materials and Methods 
4.3.1 Chemicals and reagents 
Dulbecco’s Modified Eagle’s Medium (DMEM), DMEM-F12, penicillin/streptomycin, trypsin, 
and foetal bovine serum (FBS) were purchased from Invitrogen (Life Technologies, 
Mulgrave, VIC, Australia). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT), and dimethyl sulfoxide (DMSO) were obtained from Sigma-Aldrich (Castle Hill, 
NSW, Australia). HPLC grade acetonitrile and methanol were obtained from Merck 
(Darmstadt, Germany). Purified water was generated using a MilliQ system (Millipore, 
USA). 
4.3.2 Carica papaya leaf juice preparation 
Fresh Carica papaya leaves (medium mature leaves without stem) were collected from 
Tropical Fruit World (TFW), a privately owned plantation orchard farm and research park in 
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northern New South Wales, Australia (http://www.tropicalfruitworld.com.au/). The papaya 
plants in this facility are neither protected nor endangered species and had not been 
sprayed with any chemicals. The leaves were thoroughly washed under running tap water 
to remove any particulate matter, and then rinsed with MilliQ water before processing. 
The method to obtain leaf juice was adapted from procedures used in dengue fever 
studies (Ahmad et al., 2011, Subenthiran et al., 2013) and toxicity studies (Afzan et al., 
2012, Halim et al., 2011, Ismail et al., 2014): The cleaned leaves were crushed using a 
mortar and pestle, without the addition of water. The juice was manually separated from 
the crushed leaf debris using clean muslin fabric, then lyophilised at -60°C and 0.1 mbar 
using a Christ Alpha 2-4LD freeze-dryer (Martin Christ Gefriertrocknungsanlagen GmbH, 
Germany) to obtain a dark green powder, which was portioned for storage at -80°C until 
analysis. 
4.3.3 Fractionation by preparative HPLC 
Fractionation was performed on an Agilent liquid chromatography system (Agilent 
Technologies, Inc., Wilmington, Del, USA) using a 21.2 x 250 mm, 7 µm Eclipse XDB-C18 
preparative column (Agilent) and the eluent, at a flow rate of 10 mL/min and consisting of a 
mixture of water and methanol (see Table 4.1), was monitored at three UV wavelengths 
(254, 280 and 320 nm). 
For the first step of fractionation, leaf juice powder was dissolved in water at a 
concentration of 2 mg/mL. Twenty millilitre aliquots were injected and eluted using the 
gradient shown in Table 4.1. Fractions were collected using an automatic fraction collector 
system. Fraction 1 (F1) represented 0 to 14 min elution, fraction 2 (F2) from 14 to 31.5 min 
elution, fraction 3 (F3) from 31.5 to 49 min elution, fraction 4 (F4) from 49 to 112 min 
elution. 
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Table 4.1: Gradient elution used for the first and second step of fractionations 
First step of fractionation  Second step of fractionation 
Time (min) Gradient (% MeOH)  Time (min) Gradient (% MeOH) 
0 0  0 0 
70 100  49 25 
112 100  49.1 100 
114 0  110 100 
125 0  112 0 
   120 0 
 
The second step of fractionation involved further separation of F1 and F3. In this step, four 
sub-fractions (F1.1 to F1.4) were obtained from fraction F1 using gradient elution as 
shown in Table 4.1. Fraction 1.1 (F1.1) was collected from 0 to 10.5 min elution, fraction 
1.2 (F1.2) from 10.5 to 21 min elution, fraction 1.3 (F1.3) from 21 to 31.5 min elution, and 
fraction 1.4 (F1.4) from 31.5 to 49 min elution. Fraction F3 was collected in five sub-
fractions (F3.1 to F3.5) by performing peak-based fraction collection using the detected 
absorbance at 280 nm and the same gradient as used in the first step.  
All fractions and sub-fractions (13 fractions in total) were concentrated to a small volume at 
30°C and 120 rpm under vacuum using an IKA®RV 10 rotary evaporator (IKA-Werke, 
Germany), then lyophilised using a freeze-dryer, as outlined for fresh leaf juice above. All 
lyophilised fractions were stored at -80°C until analysis. 
4.3.4 Sample preparation for cytotoxic studies 
Leaf juice and its fractions, prepared as above, were dissolved in cell culture medium at 
concentrations of 500 µg/mL (stock solutions) and aseptically filtered through a 0.22 µm 
polyvinylidene fluoride (PVDF) sterile filter (Merck Millipore, Germany). The sterile stock 
solutions were then diluted to the desired final concentrations with medium before the 
cytotoxicity assay. 
4.3.5 Cell culture conditions 
SCC25 cells (ATCC® CRL-1628™, Manassas, VA, USA) were maintained in DMEM/F12 
medium supplemented with 10% v/v heat-inactivated foetal bovine serum, 1% penicillin-
streptomycin, and 0.4 µg/mL hydrocortisone. HaCaT cells, a generous gift from Prof. 
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Norbert Fusenig (Boukamp et al., 1988) were propagated in DMEM medium supplemented 
with 10% foetal bovine serum and 1% penicillin-streptomycin. The cells were grown in a 
humidified incubator at 37C in a 5% CO2 atmosphere and passaged every 3 days. 
Experiments were performed once cultures reached 70-90% confluence. 
4.3.6 Cell viability assay 
The colorimetric tetrazolium dye procedure commonly referred to as MTT assay, 
developed by Mosmann (Mosmann, 1983), was used (with minor modifications) to 
evaluate the effects of extracts on SCC25 and HaCaT viability. SCC25 or HaCaT cells 
were plated into 96-well plates at densities of 6 × 103 cells per well in 100 µL of DMEM/F12 
(10% serum) and 3 × 103 cells well in 100 µL of DMEM (10% serum), respectively. Cells 
were incubated at 37oC for 24 hr and were subsequently treated for 48 hr with 0.5% serum 
medium containing increasing concentrations of extracts. Control cells were exposed to 
medium only. Cells were then incubated in 100 µL of MTT-containing medium (0.2 mg/mL 
MTT in 0.5% serum medium) at 37C for an additional 2 hr. The medium was then 
removed and the formazan crystals trapped in cells were dissolved in 100 µL of DMSO by 
gentle shaking for 20 min on an orbital shaker. Absorbance of the solubilised product was 
measured at 595 nm using an Imark plate reader (BioRad, USA). The absorbance of cells 
exposed to medium only was taken as 100% cell viability (i.e. the control). The results 
were expressed as a percentage of the viability of control cells ± standard error of the 
mean (SEM) from 4-8 parallel determinations in three independent experiments (n=3). 
Dose-effect analysis on SCC25 cells was performed by one-way analysis of variance 
(ANOVA) followed by Dunnett’s post-hoc tests. Differences of the effects on SCC25 cells 
among the extracts were evaluated by one-way ANOVA followed by Tukey’s multiple 
comparison tests. Differences between the SCC25 and HaCaT cell lines, and interaction 
between cell line and extract effects were analysed by two-way ANOVA with Bonferroni 
post-hoc tests. All univariate statistical analyses were carried out using GraphPad Prism 
6.0 (GraphPad Software Inc., San Diego, USA). 
4.3.7 UHPLC-QToF-MS analysis  
Profiling of the metabolites in fractions was conducted using a UHPLC-QToF-MS system 
consisting of an Agilent 1290 UHPLC system (Agilent Technologies, Santa Clara, USA) 
and an Agilent 6520 high resolution accurate mass quadrupole time-of-flight (QToF) mass 
spectrometer equipped with a multimode source operating in both Electrospray Ionisation 
(ESI) and Atmospheric Pressure Chemical Ionisation (APCI) modes. Chromatographic 
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separation was achieved using a 2.1×150 mm, 3.5 μm Eclipse Plus C18 analytical column 
(Agilent) with guard protection. Solvent A was water, and solvent B was methanol. 
Gradient elution of 0 to 10% B for 15 mins was adopted to analyse F1.1; gradient elution of 
45 to 65% B for 15 mins was used to analyse F3.2 and F3.4. A flow rate of 0.2 mL/min and 
an injection volume of 20 μL (1 mg/mL fraction F1.1 in water and 1 mg/mL fraction F3.2 or 
F3.4 in 40% v/v methanol) were used in all runs. Mass spectral acquisition was controlled 
using MassHunter software (B.02.01 SP3 - Agilent). The mass spectrometer was operated 
using a mass range of m/z 100-1700, at a scan rate of 3.0 cycles/second using the 
following acquisition parameters: capillary voltage 2500 V, nebulizer pressure 30 psi, 
drying gas flow 5.0 L/min, gas temperature 300°C, fragmenting voltage 175 V, skimmer 
voltage 65 V. 
 
Data processing and analysis were performed using Agilent MassHunter Qualitative 
software (Version B.05.00) with Molecular Feature Extractor (MFE) algorithm. The 
following cut-off settings were employed: minimum peak filters of 500 counts, peak 
spacing tolerance of 0.0025 m/z plus 7.0 ppm, assigned charge states limited to a 
maximum of two, minimum compound filters of 3000 counts. 
 
The Molecular Feature Generator algorithm was utilised to generate putative molecular 
formulae from the following common elements C, H, N, O, P, and S. Compound 
identification was carried out by searching against a Personal Compound Database 
Library (PCDL) (Agilent, USA) with the METLIN Personal Metabolite Database. 
4.4 Results and Discussion 
Although there are numerous sources of anecdotal evidence, the anticancer effects of 
Carica papaya leaves have been demonstrated only in a very few scientific studies as 
reviewed in (Nguyen et al., 2013). In contrast to the present study, none of these reported 
studies were undertaken using leaf juice. Morimoto et al, in their study reported as a 
patent, used a gel filtration chromatography method to fractionate the papaya leaf extract 
(brewed leaves in water) according to molecular weight (Morimoto et al., 2008). They 
reported two fractions that were capable of suppressing the proliferation of the tested 
cancer cell lines, one containing compounds with molecular weight 1700, 1000, 700 and 
300, and the other containing compounds with molecular weights 1700, 1000, 600, 400 
and 200. Later, in 2010, another study using molecular weight fractionation accomplished 
using a cellulose membrane tube reported that the active components (in similarly brewed 
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aqueous papaya leaf extract with growth inhibitory effects on tumour cells and also 
immunomodulatory effects) were present in the fraction that contained compounds with 
molecular weights lower than 1000 (Otsuki et al., 2010). More recently, an Australian 
research group prepared saponin-enriched water and ethanolic papaya leaf extracts, and 
found that the ethanolic extracts with higher levels of saponins were more effective in 
inhibiting the proliferation of two pancreatic cancer cell lines, MiaPaCa-2 and ASPC-1 
(Vuong et al., 2015). 
As noted above, we have previously observed that, in comparison to the commonly used 
papaya leaf decoction, papaya leaf juice exhibited a more pronounced cytotoxic effect on 
SCC25 cancer cells, and produced a selective anti-cancer effect: papaya leaf juice killed 
approximately 80% of SCC25 cells but only 25% of non-cancerous HaCaT cells (at the 
highest tested concentration of 500 µg/mL of leaf juice equivalent to 20 mg/mL of leaves) 
(Nguyen et al., 2016). In the study reported here we have, using bioassay-guided 
fractionation, explored this potentially important and selective cytotoxic effect of papaya 
leaf juice. The fractionation scheme used in this study (as described in the Materials and 
Methods section), along with the amounts obtained, is depicted in Figure 4.1. 
 
Figure 4.1: Schematic representation of two-step fractionation of leaf juice powder 
  
Leaf juice
200 mg
F1: 98.84 mg
F1.1: 84.18 mg
F1.2: 1.19 mg
F1.3: 0.96 mg
F1.4: 1.22 mg
F2: 2.96 mg F3: 7.54 mg
F3.1: 0.55 mg
F3.2: 3.72 mg
F3.3: 1.78 mg
F3.4: 0.78 mg
F3.5: 0.27 mg
F4: 3.64 mg
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In our previous study, we compared the effects of dimethyl sulfoxide and ethanol (as the 
solvent used for sample introduction) on the cells used in the cytotoxicity assay. DMSO at 
a concentration as low as 0.05% was seen to cause significant toxicity to SCC25, and 
significantly disparate effects were observed between the two cell lines. In contrast, 
ethanol up to a concentration of 1.0% did not have a significant effect on the viability of 
either cell line (Nguyen et al., 2015). These results alerted us to test the cytotoxic effects of 
the organic solvents used in the mobile phase during the fractionation process. Although 
the fractions collected from the preparative column were concentrated and then lyophilised 
to remove the solvents, any residual organic solvents could potentially affect the tested cell 
lines. Acetonitrile and methanol are the most commonly used organic mobile phase 
solvents for reversed phase chromatographic separations (Dunn et al., 2011). Therefore, a 
volume of acetonitrile or methanol equivalent to the largest volume used in our fractions 
was concentrated and lyophilised, and the residue reconstituted in the appropriate volume 
of medium to screen for cytotoxicity on the cell system. Figure 2 illustrates that methanol 
residues did not significantly affect either cell line whereas residues from acetonitrile 
reduced the cell viability of SCC25 and HaCaT lines to 66.8±1.7% and 55.0±3.3%, 
respectively. All fractionation procedures in this study were therefore performed using 
methanol as the organic solvent in mobile phase. 
         
Figure 4.2: Effect of methanol and acetonitrile residues on the survival of SCC25 
cells (A) and HaCaT cells (B). 160 mL of acetonitrile or 190 mL of methanol were 
concentrated, lyophilised and reconstituted in 3 mL of medium. Results are shown as 
mean ± SEM (n=3). ****, p<0.0001, vs control cells (one-way ANOVA with Dunnett’s post-
hoc test). 
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In the first step of our bioactivity-guided fractionation of papaya leaf juice, four fractions, 
ranging from high (F1) to low (F4) aqueous mobile phase concentrations (and hence 
respective high to low mobile phase polarities), were obtained, as shown in Figure 4.3.  
 
Figure 4.3: HPLC-UV chromatogram at 254 nm of fractions F1-F4 from leaf juice.  
 
The cytotoxic effects of these fractions on both SCC25 and HaCaT cells were examined 
and the results detailed in Table 4.2. The polar fraction F1 and moderately polar fraction 
F3 reduced the viability of SCC25 cells to 57.2 ± 2.3% and 63.6 ± 2.5%, respectively and 
exhibited selective cytotoxic activity, whereas fractions F2 and F4 did not have any effects 
on either of the cell lines tested (Figure 4.4A and 4.5). However, both the cytotoxic effect 
and the selectivity of the original (parent) leaf juice were found to be significantly greater 
than those of the fractions (Figure 4.4A and 4.5): in Figure 4.5, only 23.0% of SCC25 cells 
survived after being exposed to 500 µg/mL of leaf juice powder while 57.2%, 91.0%, 
63.6% and 94.7% of cells were viable after being exposed to individual fractions F1, F2, 
F3 and F4, respectively. The concentrations of fractions used in cell assays were 
calculated so that the amounts of material in each fraction were directly comparable to 
those in the original leaf juice powder. Hence, the observed differences in effects (between 
the leaf juice and its fractions) cannot result from simple chemical dilution effects alone. 
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Table 4.2: Effect of leaf juice and fractions on SCC and HaCaT cells 
Extract concentration 
Cell viability (%) (Mean ± SEM) 
250 μg/mL 500 μg/mL 
SCC25 HaCaT SCC25 HaCaT 
Leaf juice 49.1±1.8 88.2±2.1 23.0±2.6 75.4±1.3 
F1 63.9±1.8 70.5±0.9 57.2±2.3 67.1±1.3 
F2 94.1±1.3 95.5±1.3 91.0±0.5 93.0±3.0 
F3 67.2±0.5 85.7±1.5 63.6±2.5 83.1±1.9 
F4 95.8±2.2 95.1±1.4 94.7±2.0 92.8±1.5 
C1+2+3+4 57.7±1.9 76.7±3.1 46.2±3.0 72.4±1.5 
F1.1 64.5±3.5 71.9±4.4 60.0±3.6 65.3±7.2 
F1.2 102.8±0.7 99.4±0.8 98.5±1.3 96.9±0.5 
F1.3 105.4±3.1 103.1±0.5 105.5±2.1 101.5±1.8 
F1.4 106.0±4.1 101.1±0.7 105.0±4.6 104.1±0.4 
C1.1+1.2+1.3+1.4 62.2±2.9 74.2±4.6 56.3±2.3 71.8±3.1 
F3.1 95.7±2.4 98.5±2.2 93.9±1.9 97.9±3.3 
F3.2 67.1±2.9 79.6±3.9 60.2±2.6 80.0±1.1 
F3.3 98.3±0.3 98.8±0.6 95.0±3.0 92.5±1.9 
F3.4 72.8±2.3 82.5±1.2 65.0±1.1 78.3±0.7 
F3.5 101.5±4.1 102.5±3.1 99.7±5.1 100.0±3.1 
C3.1+3.2+3.3+3.4+3.5 62.5±1.5 75.9±1.5 62.7±0.7 69.3±2.3 
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Figure 4.4: Effect of papaya leaf juice fractions on the survival of SCC25 and HaCaT cells. (A) Leaf juice and four fractions F1-F4. 
(B) Fraction 1 and subfractions F1.1 to F1.4. (C) Fraction 3 and sub-fractions F3.1 to F3.5. Results are shown as mean ± SEM (n=3). *, 
p<0.05; **, p <0.01; ***, p <0.001, ****, p <0.0001, HaCaT vs SCC25 (two-way ANOVA with Bonferroni post-hoc test). 
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Figure 4.5: Effect of papaya leaf juice and fractions (F1, F2, F3, F4 and combination 
of four fractions) on the survival of SCC25 cancer cells. Results are shown as mean ± 
SEM (n=3). *, p<0.05; **, p <0.01; ***, p <0.001, ****, p <0.0001 (one-way ANOVA with 
Dunnett’s post-hoc test and Tukey’s multiple comparison test) 
The finding that the leaf juice (“parent fraction”) possesses significantly greater bioactivity 
than its individual fractions is not unusual in bioassay-guided fractionation (Houghton, 
2000) and several studies have reported similar observations (Jackson et al., 2000, Liu et 
al., 2005). The cytotoxic effects of stembark extract from Kigelia pinnata were diminished 
following fractionation by a silica gel column (Jackson et al., 2000). Similarly, the anti-
angiogenic efficacies of the sub-fractions of black raspberry were lower than that of the 
parent fraction (Liu et al., 2005). Houghton, in reviewing the discovery of novel drugs from 
natural sources, has suggested potential explanations for this decrease in activity after 
fractionation: i.e. breakdown or transformation of the active compounds due to hydrolysis 
or esterification during the fractionation process, and/or degradation of active compounds 
due to their separation from “protectants” in the whole extract (Houghton, 2000). To 
identify whether any loss of activity occurred during fractionation in our study using papaya 
leaf juice, all four fractions (F1-F4) were recombined in the appropriate proportions and 
amounts to produce an extract equivalent to the parent leaf juice preparation. As shown in 
Figure 4.5, the original activity of the parent leaf juice was not completely retained in the 
combined fractions with 46.2 ± 3.0% of cells remaining viable with the combined fraction 
compared to only 23.0 ± 2.6% viability with the original leaf juice. The loss of activity might 
be due to the reasons discussed above or to the fact that bioactive compounds may not be 
retained on the C18 column leading to losses during the reverse phase preparative 
chromatography fractionation process. 
110 
However, a significantly stronger effect was observed for combined versus individual 
fraction(s) with p<0.05, <0.01 or <0.001 for the difference between the effect of combined 
fraction and fraction F1, F3 or F2/F4, respectively (Figure 4.5). The explanation for this 
difference may be the occurrence of additive effects between the active compounds in the 
combined fraction. Moreover, the statistical difference of the effect of F1 from that of F3 
was found to be non-significant (p>0.05). This clearly indicates that the cytotoxic effect of 
Carica papaya leaf juice is not due to a single compound, but likely a number of 
constituents acting together to produce the overall effect. Many examples supporting this 
phenomenon can be found in reviews about additive or synergistic interactions in 
traditional and herbal phytomedicines (Williamson, 2001, Lewandowska et al., 2014, 
Ulrich-Merzenich et al., 2009, Rather et al., 2013). The assessment of synergism 
represents an emerging area in phytochemical research, seeking to explore improved 
therapeutic effects from herbal drugs used in traditional medicine (Zhang et al., 2014). 
Fractions 1 and 3 with the observed selective effects on cancer cells were further divided. 
Fraction 1 was separated into four sub-fractions using a mobile phase with greater water 
content (methanol gradient from 0% to 25% within 49 minutes) in order to better separate 
the polar compounds (Figure 4.6). During the first stage of fractionation, four primary, 
distinguishable peaks were noted in fraction F3 (Figure 4.3). Hence, five sub-fractions 
(including baseline; F3.1 to F3.5) were obtained by performing peak-based fraction 
collection using the same gradient. The fractions obtained are shown in Figure 4.7. 
 
 
Figure 4.6: HPLC-UV chromatogram at 254 nm of sub-fractions F1.1-F1.4 from 
fraction F1. 
 
F 1.1 F 1.2 F 1.3 F 1.4
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Figure 4.7: HPLC-UV chromatogram at 254 nm of sub-fractions F3.1-F3.5 from 
fraction F3. 
 
In the second stage of fractionation (of F1 and F3), we explored the previously noted 
selective cytotoxic effect (using SCC25 cancer cells and non-cancerous HaCaT cells). As 
shown in Figures 4.4B and 4.4C and Table 4.1, the results are similar to those obtained 
following the first fractionation: higher selectivity in cancer cell toxicity observed with the 
parent fractions (F1 and F3) compared to any of the single fractions (F1.1 to F1.4 and F3.1 
to F3.5). Although somewhat less active when compared to the parent fraction, the 
combined sub-fractions in general displayed an increased selectivity in cytotoxic effect 
compared to the individual sub-fractions. However, fractions 3.2 and 3.4 showed an 
activity lower than that of the parent fraction (F3), but similar to or better than the 
combined fraction. Because of this observation, and since the re-combination of F1 sub-
fractions also displayed cancer cell selectivity, we explored the chemical composition of 
three fractions (1.1, 3.2 & 3.4) using LC-MS and the associated data analysis software as 
described above. 
 
Figures 4.8A-B-C and 4.8X-Y-Z show extracted ion chromatograms from the LC-MS-
based analysis of sub-fractions 1.1, 3.2 and 3.4 in positive and negative ion mode, 
respectively. Using the Molecular Feature Extraction algorithm, 160, 161 and 95 features 
were found in positive ion mode for fractions F1.1, F3.2 and F3.4, respectively whilst 
almost a thousand features were observed for each fraction in negative ion mode. Sub-
fractions 3.2 and 3.4 were obtained by performing peak-based fraction collection as single 
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peaks; however, each fraction actually comprises of hundreds of features, precluding 
further isolation of interesting compound(s) in this complex mixture. 
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Figure 4.8: LC-MS extracted compound chromatograms of sub-fractions. (A) F1.1, (B) F3.2 and (C) F3.4 in positive ion mode. (X) 
F1.1, (Y) F3.2  and (Z) F3.4 in negative ion mode.  
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Table 4.3 lists ten features in positive ion mode with the largest abundance in each fraction 
together with their putative empirical formulae generated from the accurate mass values 
and the number of hits obtained by searching against METLIN Personal Metabolite 
Database (64,092 compounds) using a mass tolerance window of ≤ 10 ppm. As can be 
seen in Table 4.3, the most dominant constituents in each fraction only occupy between 
11% to 23% of the total abundance, highlighting possible difficulties in performing further 
fractionation steps.  
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Table 4.3: List of 10 compounds in positive ion mode with largest abundance in 
each fraction 
Experimental 
Mass 
m/z  
% 
abundance 
in fraction 
Putative 
empirical 
formula 
Error 
(ppm) 
Number of hits 
against 
METLIN  
Sub-fraction 1.1  
174.1000 175.1073 15.48 C7H14N2O3 2.4 5 
132.0230 150.0568 4.78 C5H14NO2S 1.2 - 
342.1162 381.0793 3.85 C12H22O11 0 30 
245.1721 246.1794 3.4 C11H23N3O3 7.4 2 
188.1150 189.1223 2.72 C8H16N2O3 5.7 11 
175.0025 176.0101 2.39 ND - - 
115.0629 116.0702 2.21 C5H9NO2 3.5 5 
311.1591 312.1664 1.81 C13H21N5O4 0.7 6 
Sub-fraction 3.2  
756.2111 757.2191 11.15 C33H40O20 0.3 71 
875.2854 876.2927 5.59 ND - - 
1534.3953 1535.4028 4.64 C75H75O35 3.8 1 
442.2905 443.2978 3.98 ND - - 
417.2363 418.2435 3.82 C16H31N7O6 -6.5 6 
610.1535 611.1608 3.29 C27H30O16 -0.2 100 
343.2465 344.2541 2.54 C17H33N3O4 1.8 12 
740.2148 763.2034 2.18 C33H40O19 2.1 30 
636.384 418.2436 1.55 ND - - 
511.3105 512.3178 1.41 ND - - 
Sub-fraction 3.4 
632.1361 633.1434 23.19 ND - - 
350.207 351.2143 11.17 C20H30O5 6.6 32 
610.1538 611.1613 6.5 C27H30O16 -0.7 100 
1242.2804 1243.288 5.89 ND - - 
640.4156 663.4047 2.9 C35H60O10 4.8 1 
542.1795 543.1868 2.84 C28H30O11 1.3 1 
594.1586 617.1478 2.53 C27H30O15 -0.2 106 
756.2103 779.1994 2.33 C33H40O20 1.3 71 
1258.2542 1259.2607 2.25 ND - - 
762.196 763.2045 2.2 ND - - 
   ND: Not determined  
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Bioactivity-guided fractionation was performed to tentatively identify the compounds that 
may be responsible for the selective cytotoxicity observed for papaya leaf juice in this 
study. It is unlikely, however, that further fractionation and isolation of a “single bioactive 
compound” is feasible using this analytical system. As discussed above, incubation of the 
active fractions 1 and 3 with the cell-based assay systems allowed some 57.2% and 
63.6% of the cancer cells respectively to remain viable. These fractions were not adjacent 
(separated by fraction 2) and it is hence likely that there will be few, if any common 
compounds in these two fractions. In addition, to explore one of these fractions in search 
of an active compound would mean disregarding some 40% of the anti-cancer activity that 
is present in the other fractions. It appears therefore, that some chemical combinatorial 
effect may play a significant role in the selective cytotoxic activity of papaya leaf juice on 
cancer cells; a similar trend was also noted with additional sub-fractionation. In itself this 
observation should not be surprising since the causes of impaired cell viability may be 
multifactorial in nature and require therefore a multiplicity of chemical/receptor interactions 
to generate a multi-target effect. The search for anticancer activity in single agents from 
plant-based sources has had only limited success (Cragg & Boyd, 1996), providing an 
emerging impetus for studies describing and investigating phytochemical additive or 
synergistic effects (Ulrich-Merzenich et al., 2010).  
4.5 Conclusion 
Papaya leaf juice was found to display selective cytotoxicity towards SCC25 cancer cells 
relative to non-cancerous HaCaT cells. Bioassay-guided liquid chromatography 
fractionation studies were carried out using methanol as the organic mobile phase solvent. 
These studies indicated that multiple compounds might be responsible for the observed 
cell toxicity of papaya leaf juice when both a polar fraction and a medium-low polar fraction 
were shown to possess cytotoxic potential. Such compounds in those fractions were also 
found to act in concert to yield an improved effect when combined. However, the 
magnitude of the selective effects on cell viability resulting from these re-combined 
fractions was significantly lower than those of the parent leaf juice thereby indicating that 
there are losses during the fractionation process. Our data, although preliminary, shed 
light on further research avenues using Carica papaya leaf juice as a whole extract rather 
than after fractionating the juice. Future investigations will also need to focus on 
standardisation of the whole extract by potentially using high resolution techniques such as 
NMR, which can capture additional structural information relating to the components 
present in complex mixtures and then performing bio-informatics analysis (metabolomics). 
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Such an approach, when coupled with clinical trials, may provide sufficient scientific 
rationale for the use of the whole extract as a cancer treatment. 
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Chapter 5: General Discussion                  
and Future Directions 
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This chapter discusses the findings of the thesis and provides suggestions for future 
research arising from the present work. 
5.1 General discussion 
Plant-derived natural products have been one of the most successful sources of 
pharmacologically active compounds, either directly as therapeutic agents or as lead 
compounds for new drug development, owing to the vast number of secondary metabolites 
produced within the plant kingdom (with an estimation of more than 200,000 metabolites) 
(Hartmann, 2007). Recent reviews of the status and trends of natural products in drug 
discovery continue to confirm the importance of plants as unique therapeutic solutions and 
as resources for exploration in modern natural product research (Dias et al., 2012, Harvey 
et al., 2015, David et al., 2014). 
     
The therapeutic capabilities of Carica papaya leaves against cancer have been reported in 
traditional medicine of many different countries but limited scientific evidence has been 
found in the literature (Nguyen et al., 2013). The use of various forms of papaya extract for 
the treatment of different skin diseases has also become widespread with in vitro and in 
vivo scientific validation (Hewitt et al., 2000, Mikhal'chik et al., 2004, Nayak et al., 2007). 
Therefore, the studies presented in this thesis were devised to investigate the selective 
cytotoxic activity of different extracts from Carica papaya leaves on cancerous versus non-
cancerous epithelial cell lines, and to explore the bioactive compounds in the extracts in 
order to contribute a scientific basis for validation of the traditional use of Carica papaya 
leaf for cancer, and especially skin cancer treatment. 
 
This thesis comprises three studies using different extracts of papaya leaves. The first 
study demonstrated that the use of solvents at acidic pH value provided extracts with 
significantly selective cytotoxicity towards the human squamous cell carcinoma SCC25 
cells relative to non-cancerous human keratinocyte HaCaT cells, and that the serial 
extraction scheme showed better discrimination of cytotoxic effects in comparison to the 
parallel scheme. Comparative analysis of LC-MS profiles of serial extracts in this study 
revealed flavonoids or flavonoid glycosides as the principal compounds in the acidic 
extracts. The second study explored the differences in the effects and chemical profiles 
between papaya leaf juice and a well-known Aboriginal remedy, papaya leaf decoction. To 
the best of our knowledge, this is the first study to explore papaya leaf juice as a possible 
cytotoxic agent. The pronounced cytotoxic effects on squamous carcinoma SCC25 cells 
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and more importantly, the significant cancer-selective effect of papaya leaf juice was a 
highlight of this study. The effects imparted by the long heating process of the Aboriginal 
preparation on the cytotoxic activity were found to be significant. This part of the thesis 
also included LC-MS based-metabolomic investigation of discriminatory features (potential 
compounds responsible for the higher selective activity imparted by leaf juice in 
comparison to leaf decoction). The third study used bioassay-guided fractionation by 
preparative chromatography to explore the compounds responsible for the selective anti-
cancer propertied of papaya leaf juice. Two levels of fractionation revealed that multiple 
compounds in leaf juice might act in combination to yield the cancer-selective cytotoxic 
effects of this preparation. 
 
All investigations of cytotoxic effects of the extracts in this thesis employed the MTT (3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay; therefore, various 
parameters of this method have been optimised to obtain a robust method (Chapter 2) to 
prevent the reported under- or over-estimation of activity for the samples (Wang et al., 
2010, Vistica et al., 1991, Carmichael et al., 1987). One significant finding resulting from 
this optimisation process was the effect of organic solvents on the tested cell lines: DMSO, 
even at a concentration of 0.05%, causes significant toxicity to SCC25 and importantly a 
significantly different effect between the two cell lines. Therefore, if DMSO had been used 
with a final concentration in the medium from 0.1% to 1.0% to solubilise ethanolic extracts 
following method routinely employed in other studies (Wang et al., 2008, Kaneshiro et al., 
2005, Manosroi et al., 2006), the results obtained for selective effects of extracts would 
have been inaccurate. In addition to this finding, we also tested the potential effect of the 
mobile phase used for fractionation of papaya leaf juice on the viability of the cells as the 
trace amounts of organic solvent (or more likely the impurities therein) remaining after the 
evaporating/drying of the fractions collected in mobile phase might have an impact on the 
cells. Consequently, methanol was chosen as the organic solvent phase for all 
fractionation procedures as it did not affect either cell line whereas acetonitrile reduced the 
cell viability of both SCC25 and HaCaT cells significantly (Chapter 4). 
  
Using this thoroughly-optimised MTT assay, the effects of papaya leaf extracts on 
squamous carcinoma SCC25 cells were revealed. This part of the work made an original 
contribution to the knowledge of the activity of papaya leaves on this type of cancer cell 
lines, whereas their effects have previously been reported on the growth of other cancer 
cell types: breast, stomach, lung, pancreatic, colon, liver, ovarian, cervical, neuroblastoma, 
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lymphoma, leukaemia and other haematological cancers (Morimoto and Dang, 2008, 
Otsuki et al., 2010, Rumiyati, 2006). Moreover, the question of whether the papaya 
extracts can exert the growth inhibition selectively towards cancer cells was answered with 
the inclusion of immortal, non-cancerous human keratinocyte cells (HaCaT) to perform 
experiments in parallel with SCC25 cancer cells. The selective effect of extracts was 
evaluated as an important factor throughout the study as it represents a highly desirable 
feature of potential therapeutic agents. 
 
The aim of screening for candidate extracts with selective cytotoxic effects was achieved, 
facilitating the comparison of chemical profiles among extracts with different activities by 
LC-MS based-metabolomics to tentatively identify the bioactive compounds. The field of 
metabolomics and its application in plant research affords the systematic study of complex 
mixtures of plant extracts, and enables the link between specific phytochemicals and 
observed biological activities to be established without exhaustive isolation of active 
compounds. In Chapter 2, the comparative analysis of the chemical constituents among 
serial extracts to identify the compounds that are present exclusively or at higher 
concentrations in the acidic extracts compared to basic extracts revealed flavonoids to be 
the dominant class of database-identifiable compounds in the acidic extracts, of which 
several have previously been reported to possess anticancer activities. This result was 
supported by the elevation of total phenolic and flavonoid contents in two acidic serial 
extracts. Similarly, in Chapter 3, the multivariate analysis for LC-MS profiles of leaf juice 
and leaf decoction/brewed leaf juice was employed to study the compounds altered by the 
long heating process applied during the traditional Aboriginal remedy preparation, which 
could be linked with the better effects of papaya leaf juice. Although discriminatory 
features were shortlisted from thousands of original features, our study faced the common 
challenge in plant metabolomics of compound identification, in which database searching 
and matching based on accurate mass data alone provides numerous compound identities 
for each mass (Shyur et al., 2013). However, the efforts of direct comparison of 
chromatographic and tandem mass spectral data to available reference compounds in this 
part of the thesis constitute a leap forward in the reporting of “identities” by other studies in 
the field, where lists of masses and possible identities have been published with seemingly 
no attempt at real identification (Zunjar et al., 2014, Sirdaarta et al., 2015, Arkhipov et al., 
2014). 
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Bioassay-guided fractionation by preparative chromatography of papaya leaf juice, the 
preparation found to possess the greatest selectivity in cytotoxic effects, clearly indicated 
that selective cytotoxic effect of C. papaya leaves cannot be attributed to a single 
constituent, but indeed to a number of constituents with varying polarities acting together 
to produce the overall effect (Chapter 4). Although the experiments did not result in the 
isolation of “a single bioactive compound”, it could be explained by the complexity of 
metabolites and their diverse action in the extracts, which is the bottleneck of natural 
product discovery research (Hegeman, 2010, Shyur et al., 2013, Wolfender et al., 2015). 
 
In conclusion, although one of the desired outcomes (structural elucidation of active 
constituents responsible for the bioactivity) has not been achieved in this thesis, the data 
from the studies, taken together, indicate that Carica papaya leaves do possess selective 
cytotoxic activity on squamous carcinoma SCC25 cells. The plant should be considered to 
be a source for continuous research and development of novel skin cancer therapeutics.  
5.2 Future directions 
The findings of the present study have produced many ideas for future research, and 
continuation of the exploration of bioactive compounds in Carica papaya. 
1. The extraction procedure employed in this thesis used polar and medium-polar 
solvents. It would therefore be of interest to investigate the extracts obtained with non-
polar solvents. The choice of organic solvents should be made whilst taking into 
account their effects on the tested cells. 
 
2. Study of other parts of papaya plants, especially the edible parts in their various 
stages of ripening will be useful especially as a nutraceutical agent. 
 
3. During the fractionation process, the original activity of the parent leaf juice was not 
completely retained in the combined fractions, which suggested a loss of activity. 
Reversed-phase liquid chromatography (RPLC) with a C18 column, on which several 
polar metabolites might not be retained, was utilised for fractionation in this study, 
which may lead to the difference in the activity between the original juice and 
combined fractions. Therefore, it would be desirable to carry out a fractionation on a 
hydrophilic interaction liquid chromatography (HILIC) column, as it offers a 
complementary selectivity to a RPLC column. 
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4. The observation concerning the effects of an Aboriginal papaya preparation (brewing 
the leaves at boiling temperature) on the cytotoxic activity together with the variations 
of brewing time in the literature suggests further investigations of the effects of 
different factors such as temperature, time and water to leaf ratio on bioactivity of 
papaya leaves. Such studies would assist in optimising the extraction conditions to 
obtain a preparation with the highest selective activity.  
 
5. The leaf juice possesses significant selective cytotoxicity on squamous cell carcinoma 
cells, however, it did not cause the decrease in the viability of either colon cancer 
HCT116 cells or HT29 cells. Papaya leaf juice could be subjected to further work with 
other directly accessible cancer types, such as melanoma.  
 
6. If further efforts to identify bioactive compound(s) in papaya leaves confirm that Carica 
papaya probably belongs to category of plants with a combination of complementary 
active compounds, it would be worthwhile to standardise the whole extract, formulate 
an active preparation and conduct clinical trials to provide sufficient scientific rationale 
for its use in cancer treatment.  
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Table S1: List of 90 discriminatory metabolites in leaf juice extracts in positive ion 
mode 
Experimental 
Mass 
Retention 
time 
pq[1] [M+H]+ 
Molecular 
formula 
Error 
(ppm)* 
Number 
of hits** 
218.1270 2.772 -0.01601 219.1343 C9H18N2O4 1 10 
228.1474 4.129 -0.00849 229.1547 C11H20N2O3 0 2 
230.1638 5.089 -0.03722 231.1711 C11H23N2O3 3 4 
246.1788 15.822 -0.03722 247.1861 ND - - 
249.0869 4.864 -0.0205 250.0942 C10H19NO2S2 4 2 
269.2002 17.858 -0.03722 270.2075 C15H27NO3 4 2 
276.2100 20.128 -0.00817 277.2173 C18H28O2 3 74 
278.2253 21.766 -0.03723 279.2326 C18H30O2 2 78 
281.2001 5.315 -0.03723 282.2074 C11H28ClN5O 6 1 
292.2048 20.694 -0.03721 293.2121 C18H28O3 3 19 
292.2048 15.866 -0.03722 293.2121 C18H28O3 3 19 
292.2051 17.499 -0.03723 293.2124 C18H28O3 4 19 
294.2202 17.244 -0.03722 295.2275 C18H30O3 2 44 
306.2205 20.619 -0.03722 307.2278 C19H30O3 3 12 
317.2006 22.543 -0.03721 318.2079 C19H27NO3 4 4 
327.2419 15.810 -0.03723 328.2492 C18H33NO4 2 4 
329.2572 17.326 -0.03722 330.2645 C18H35NO4 1 1 
348.2668 19.301 -0.0254 349.2741 C22H36O3 1 7 
348.2670 25.149 -0.03722 349.2743 C22H36O3 1 7 
348.2671 20.646 -0.02536 349.2744 C22H36O3 1 7 
348.2672 24.433 -0.03723 349.2745 C22H36O3 2 7 
348.2673 25.832 -0.03723 349.2746 C22H36O3 2 7 
348.2676 31.494 -0.03722 349.2749 C22H36O3 3 7 
366.2776 23.495 -0.03722 367.2849 ND - - 
366.2778 18.859 -0.03722 367.2851 ND - - 
366.2778 23.858 -0.03722 367.2851 ND - - 
366.2779 24.957 -0.03722 367.2852 ND - - 
366.2781 21.147 -0.03722 367.2854 ND - - 
373.1388 5.509 -0.03722 374.1461 C20H24ClN3S 2 1 
381.2678 34.376 -0.03722 382.2751 C18H40NO5P 8 1 
394.0674 5.511 -0.03723 395.0747 C21H14O8 3 4 
456.1160 8.384 -0.03722 457.1233 ND - - 
458.2077 24.602 -0.03723 459.2150 C24H30N2O7 5 1 
490.3416 29.234 -0.03722 491.3489 C33H46O3 6 1 
490.3419 26.945 -0.0316 491.3492 C33H46O3 5 1 
150 
Experimental 
Mass 
Retention 
time 
pq[1] [M+H]+ 
Molecular 
formula 
Error 
(ppm)* 
Number 
of hits** 
490.3420 27.455 -0.01512 491.3493 C33H46O3 5 1 
492.3577 15.195 -0.00937 493.3650 C33H48O3 5 2 
500.3622 37.079 -0.03722 501.3695 C30H48N2O4 1 1 
500.3630 35.385 -0.03249 501.3703 C30H48N2O4 3 1 
502.3786 39.863 -0.03722 503.3859 ND - - 
503.2376 6.958 -0.03723 504.2449 
C28H40O8 
C29H36N4O4 
4 
6 
5 
1 
504.2703 21.026 -0.03722 505.2776 ND - - 
508.3524 13.774 -0.03723 509.3597 ND - - 
516.3561 32.901 -0.03722 517.3634 ND - - 
516.3570 30.175 -0.03722 517.3643 ND - - 
518.3712 26.051 -0.03723 519.3785 ND - - 
518.3721 11.908 -0.03723 519.3794 ND - - 
518.3727 33.016 -0.03723 519.3800 ND - - 
518.3727 37.749 -0.03723 519.3800 ND - - 
518.3729 32.371 -0.03723 519.3802 ND - - 
518.3740 16.559 -0.03723 519.3813 ND - - 
520.3886 15.931 -0.03722 521.3959 C35H52O3 5 1 
520.3886 17.721 -0.03723 521.3959 C35H52O3 5 1 
526.3782 38.838 -0.03722 527.3855 ND - - 
536.3835 15.649 -0.03722 537.3908 C35H52O4 5 1 
570.4043 30.793 -0.03723 571.4116 ND - - 
572.4199 33.242 -0.03722 573.4272 ND - - 
592.2686 33.257 -0.03722 593.2759 
C29H40N2O11 
C27H45O12P 
C35H36N4O5 
9 
6 
0 
1 
1 
1 
592.2687 28.522 -0.03722 593.2760 
C29H40N2O11 
C27H45O12P 
C35H36N4O5 
9 
6 
0 
1 
1 
1 
592.3726 24.854 -0.03722 593.3799 
C37H52O6 
C38H48N4O2 
6 
8 
1 
1 
614.2349 28.523 -0.03722 615.2422 C35H34N4O5 4 2 
630.3521 20.668 -0.03722 631.3594 C39H50O7 5 1 
632.3675 19.871 -0.03722 633.3748 C40H48N4O3 8 1 
648.3626 23.450 -0.03722 649.3699 ND - - 
650.2550 14.072 -0.03722 651.2623 
C39H38O9 
C32H38N6O7S 
C32H42O14 
5 
1 
3 
1 
1 
2 
151 
ND: Not determined         
*Error (ppm): the difference between experimental mass and theoretical mass of compound/theoretical mass 
of compound 
**: Hits obtained from METLIN database 
 
  
Experimental 
Mass 
Retention 
time 
pq[1] [M+H]+ 
Molecular 
formula 
Error 
(ppm)* 
Number 
of hits** 
650.3782 15.881 -0.03722 651.3855 C39H54O8 5 2 
650.3789 22.323 -0.03722 651.3862 C39H54O8 5 2 
658.4232 24.566 -0.03723 659.4305 C42H58O6 1 1 
661.4609 20.237 -0.03722 662.4682 C35H67NO8S 1 1 
663.1115 1.809 -0.03722 664.1188 C21H27N7O14P2 3 2 
665.2897 6.320 -0.03723 666.2970 ND - - 
684.4712 26.276 -0.03722 685.4785 C38H69O8P 2 12 
684.4716 29.359 -0.03722 685.4789 C38H69O8P 2 12 
684.4720 22.011 -0.03722 685.4793 C38H69O8P 1 12 
684.4721 20.107 -0.03723 685.4794 C38H69O8P 1 12 
686.4874 20.407 -0.03722 687.4947 C38H71O8P 1 16 
705.4864 20.379 -0.03722 706.4937 ND - - 
742.3362 15.253 -0.01875 743.3435 C35H50N8O6S2 9 1 
742.3363 28.221 -0.03722 743.3436 C35H50N8O6S2 9 1 
742.3365 29.984 -0.03017 743.3438 C35H50N8O6S2 9 1 
749.5133 20.510 -0.03722 750.5206 C39H76NO10P 9 10 
750.3415 35.361 -0.03723 751.3488 ND - - 
768.3525 16.556 -0.03723 769.3598 ND - - 
793.5397 20.636 -0.03722 794.5470 ND - - 
814.4696 20.636 -0.03722 815.4769 
C42H71O13P 
C42H70O15 
7 
2 
4 
1 
837.5664 20.752 -0.03722 838.5737 C47H75N5O8 5 1 
858.4956 20.749 -0.03722 859.5029 ND - - 
881.5911 20.858 -0.03723 882.5984 C52H84NO8P 2 6 
946.5479 20.960 -0.03722 947.5552 C48H82O18 2 4 
1283.724 14.106 -0.03722 1284.7313 ND - - 
152 
Table S2: List of 104 discriminatory metabolites in leaf juice extracts in negative ion 
mode 
Experimental 
Mass 
Retention 
time 
pq[1] [M-H]- 
Molecular 
formula 
Error 
(ppm)* 
Number 
of hits** 
131.0935 2.620 -0.02883 130.0862 C6H13NO2 8 15 
144.1241 2.803 -0.03378 143.1168 ND - - 
146.0587 1.919 -0.02235 145.0514 C6H10O4 5 18 
146.1048 2.210 -0.03377 145.0975 C6H14N2O2 4 7 
147.0438 1.869 -0.00772 146.0365 ND - - 
148.0245 1.777 -0.03373 147.0172 ND - - 
148.0521 3.312 -0.00719 147.0448 C9H8O2 2 9 
149.0503 2.450 -0.02330 148.043 C5H11NO2S 5 3 
165.0788 3.312 -0.02668 164.0715 C9H11NO2 1 15 
174.0956 1.965 -0.02627 173.0883 ND - - 
188.1137 2.823 -0.02098 187.1064 ND - - 
188.1148 1.999 -0.03378 187.1075 C8H16N2O3 6 9 
188.1158 2.497 -0.03486 187.1085 C8H16N2O3 6 9 
204.1048 1.958 -0.02549 203.0975 ND - - 
214.1568 10.338 -0.03377 213.1495 C12H22O3 0 15 
216.1471 3.324 -0.00857 215.1398 C10H20N2O3 1 1 
218.1237 2.765 -0.03378 217.1164 ND - - 
218.1258 2.503 -0.02262 217.1185 C9H18N2O4 3 10 
226.1204 7.518 -0.03377 225.1131 C12H18O4 0 7 
228.1362 5.377 -0.03377 227.1289 C12H20O4 0 7 
228.1364 5.961 -0.03378 227.1291 C12H20O4 1 7 
230.1632 5.339 -0.03116 229.1559 C11H22N2O3 0 4 
232.1396 2.833 -0.00761 231.1323 ND - - 
242.1255 3.195 -0.02459 241.1182 C11H18N2O4 4 3 
244.1781 7.192 -0.03377 243.1708 C12H24N2O3 2 6 
244.1789 7.683 -0.03392 243.1716 C12H24N2O3 0 6 
245.172 2.511 -0.03377 244.1647 C11H23N3O3 7 2 
248.1192 3.752 -0.03029 247.1119 C10H20N2O3S 1 2 
254.1365 2.508 -0.03377 253.1292 
C14H22O2S 
C11H18N4O3 
9 
5 
2 
5 
259.1612 2.770 -0.03378 258.1539 ND - - 
259.187 2.908 -0.03377 258.1797 C12H25N3O3 9 4 
260.1205 1.888 -0.03378 259.1132 ND - - 
262.1348 5.904 -0.03289 261.1275 
C11H22N2O3S 
C19H18O 
1 
3 
4 
1 
264.1475 7.581 -0.03424 263.1402 C14H20N2O3 0 5 
271.1781 3.942 -0.02186 270.1708 ND - - 
153 
Experimental 
Mass 
Retention 
time 
pq[1] [M-H]- 
Molecular 
formula 
Error 
(ppm)* 
Number 
of hits** 
276.0996 3.859 -0.03377 275.0923 C15H16O5 0 9 
276.111 4.481 -0.02385 275.1037 ND - - 
276.2089 20.293 -0.03377 275.2016 C18H28O2 0 74 
292.2039 21.197 -0.03377 291.1966 C18H28O3 0 19 
294.1042 1.952 -0.03377 293.0969 C10H18N2O8 7 3 
294.2195 23.059 -0.03376 293.2122 C18H30O3 0 44 
294.2197 22.286 -0.03378 293.2124 C18H30O3 0 44 
294.2197 20.056 -0.02652 293.2124 C18H30O3 0 44 
296.2351 22.181 -0.03378 295.2278 C18H32O3 0 52 
296.2354 21.682 -0.03378 295.2281 C18H32O3 0 52 
308.199 15.116 -0.03377 307.1917 C16H27F3O2 8 2 
310.2144 16.464 -0.02346 309.2071 C18H30O4 0 25 
310.2145 18.215 -0.03361 309.2072 C18H30O4 0 25 
310.2145 14.820 -0.03002 309.2072 C18H30O4 0 25 
310.2146 15.708 -0.03182 309.2073 C18H30O4 0 25 
310.2151 17.295 -0.02310 309.2078 C18H30O4 2 25 
312.2297 17.246 -0.03376 311.2224 C18H32O4 1 51 
312.23 16.175 -0.01626 311.2227 C18H32O4 0 51 
312.23 16.760 -0.01046 311.2227 C18H32O4 0 51 
312.2302 18.203 -0.03378 311.2229 C18H32O4 0 51 
312.2303 18.916 -0.03377 311.223 C18H32O4 0 51 
314.2455 18.641 -0.03377 313.2382 C18H34O4 0 43 
314.2458 17.677 -0.02581 313.2385 C18H34O4 0 43 
316.2617 20.420 -0.03377 315.2544 C18H36O4 18 43 
324.2303 20.603 -0.03377 323.223 C19H32O4 0 5 
326.2091 11.883 -0.03377 325.2018 C18H30O5 0 8 
326.2094 12.288 -0.03377 325.2021 C18H30O5 0 8 
338.2091 16.609 -0.03376 337.2018 
C20H28F2O2 
C19H30O5 
C20H26N4O 
9 
0 
4 
1 
7 
1 
340.2251 14.966 -0.03377 339.2178 C19H32O5 0 2 
342.2397 13.928 -0.03378 341.2324 C19H34O5 2 4 
342.2403 16.940 -0.03377 341.233 C19H34O5 0 4 
354.2405 16.938 -0.03377 353.2332 
C20H34O5 
C21H32F2O2 
0 
9 
99 
1 
366.2769 20.580 -0.02553 365.2696 ND - - 
366.2771 19.219 -0.01114 365.2698 ND - - 
392.1114 3.857 -0.03377 391.1041 C19H20O9 1 4 
420.2509 17.570 -0.02156 419.2436 C24H36O6 0 2 
154 
Experimental 
Mass 
Retention 
time 
pq[1] [M-H]- 
Molecular 
formula 
Error 
(ppm)* 
Number 
of hits** 
422.2675 21.278 -0.02330 421.2602 C24H38O6 1 11 
424.2823 23.071 -0.03376 423.275 C24H40O6 0 46 
426.2982 11.676 -0.03377 425.2909 C20H38N6O4 6 1 
428.2049 5.985 -0.03377 427.1976 C21H32O9 0 1 
428.2051 7.697 -0.03377 427.1978 C21H32O9 1 1 
428.2053 6.511 -0.03377 427.198 C21H32O9 1 1 
456.2583 6.699 -0.03377 455.251 C24H40O6S 8 3 
456.2723 10.374 -0.03377 455.265 ND - - 
492.3565 15.158 -0.03593 491.3492 C33H48O3 7 2 
492.3569 15.772 -0.03377 491.3496 C33H48O3 6 2 
494.3716 16.218 -0.03566 493.3643 ND - - 
506.1789 3.426 -0.03377 505.1716 C25H30O11 0 2 
506.1792 3.937 -0.03377 505.1719 C25H30O11 0 2 
515.2961 5.874 -0.03377 514.2888 C26H45NO7S 8 9 
518.3717 16.511 -0.03377 517.3644 ND - - 
520.3869 17.704 -0.03377 519.3796 C35H52O3 9 1 
560.0625 1.760 -0.02494 559.0552 ND - - 
560.116 1.544 -0.00968 559.1087 C26H24O14 1 2 
590.127 1.532 -0.01742 589.1197 
C34H22O10 
C26H24O15 
9 
0 
1 
1 
601.1219 1.615 -0.03108 600.1146 ND - - 
608.136 1.527 -0.02893 607.1287 C27H28O16 2 8 
612.2995 14.870 -0.03377 611.2922 C33H44N2O9 8 1 
646.3587 21.936 -0.03375 645.3514 C32H54O13 3 2 
648.3625 15.873 -0.03376 647.3552 ND - - 
650.3775 15.846 -0.03377 649.3702 C39H54O8 6 2 
650.378 14.101 -0.03377 649.3707 C39H54O8 5 2 
666.373 16.823 -0.03376 665.3657 ND - - 
668.3877 16.132 -0.03376 667.3804 ND - - 
668.3885 16.495 -0.03376 667.3812 ND - - 
686.4853 20.204 -0.03376 685.478 C38H71O8P 4 16 
710.0546 1.738 -0.03377 709.0473 ND - - 
710.1158 1.660 -0.00807 709.1085 ND - - 
712.2212 5.498 -0.03377 711.2139 C32H40O18 0 3 
ND: Not determined         
*Error (ppm): the difference between experimental mass and theoretical mass of compound/theoretical mass 
of compound 
**: Hits obtained from METLIN database 
